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For any trait of interest to the geneticist, such as disease phenotypes and 
economically important agricultural phenotypes, there are differences in the 
measurements taken for any set of individuals randomly chosen from the population. 
These differences or variation may be attributed to two sources, the environment of 
the individuals and their genes. There is particular interest to estimate the 
contribution of the genes to the observed variation in measured phenotypes because 
such values influence actions aimed at human disease management and improving 
agricultural yield. For instance, a large genetic contribution to a phenotype of interest 
will mean efforts should be made to identify genes involved and that further efforts 
should be made to know the mechanisms by which these genes influence the 
phenotype. But in instances where a low genetic contribution to phenotypic variation 
is estimated, it will be prudent to look into the environment of the individuals for 
answers. There is therefore the need to develop effective ways of estimating the 
genetic contribution to the observed phenotype differences because the values 
inform important decisions in genetics research. Biased or inaccurate estimates will 
undermine efforts aimed at disentangling the genetic underpinning of phenotypic 
variation and consequently disease management or improvement of agricultural 
yield. This thesis examines the performance of some of the existing statistical 
methods used and develops novel statistical methods to highlight how violations of 
model assumptions impact the estimates of genetic contribution to the phenotypic 
variation. It was found that the inappropriate use of methods affects the estimates 
obtained and that there are benefits in using methods which capture important 











One aspect of the effort to disentangle the genetic component of complex traits is 
the mapping of genetic loci that are associated with variations in complex traits. The 
model used to assess these genetic associations is vital because any inaccurate or 
biased estimate obtained will undermine the effort to unravel the genetic 
component of complex traits. This project, therefore, explores in detail the 
performance of existing analytical methods and develops novel statistical methods 
to bring to the fore how violations of the model assumptions impact model 
estimates. Using a linear mixed effects model, a genome-wide association analysis of 
eight urine phenotypes was performed on 2,934 individuals, where it was shown that 
violations of the model assumption of normality of residuals impact heritability 
estimates and subsequent genetic associations. The issue of normality was explored 
further in a simulation study that used a Bayesian mixture model that assumed that 
the effect SNPs of complex traits are drawn from a mixture of four normal 
distributions instead of one. The Bayesian mixture model was applied to the urine 
phenotypes and it was shown that the effect SNPs are constituted from more than 
one normal distribution and over 99% of genotyped SNPs were sampled to have no 
effect on the urine traits. The urine traits were also shown to have a polygenic 
architecture with much of the additive genetic variance being explained by SNPs with 
small to moderate effects. Departing from SNP based approaches, I present a novel 
analytical approach that utilises a relationship matrix that is based on natural 
haplotype blocks defined by recombination boundaries in the genome. This method 
was developed on the premise that haplotypes provide a better strategy for 
capturing the true genomic relationship amongst individuals in the presence of rare 
variants and thus provide real benefit over SNPs in recovering much of the hidden 
heritability of complex traits and in the identification of novel gene variants. The 
method was implemented on simulated data and was explored in detail. The results 
from the simulation showed that the haplotype approach complemented existing 
GWAS analytical approaches by capturing regions in the genome contributing to the 
phenotypic variation that existing GWAS methods fail to capture. It was further 
demonstrated that there are real benefits to be gained from this approach by 
applying it to real data from circa 20,000 individuals from the Generation Scotland: 
Scottish Family Health Study. Height and major depressive disorder were analysed, 
and novel genomic regions were identified for both traits. In conclusion, this thesis 
shows that inappropriate use of analytical models can impact results which may have 
consequences on conclusions we draw from genetic association studies. Also, the 
thesis shows the benefits of implementing models that capture important features 
of the underlying architecture driving the variation in complex traits. Lastly, the thesis 
also demonstrates that haplotype methods can complement conventional SNP-
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The prospects of the Human Genome Project (HGP) (Lander et al., 2001) were 
exciting in many respects. Perhaps, the single most exciting amongst them was being 
able to deliver health benefits from DNA sequence information, by providing 
explanations to the genetic basis of medically relevant phenotypes (Collins et al., 
2003).  
To deliver this promise, investigators began exploring the human genome 
through linkage disequilibrium mapping which revealed patterns in the distribution 
of DNA sequence variants (Gibbs et al., 2003). This essentially led to the cataloguing 
of the most common source of variation in the genome, Single Nucleotide 
Polymorphisms (SNPs), to try and unlock the genetic basis of observed traits 
variation. Nearly two decades now after the completion of the HGP and with 
development of high throughput genotyping technologies that genotype these SNPs, 
numerous studies designed to find disease risk SNPs across the whole genome have 
tried to explain the causes of and responses to common chronic diseases (that affect 
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a large proportion of the population) by estimating their association to these SNPs 
(Burton et al., 2007; McCarthy et al., 2008). 
These whole-genome studies have tremendously improved our 
understanding of the genetic component of the phenotypic variation, although much 
of the genetic variation in most traits remains to be characterized and explained. It 
should be noted also that these genetic association studies as we know them today 
are a culmination of ground-breaking work spanning three centuries back to the 19th 
Century. Right from the days of Darwin, the study of trait inheritance – later known 
as genetics – has progressed steadily to the 21st-century science we know today and 
with it the development of our understanding of the genetic basis of observed traits, 
more importantly, diseases.     
 Our evolving understanding of the genetics of traits; from Darwin 
to genome-wide association studies (GWAS)  
Ultimately, Mendel’s work was crucial to the general acceptance of Darwin’s 
theory of evolution by natural selection. Although this was not immediately obvious 
when Mendel was rediscovered in the early 20th century (Hill, 1984). Mendel had 
discovered that traits are inherited in a particulate or discrete manner (Moore, 2001). 
This upon rediscovery, rather naively offered a disparate view from Darwin’s view of 
blending inheritance of traits (Moore, 2001), in which progeny are seen as 
intermediate between parents (Darwin, 1859). Trait variation, as observed by Darwin 
and argued by the biometricians (Hill, 1984), was a continuous progression that 
blended into each other gradually in an unbroken manner which makes it almost 
impossible to pinpoint where one becomes the next. This was a clear departure from 
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the apparently large and discrete variation in traits as put forward by Mendel. This 
sparked a debate about the basis of inherited traits. 
The continuous versus discrete debate and how they explain evolution by 
natural selection dominated trait inheritance discourse in the very early days of the 
field until laboratory experiments on artificial selection offered some resolution (Hill, 
1984). Notable were Morgan’s experiments on the patterns of inheritance of 
characters in Drosophila (Morgan and Bridges, 1916) which showed that there was a 
link between Mendel’s discrete inheritance and Darwin’s gradualist and continuous 
inheritance. Morgan and his colleagues showed that the aggregate effect of many 
different loci behaving in a discrete Mendelian manner could produce the gradual 
and continuous distribution of traits as observed by Darwin to explain evolution 
(Kennedy, 2001). This effectively put to bed a hotly contested debate and allowed 
focus perhaps to be shifted onto the mathematical quantification of the trait 
variation.  
Ronald Fisher, in his paper presented to the Royal Society of Edinburgh, 
showed that the observed variation in a trait and correlation between relatives could 
be used to partition the observed variation (phenotype) into the unobserved genetic 
(genotype) and environment components (Fisher, 1918). He further partitioned the 
genetic component of trait variation into the additive, dominant and epistatic 
components. And it was Fisher who originally proposed a way to directly estimate 
the contribution of genes to the variation observed in traits, which became known as 
the heritability.  
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Fisher’s works together with works such as the estimation of inbreeding 
effects by Wright and further work by Haldane offered a lasting theoretical resolution 
to the initial debate and helped set the stage for the mathematically intensive field 
of quantitative genetics in the 1930s (Hill, 1984). Wright defined the inbreeding 
coefficient f – the correlation between gametes produced by the two parents. This 
was later estimated as the probability that two alleles at any locus in an individual 
are Identical by Descent (IBD) from the common ancestor of the two parents (Hill, 
1984), thus making the concept of inbreeding useful in the estimation of 
relationships between individuals and essentially the estimation of the genetic 
variance (Powell et al., 2010). 
With the phenotypic variation mathematically defined, research focus shifted 
to using genetic markers to quantify the genetic component of the variation or 
heritability. Understanding the genetic variation, both in humans and in other 
organisms, presents huge medical and agricultural benefits and may also offer some 
useful explanations of the evolutionary process. For instance, in humans, heritability 
estimates showed that fitness-related traits like fertility had low estimates whilst 
traits like height had very high estimates, offering a view of how selection acts on 
alleles with respect to their role in fitness.  
Initial studies on heritability estimation were done by regressing offspring 
trait values against the average trait values of parents (Falconer, 1960). Later studies 
that incorporated molecular information were largely made possible by the 
introduction of the technique of protein electrophoresis into population genetics 
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(Harris and Hopkinson, 1976). Consequently, variations at the protein level were 
assayed for in several organisms.  
The advent of DNA based techniques offered researchers the opportunity to 
look directly into the genetic material to measure genetic variation. Restriction 
Fragment Length Polymorphisms (Botstein et al., 1980) and Southern blotting 
techniques (Southern, 1975) were among the first DNA based techniques developed. 
Later the polymerase chain reaction (PCR) (Mullis et al., 1986) was developed and 
with it an array of techniques which enabled large-scale analysis of genetic variation 
through microsatellite markers.  
Then came along genomics and its hopes of offering an all-encompassing 
approach to study genetic inheritance which would provide biologists with the 
opportunity to study traits (mostly diseases) in organisms to an extent not previously 
thought possible. The successes of the human genome project (Lander et al., 2001), 
made this genomics era a reality (Collins et al., 2003).  
Eventually, the International HapMap Consortium, in 2003, employing an 
approach which had become widely used to study genetic variation, fully sequenced 
subsamples of different human populations to identify set of polymorphisms such as 
Copy Number Variations (CNVs) and SNPs (Gibbs et al., 2003). The most common 
form of variation identified by the consortium were SNPs (Gibbs et al., 2003; Frazer 
et al., 2007) and thus SNP information was used to develop genotyping arrays which 
would be used in studies to genotype these SNPs in much larger human samples 
(Burton et al., 2007; Frazer et al., 2007). Association testing of genotyped SNPs with 
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phenotypic variation would become known as a Genome-Wide Association Study 
(GWAS) (Burton et al., 2007; McCarthy et al., 2008). There have since been more than 
3,000 GWAS published with more than 59,000 unique SNP – trait associations 
reported (MacArthur et al., 2017). 
 The genetic traits 
All traits of interest to the geneticist fall under two broad categories. These 
are Mendelian traits and complex traits.  Mendelian traits or disorders are 
monogenic which means that a single gene is sufficient to cause phenotype. They 
segregate in families, but can also be sporadic, e.g. new mutations arising de novo in 
singletons. They can occur in several modes which are grouped according to whether 
they are dominant or recessive, and autosomal or sex-linked (Chial, 2008). Conditions 
such as haemophilia, cystic fibrosis, sickle-cell anaemia, and polycystic kidney disease 
are examples of Mendelian disorders.  
Mendelian disorders are usually individually rare (Antonarakis and 
Beckmann, 2006) and the variants that cause them are highly penetrant (Bodmer and 
Bonilla, 2008), which means a greater number of carriers of the disease-causing 
alleles develop the associated disease conditions. These alleles are usually kept at 
very low frequencies in populations by selection because of their large and 
deleterious effect on fitness (Bodmer and Bonilla, 2008). The range and frequencies 
of alleles controlling these Mendelian disorders differ among populations 
(Björkegren et al., 2015).   
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Multiple genetic and environmental factors affect most common diseases like 
diabetes, hypertension, coronary artery disease, chronic kidney disease and 
biometric traits like height, weight, and body mass index. And as a result, these traits 
are termed complex traits. The genetic variants that confer risk of development of 
these traits are many and may individually explain only a small fraction of the genetic 
variation (Burton et al., 2007). These variants have low to moderate penetrance 
(Bodmer and Bonilla, 2008) and could be highly influenced by the environment 
(Burton et al., 2007). 
 The variation in traits 
For any trait, like height, for example, there are differences in the 
measurements taken for any set of individuals sampled from a population. These 
differences in the trait values may be the results of two main influences. Influences 
attributed to the genes of the individuals and influences collectively attributed to the 
environment of the individuals. 
The genetic contribution to the differences in the trait can be ascribed 
primarily to the randomness that is introduced by Mendelian segregation during 
gamete formation and to random mating and random fertilisation. These create 
differences in the measured trait values based on what set of alleles an individual 
inherited because different alleles may affect a trait differently. The alleles can also 
introduce systematic differences by virtue of an individual being a male or female: 
for instance, for height, on average, males will be taller than females in the 
population.  
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The environmental factors that generate differences in the observed trait 
values are numerous. For starters, the process of trait measurement itself can 
generate differences. That is, the measuring instrument may lack finer graduations 
and thus introduce rounding errors in the measured trait values. Different people 
taking repeated measurements of the trait may generate differences. Other factors 
influencing the life history of sampled individuals such as access to essential nutrition 
(in our example trait, height, lack of essential nutrients can result in stunting) or 
individual’s lifestyle such as whether an individual drinks or smokes (this influences 
measures of cardiovascular traits), may generate differences in measured trait 
values.  
So, for every individual sampled in the population, the measured trait value 
will deviate from an expected value or population mean by some value attributable 
to the factors described above and others. This deviation is termed the error – where 
error here does not necessarily refer to some mistake made but rather to the 
difference between an observed trait value and the expected value.  
Statistically, if we start from the premise that the study individuals are 
randomly sampled from the study population then we can assume that the observed 
deviations around the expected value (i.e. the errors) are random numbers coming 
from some statistical distribution. We can, therefore, model a vector of trait values, 
, with length  linearly as 
 =  +                                                            (1.1) 
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where  is a  × 1 vector of   model parameters,  is an  ×   matrix called the 
design matrix and it contains columns that assign the observed trait values to 
elements in the parameter vector . The expected trait value given the model, i.e. 
the expectation of ,  = , and   is a vector of errors.  
The standard linear model used in genetics studies assumes that the errors 
(deviations) are sampled from a normal distribution. Thus, two parameters are of 
importance. The first parameter is the mean around which the observed trait values 
cluster. The second is a parameter that describes the dispersion of the observed 
values around this mean. In describing this dispersion parameter for say height, it is 
intuitive to see that individuals shorter than expected will deviate negatively from 
the mean whiles those taller than expected will have a positive deviation. Summing 
the positive and negative deviations may cancel out when calculating the average 
deviation from expectation for a sample of individuals. Therefore, the average of the 
square of these individual deviations from the expectation is calculated instead. This 
is the variance of the trait or trait variation. And given the linear model (equation 
1.1), the vector of traits  is assumed to be normally distributed ~!(, "#$%), " is 
an  ×  identity matrix and #$% is the variance of the errors (trait variance). 
The trait variance is of primary interest to geneticists and animal breeders 
and it is to be estimated. Most importantly, we like to quantify how much of this 
variance is due to the environment and how much is down to the genetics of study 
individuals. If a trait is under sufficient genetic control (i.e. much of the trait variation 
is explained by variation in genes) then it will be prudent to implement policies and 
interventions that target the genes. If on the other hand much or all the variation is 
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due to the environment, then interventions that target the environment could be 
implemented. 
 The genetic component of the trait variation 
The trait variation, as already mentioned, can have a genetic component and 
a part that is attributed to the environment. The genetic component of the variation 
could be further dissected into three parts, the additive component – which is the 
aggregate sum of the effects of all gene variants that directly affect a trait, the 
dominant component – which is the effect of the interaction between the alleles of 
a gene at a given gene locus, and the epistatic component – which is the effect of the 
interaction between different gene variants at different gene loci.  
Heritability is the term used to describe the genetic component of the trait 
variation. It can be defined in the broad sense which will encompass contributions 
from all the three components of the genetic variation. It can also be defined in the 
narrow sense which includes a contribution from only the additive genetic 
component.  
Genetically, there are two categories of traits, Mendelian and complex traits, 
and these two categories have very different genetic architectures which make the 
approaches to studying and estimating their heritability also different.  
1.4.1 The study of Mendelian traits 
The heritability of Mendelian traits has traditionally been estimated using 
pedigree-based studies of families with individuals affected by these conditions 
(Chial, 2008). The study of the inheritance process of Mendelian traits provides useful 
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insights into the genetic mechanism underlying all forms of genetic diseases 
(Antonarakis and Beckmann, 2006).  
The successes of familial and linkage studies in helping to understand rare 
Mendelian variants inspired the studies of complex traits and thus have been argued 
to be given more prominence in genetic studies (Antonarakis and Beckmann, 2006). 
But in a world of limited resources and funds, studying complex traits is rather more 
appealing. This is because such traits affect so much of the population and thus offer 
a far greater benefit in terms of the reach of research output and commercial gains, 
and thus there is a bigger focus on the study of complex traits currently. The field 
receives more funding from research councils and pharmaceutical companies.  
1.4.2 The study of complex traits 
Twins were used initially to estimate the genetic variation or heritability of 
complex traits in humans. The twin methods were grounded on the assumption that 
twins share the same environment (Kendler et al., 1993), such as the same prenatal 
environment and the same home environment. Thus, identical (monozygotic) and 
fraternal (dizygotic) twins should be equally correlated to the environmental factors 
that influence the trait of interest. Therefore, if there is excess similarity observed in 
monozygotic twins over dizygotic twins for a trait under study, then the trait is 
affected by genetic factors. The genetic contribution to the trait variation can then 
be estimated because monozygotic twins completely share their genetic information 
while dizygotic twin share just half of it on average and thus will have half of the twin 
pair correlation of monozygotic twins.  
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The twin approach gave high estimates of the heritability and was fairly easy 
to obtain. But their heritability estimates were in effect the broad sense heritability 
and thus couldn’t distinguish the additive genetic component and ultimately couldn’t 
identify gene variants. Also, this approach couldn’t adequately account for the effect 
of shared family environments which some argue might have inflated the heritability 
estimates obtained (Yang et al., 2010).  
The heritability estimates obtained by the twin approach for all human traits, 
therefore, are higher bound estimates. These estimates have subsequently been 
shown to be higher than what could be explained by genetic markers like SNPs 
currently used in GWAS to estimate heritability (Clarke and Cooper, 2010; Maher, 
2008; Manolio et al., 2009). SNP based estimates of heritability are mostly in the 
narrow-sense (Yang et al., 2010) depending on the family structure in the data and 
on whether the effects of siblings, for example, are accounted for (Xia et al., 2016).  
The successful completion of the International HapMap Consortium project 
(Frazer et al., 2007) marked the end of twin studies and spurred the development of 
studies that targeted the population as a whole (Burton et al., 2007; McCarthy et al., 
2008).  
Initially, these studies utilized genotyping arrays developed from the more 
common SNPs among those discovered by the HapMap Consortium to genotype 
larger population samples. Recent studies utilize very dense genotyping arrays that 
incorporate rare SNPs. Those SNPs that appear on genotype arrays have been chosen 
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such that they are distributed as evenly as possible across the entire chromosomes 
of individuals (Burton et al., 2007).  
These genotyped SNPs are rarely causal in terms of the traits being analysed 
but are located close to the causal variants that may directly affect these traits. 
Because variants that are close to each other on chromosome segments typically do 
segregate together more often than would happen due to chance (Reich et al., 2001), 
they show some correlation (Barrett, 2011). This non-random correlation is termed 
linkage disequilibrium (LD) and correlated SNPs are said to be in LD.  
LD is the driving force behind genetic association studies using SNPs, since, 
for every variant that directly affects a trait, there might be genotyped SNPs nearby 
that are in LD with it, thus allowing genotyped SNPs to be associated with traits under 
study. The genetic association studies that exploit the LD between genotyped SNPs 
and ungenotyped possible causal variants are termed Genome-wide Association 
Studies (GWAS) because genotyped SNPs are selected to span the entire genome of 
individuals.      
 The genome-wide association study of complex traits   
For a set of study individuals, the association between a trait of interest and 
variants at genomic loci is determined by regressing a vector of measured trait values 
on allele counts of SNPs genotyped for those individuals. The genotyped SNPs serve 
as proxies for all genomic loci. The genotyped SNPs are represented as a matrix of 
numerical codes taking the values of 0, 1 or 2 for each locus for each study individual. 
For each locus, there will be one of three possible genotypes derived from two 
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alleles. Each locus has a major and minor allele depending on their respective 
frequencies in the study population. The genotype codes used in GWAS are 
commonly derived as counts of the number of minor alleles at each locus. And once 
this is done, the minor alleles are termed as the effect alleles and their effects are 
estimated. This coding convention is commonly used because it makes evolutionary 
sense to assume that the allele with the smallest frequency arose recently by 
mutation and thus will have a differential effect on the trait. The major allele at the 
locus is then called the reference allele. 
Three types of genetic models can be fitted for a GWA analysis. The most 
commonly used model is the additive genetic model which takes genotype coding 0, 
1, and 2 for counts of the effect allele in the genotype. The second model is the 
dominant genetic model in which genotypes are coded as 0, 2, and 2 for the genotype 
with no effect allele, the genotype with one effect allele and the genotype with two 
effect alleles respectively. The third model is the recessive genetic model with 
genotype coding 0, 0, and 2 for the genotype with no effect allele, the genotype with 
one effect allele and the genotype with two effect alleles respectively. The dominant 
and recessive models are less used in GWA analysis.  
The GWA analysis model fits the effect of each locus as fixed and regresses 
the vector of trait values on each locus one at a time starting from the first locus on 
chromosome one to the last locus on chromosome 22. Thus, a typical GWA analysis 
involves hundreds of thousands of regressions testing hundreds of thousands of 
genomic loci. The evidence of association between a trait and a genomic locus is 
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evaluated by p-values calculated for the null hypothesis of no association (Stephens 
and Balding, 2009).  
The multiple testing of numerous loci presents a statistical problem of 
potentially having a lot of false positive associations for GWA analysis. This problem 
is dealt with by setting stringent thresholds for loci association p-values to pass 
before a locus is accepted as being genome-wide significantly (GWS) associated with 
a trait. This threshold has been calculated for European populations to be a p-value 
< 1 × 10&' (Pe’er et al., 2008). However, a p-value < 5 × 10&( is widely used now. 
The first wave of GWA studies followed a case-control study design (Burton 
et al., 2007; McCarthy et al., 2008). These studies targeted binary traits which are 
defined by study participants answering yes or no to certain questions or having a 
status of disease or no disease. Then there was a shift towards population-based 
cohort studies that targeted continuous traits. These studies have been successful in 
improving our understanding of the genetic architecture of complex traits by making 
it possible to associate genomic regions to certain traits that affect populations 
(Visscher et al., 2012). And to some extent, the role the environment plays in these 
associations may also be shown for example in GWA studies that model gene-
environment interactions (Thomas, 2010).  
GWA studies, however, traditionally suffer potential drawbacks, some of 
which have been addressed. For instance, in GWA studies, it is commonplace for the 
study participants to be population stratified – individuals may not all come from the 
same ancestral or genetic population. Because of this, for some of the study 
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individuals, their allele frequencies for some of the genotyped SNPs will be different 
from the rest of the study population. Consequently, if the issue of population 
stratification is not adequately dealt with it may generate spurious associations in 
GWAS (Price et al., 2006). Because those stratified loci may be correlated with the 
trait, investigators may wrongly infer genetic association, whereas the association is, 
in fact, a result of individuals having different ancestral populations. Methods exist 
to detect and adjust for population stratification, so it is no longer a major issue.  
But some inherent limitations still prevail in GWA studies. Among them is the 
issue of common SNPs on arrays only having modest effects sizes and explaining only 
a fraction of the genetic variation of the traits (Burton et al., 2007). There is also an 
issue of low power associated with GWA studies (Pe’er et al., 2006). The power of a 
GWA study is shown to be a function of the number of individuals sampled, the effect 
size of the genetic variants and the frequency of the alleles of the variants (Seng and 
Seng, 2008). The last two are mostly unknown until after the genetic variants have 
been uncovered and so the sample size remains the major controllable factor to 
improve power – the larger the sample size, the better the power (Burton et al., 2007; 
Sham and Purcell, 2014). Also, the extent of coverage of the genotyped SNPs affect 
power and so increasing the genome coverage of the SNPs (increasing the marker 
density) also improves power (Burton et al., 2007). 
Although current GWA studies have a markedly improved power in terms of 
increased sample size and marker density (Gudbjartsson et al., 2015; Sudlow et al., 
2015), they remain vulnerable to a range of errors and biases (McCarthy et al., 2008). 
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And some of these vulnerabilities contribute to the problem of the GWAS estimates 
of the genetic variation not fully accounting for heritability (Manolio et al., 2009). 
 Some of the heritability is “missing” 
The science of explaining the genetic basis of trait variation, by the turn of the 
21st century, had come to a point where we could for the first time, literally look into 
the human genome (the full DNA complement of an individual) to find the genetic 
component of common traits and diseases. By implementing analytical methods like 
the GWA analysis, researchers could map genomic loci that affect traits of interest 
and estimate the heritability of traits using loci that are genome-wide significant. But 
curiously, the heritability was not to be seen, it was apparently ‘missing’ (Maher, 
2008). The heritability explained by genome-wide significant loci did not add up to 
that estimated from family studies. For instance, for a highly heritable trait like height 
which has heritability estimate of 80% from pedigree studies, the SNP heritability 
from genome-wide (GW) significant SNPs was less than 10% (Maher, 2008).  
Finding the ‘missing heritability’ then became a priority in the field and 
stimulated a lot of discussion amongst population geneticists, human geneticists, 
animal geneticists and evolutionary biologists alike. Many investigators have since 
argued extensively as to where they think the problem of the missing heritability 
arises from and some propose how they think it could be resolved (Manolio et al., 
2009).  
The many possible ways that were proposed to potentially account for the 
missing heritability include, looking at copy-number variations (CNVs) (McCarroll, 
2008); investigating the effects of non-additive effects such as epistatic interactions 
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amongst genes (Hemani et al., 2013); and also looking beyond sequence variation to 
look at the effect of epigenetic inheritance (Slatkin, 2009). Others reasoned that 
GWA studies which could capture rare gene variants with larger effects (Cirulli and 
Goldstein, 2010) and common gene variants with very small effects (Yang et al., 2010) 
could account for some of the missing heritability. Others suggested that adequately 
accounting for effects of close relatives by excluding one of each pair of relatives from 
analysis would provide more meaningful estimates of heritability explained by 
variants assayed (Yang et al., 2010), while others shared a different opinion and 
suggested models to adequately account for closely related individuals by including 
two different relationship matrices (one that accounts for all relationships and one 
that accounts for close relationships) in heritability calculations (Zaitlen et al., 2013). 
There is also the belief that perhaps we may be chasing ‘phantom’ heritabilities 
instead of ‘missing’ heritabilities because estimates of the total heritabilities could 
have been inflated by genetic interactions (Zuk et al., 2012). 
 The ensuing race to find the missing heritability led to the adoption of 
approaches that already existed and had been developed in animal breeding studies 
to try and predict the genetic values of individuals in breeding programs using 
genome-wide markers (Meuwissen et al., 2001; VanRaden, 2008). These techniques 
employ maximum likelihood approaches which fit Genetic Relationship Matrices 
(GRMs) in the estimation of the heritability from genome-wide SNPs. The technique 
was called Genomic-relatedness-matrix Restricted Maximum Likelihood (GREML) 
(Benjamin et al., 2012).  
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A study that used this GREML approach to study height found that all 
genome-wide SNPs, as opposed to GWS SNPs, explained more than 50% of the 
genetic variation in human height (Yang et al., 2010). This was a significant step in 
the search for the missing heritability. The success of this study led to the 
development of a tool, Genome-wide Complex Trait Analysis (GCTA) (Yang et al., 
2011), that has since been used widely in complex traits heritability studies. Other 
tools that use the same approach have since been developed (Canela-Xandri et al., 
2015). One such tool called Regional Heritability Advanced Complex Trait Analysis 
(REACTA) (Cebamanos et al., 2014) quantifies the local contribution of genomic 
regions to the total genetic variation of complex traits.  
These GREML approaches generate lower-bound estimates of the narrow 
sense heritability as opposed to the estimates generated in twin studies (Benjamin 
et al., 2012). These GREML approaches have improved heritability estimates, but 
usually, do not model other structural variants like copy number variants and also 
cannot account for the non-additive components of the genetic variation. The latter 
may not be a big issue because the non-additive variation such as the dominance 
genetic variation has been shown to account for a very small proportion of the 
genetic variation of complex traits in humans (Zhu et al., 2015).   
In the GREML approach, a Genomic Relationship Matrix (GRM) or kinship 
matrix is fitted to estimate the heritability. The relationship coefficients in these 
matrices are directly estimated from SNP genotype data. These relationship 
coefficients are normalised by per loci standard deviation which gives more weight 
to rare SNPs (Yang et al., 2010). A study that looked at these GRMs suggested 
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additional adjustment for local LD among SNPs (Speed et al., 2012). The argument 
was that some causal variants may be over-tagged (over-represented) by the 
genotyped variants due to their LD with them and thus may result in biased estimates 
of the additive genetic variation. But these LD adjustments have been argued not to 
work well in denser SNP arrays (Lee et al., 2013). There were also suggestions to 
employ different weights based on the minor allele frequency (MAF) of SNPs in the 
calculation of the GRM (Speed and Balding, 2015). These arguments led to an 
extension to the GREML model that clustered SNPs according to their MAF and 
regional LD (Yang et al., 2015).   
Interestingly, amidst these arguments and counter-arguments, investigators 
have collectively not lost sight of the fact that full DNA resequencing of all samples 
remains the only way of knowing the full contribution of the genetic variation to the 
phenotypic variation (Bodmer and Bonilla, 2008; Cirulli and Goldstein, 2010; Manolio 
et al., 2009; Wray et al., 2013). Even with that, the contribution of some variants can 
be difficult to estimate individually because their individual effects are small and thus 
will need to be analysed collectively within a region. 
1.6.1 Beyond the missing heritability and the rewards of trait prediction 
Quantifying the genetic component of trait variation and the subsequent 
mapping of associated genetic loci is the primary aim of the genetic study of complex 
traits. However, this aim can be extended to trying to predict the unobserved 
phenotypes of a set of individuals based on the phenotypes observed for another set 
of individuals (Wray et al., 2013).  
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Trait prediction is useful in offering assistance in human genetic counselling 
and disease management. The heritability estimate of a trait conveys useful 
information like the extent to which the trait is under the control of genes. This 
information would influence actions aimed at reducing the prevalence of a disease. 
For instance, whether efforts should be made to identify genes involved and make 
further efforts to know the mechanisms by which these genes influence disease 
susceptibility or perhaps just look at environmental contributions for answers. 
Mapping disease risk gene loci can be used in diagnosis to predict the chances of an 
individual carrying risk alleles developing the disease in the future.   
In agriculture, trait prediction is useful for predicting progeny performance in 
plant and animal breeding.  The heritability estimate of traits helps breeders to make 
informed guesses about the outcome of breeding experiments. For instance, what to 
expect if only individuals with a trait value greater than a certain threshold are 
allowed to breed. This provides significant economic gains.  
 Other genetic markers (haplotypes) 
In diploid organisms, there are two alternative SNP alleles at any given genomic 
locus. These two alternative alleles form the genotype at that locus. A set of linked 
SNP alleles on the same chromosome is called a haplotype.  
Haplotypes are formed within haplotype blocks on a chromosome. The 
haplotype blocks arise due to recombination on chromosomes and thus these blocks 
are bounded by recombination hotspots (Daly et al., 2001). Within a haplotype block, 
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there is little, or no recombination occurring (Frazer et al., 2007). Therefore, the SNPs 
within a haplotype block tend to be inherited together.  
The SNP alleles within a haplotype block combine differently for individuals in 
the population to generate several haplotype patterns. For a haplotype block 
containing two SNPs, then there can be four possible combinations of the alleles to 
generate four haplotypes. For a diploid individual, there can be nine possible 
haplotype pairs at this two-SNP haplotype block. Any pair of haplotypes is called a 
diplotype.  
These diplotypes can be used analogously to genotypes to map genomic loci 
associated with traits of interest. In a GREML setting, diplotypes can be used to 
calculate relationship-values between individuals which can be used to estimate the 
genetic variance. 
 Aims of this study 
One thing which is becoming increasingly clear from all the GWA studies and 
the missing heritability debates is that the way genetic associations are assessed by 
investigators is critical and has a huge role to play in the estimation of genetic 
variation. Naive estimations of these genetic associations may lead to erroneous 
results, which in effect would impact on our ability to unravel the genetic 
underpinning of complex traits. This study, therefore, aims to critically explore the 
statistical models used in determining genetic association and more importantly, 
highlight how violations of the model assumptions impact model estimates. The 
study also aims to develop analytical methods that incorporate other genetic variants 
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such as haplotypes and test these models on simulated datasets and human 
population data collected by ourselves and our collaborators.   
This project uses large human datasets containing dense SNP genotypes and 
phased data along with phenotypic records to investigate how genetic information 
should be used to quantify the genetic component of variation and to determine 
causative genetic variants and how they contribute to the phenotype variation.  
The thesis contains five data chapters that seek to address the aims of this 
study. Chapter two introduces the basic model used in heritability estimation and 
association analysis using packages in R and specialized genetic software such as 
PLINK (Purcell et al., 2007), GCTA (Yang et al., 2011), REACTA (Cebamanos et al., 
2014) and DISSECT (Canela-Xandri et al., 2015). This chapter explores these models 
using urine phenotypes collected from individuals in the Generation Scotland: 
Scottish Family Health Study (GS: SFHS) (Smith et al., 2006).  
Chapters three and four explore the merits of utilising Bayesian analytical 
approaches in a genome-wide association setting. Chapter three uses simulated 
complex phenotypes to explore the Bayesian model and makes a comparison to the 
Genomic Best Linear Unbiased Predictor (GBLUP) method. Chapter four tests the 
Bayesian model on urine phenotypes from GS: SFHS individuals. 
Chapters five and six implement a regional GREML model that analyses the 
genome in natural blocks delimited by recombination hotspots. Chapter five tests the 
regional GREML model in a simulation study and chapter six applies the model to 
human complex trait data from GS: SFHS and UK Biobank (Sudlow et al., 2015). 
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The concluding chapter of the thesis discusses the wide-reaching implications 
of all the results of the data chapters to the genetic study of human complex traits 
and discusses directions and strategies for future studies in the field.      
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Chapter 2  
2 Investigating the genetic control of urinary traits in 




  Kidney failure is a global public health challenge with several million people 
requiring treatment (Xue et al., 2001). This presents a distressing economic burden 
on health care systems and thus raises the need for research aimed at reducing the 
incidence of and severity of renal failures among people. One of such research 
approaches is the Genome-wide Association (GWA) study, which for the past decade 
has been incredibly successful in stacking up evidence to suggest that genetic 
predisposition plays a crucial role in the aetiology of complex human diseases by 
detecting trait-locus associations.  
The GWAS approach, so far, has been a robust tool for the study of complex 
traits related to kidney function and disease – with a myriad of GWA studies attesting 
to this fact (Piras et al., 2017). For example, Chambers et al. (2010) identified five loci 
associated with serum creatinine, a marker of kidney function. Also, genome-wide 
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scans in over 90,000 Caucasian individuals by Köttgen et al. (2010) identified 20 novel 
genome-wide significant loci for reduced renal function and CKD. Collectively, these 
and many more GWAS findings (Hishida et al., 2018; Wuttke et al., 2016) have shed 
some light on kidney function and the aetiology of kidney disease.  
Measures of urine electrolytes provide useful information on kidney function 
in people and are used routinely by clinicians as biomarkers of kidney damage 
(Wallace et al., 2008). For instance measures of creatinine are used to calculate 
functional excretion of Na+ and renal failure index (Reddi, 2014). Such measurements 
are intermediate phenotypes that are associated with the disease but not by 
themselves symptoms of the disease and are heritable (Cirulli and Goldstein, 2010).  
The use of such intermediate phenotypes (endophenotypes) has been 
proposed as a more amenable alternative to the actual disease itself in assaying for 
genetic risk variants (Hall and Smoller, 2010). The reason for this is that these 
intermediate phenotypes may be closer to the underlying genetic liability than the 
actual disease (Almasy and Blangero, 2001; Ghosh and Collins, 1996). Another reason 
is that endophenotypes may be clinically and ethnically more homogeneous than 
disease endpoints (Ghosh and Collins, 1996) and thus help to deal with the problem 
of heterogeneity in disease status ascertainment. Wrongly defining cases and 
controls for a disease can result in spurious genetic associations which can make it 
impossible to replicate the results in other cohorts. GWA scans to identify significant 
associations in kidney disease endophenotypes like urine measures of potassium, 
sodium, calcium etc. and subsequent estimates of heritability, potentially, will at a 
first instance improve our understanding of the genetic underpinning of renal 
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pathogenesis which ultimately will translate into providing new insights into kidney 
disease biology. There has been a GWA study of urine sodium, potassium and 
creatinine (Wallace et al., 2008), however, no genome-wide significant association 
was identified. 
On this premise, this study set out to investigate the genetic control of urine 
electrolyte measures of 3,000 individuals from the Generation Scotland: Scottish 
Family Health Study (GS: SFHS) (Smith et al., 2006). The GS: SFHS involves about 
24,000 individuals recruited from across Scotland and have measurements for a wide 
variety of health-related phenotypes taken on them. Among these phenotypes are 
measurements for 8 urine electrolytes measured for about 3,000 individuals. The aim 
was to perform a mixed model GWAS on the individuals for all the 8 urine traits in a 
bid to uncover genetic risk loci underlying these kidney disease endophenotypes and 
then estimate genome-wide and regional heritabilities to understand how the 
underlying genetic variation could influence the inheritance of these traits in a way 
that will inform future research directions on renal function and failure.    
 Methods 
2.2.1 The Generation Scotland kidney phenotypes dataset 
The data comprised of 2,934 individuals from Glasgow (2,363) and Aberdeen 
(571) which formed part of a larger dataset of 10,000 out of the 23,960 individuals 
that were initially genotyped in the Generation Scotland: Scottish Family Health 
Study (GS: SFHS) (Smith et al., 2012). DNA from the individuals had been analysed 
using the Illumina HumanOmniExpressExome8v1-2_A chip (~700K genome-wide SNP 
chip). These individuals had phenotype measures for the urine concentrations of, 
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Sodium, Potassium, Chlorides, Calcium, Glucose, Phosphorus, Magnesium, urine 
osmolarity and Creatinine. The phenotype data included the covariates sex, age and 
Clinic location (which was a vector of numbers representing recruitment centres in 
Aberdeen and Glasgow).  
Standard QC filters were applied to the genotype data in GenABEL (Aulchenko 
et al., 2007) and also in PLINK version 1.9 for the PLINK version of the data. The QC 
excluded SNPs and individuals with a call rate of less than 98%, SNPs with MAF<0.01 
and SNPs that were out of Hardy-Weinberg equilibrium (p-value 0.000001). All the 
individuals and 562,273 SNPs successfully passed all QC filters and were used in 
analysis downstream. 
2.2.2 Principal components analysis to check for population substructure and 
ancestry 
The resulting data after applying the QC filters were used to investigate the 
level of population stratification and ancestry of the individuals. The analysis to check 
for population substructure was done in R using an approach which involved the 
calculation of a covariance matrix ) of all individuals in the sample using all the 
genome-wide markers. The resulting matrix is positive semi-definite, and thus 
decomposes into a diagonal matrix *  which has non-negative elements and an 
orthogonal matrix  (Freedman, 2009) such that  
+ = ,-                                                                       (2.1) 
The columns of  represent the eigenvectors of ) and the diagonal elements of the 
matrix *  are the eigenvalues of ) . The principal components analysis (PCA) is 
performed such that the first two principal components (PCs), after a 
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multidimensional scaling of  ),  are computed and returned. The principal 
components are the columns of  or the eigenvectors of ). The first component is 
the column that generates the greatest variance among the study subjects after a 
linear arrangement of the columns of   i.e. the eigenvector with the largest 
eigenvalue. The variances of the components shrink as one moves away from the 
first PC. A plot was generated from the first two PCs.  
A second plot was generated to investigate the ancestry of GS: SFHS 
individuals using analyses in PLINK (version 1.9) that merged the individuals of the 
GS: SFHS data with the individuals from 14 ancestral populations (Table 2.1) in the 
1000 Genomes (1kG) project (Consortium, 2012).  
Table 2.1. The 14 different populations from the 1000 Genomes Project that were used as 
reference ancestral populations in this study 
Population Code Population Description Super Population Code 
CHB Han Chinese in Beijing, China EAS 
JPT Japanese in Tokyo, Japan EAS 
CHS Southern Han Chinese EAS 
CEU Utah Residents (CEPH) with Northern and Western 
European Ancestry 
EUR 
TSI Toscani in Italia EUR 
FIN Finnish in Finland EUR 
GBR British in England and Scotland EUR 
IBS Iberian Population in Spain EUR 
YRI Yoruba in Ibadan, Nigeria AFR 
LWK Luhya in Webuye, Kenya AFR 
ASW Americans of African Ancestry in SW USA AFR 
MXL Mexican Ancestry from Los Angeles USA AMR 
PUR Puerto Ricans from Puerto Rico AMR 
CLM Colombians from Medellin, Colombia AMR 
 
The PLINK analyses involved pruning the genotype data of the merged dataset 
based on LD. The LD-thinned data was used to compute a covariance matrix which 
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was subsequently transformed into a distance matrix in PLINK. The first two PCs were 
plotted in R to show how the GS: SFHS individuals clustered with respect to the 
individuals from different ancestral populations.  
2.2.3 Phenotype data transformation and regression to generate residuals  
The residuals for the kidney function traits were obtained after regressing the 
trait values on the covariates; age, sex, clinic location and creatinine. For a vector of 
phenotypes with length  , the linear regression model for fitting the effects of 
measured covariates is given as   
   = 1. +  +                                                            (2.2) 
where  is an  × 1 vector of measured traits. 1 is a vector of 1s and . is the trait 
mean.  is an  × / design matrix of the fitted covariates. Creatinine was fitted in 
the regression model as a quadratic function.  is a / × 1 vector of fixed effects and 
  is the residual error which is random. To estimate    (the effects of the fitted 
covariates on the measured trait values) from the data, the linear regression model 
makes some assumptions that link the model to the data. First the model assumes 
that the expectation of  , ( ()  is effectively described by a simple observed 
function of the fitted variables on the right hand of equation (2.2) (linear function for 
age, sex and clinic location, and a quadratic function for creatinine)  (i.e. the values 
of the vector  are observed values of 1. +  + ) (Freedman, 2009). Second is the 
assumption of normality in the distribution of the residuals and third is the 
assumption of no relationship between the expectation and the measure of the 
dispersion of data points around this expectation (i.e. constant variance with 
changing mean).  
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If these assumptions are not met, then transforming the values of  may 
provide some improvement to the solution (Box and Cox, 1964). The model 
diagnostic plots provide a means to visually assess these assumptions to know if the 
model fits the data well enough. These are plots of Residuals versus fitted values, 
Normal Q-Q plot, Scale-Location plot and the residuals versus leverage plots. 
In this study, kidney function traits in which the model was not well behaved 
were transformed using Box-Cox transformations (Box and Cox, 1964) in R. The Box-
Cox transformation of the 01ℎ value of  is defined as      
34 = 34 − 15  6ℎ7 5 ≠ 0                                               (2.3) 
where 3 is the 01ℎ value of the vector of observations and 5 is the transformation 
parameter. For 5 = 0, the natural log of  is taken in place of equation (2.3) i.e. 34 =
9:;(3) 6ℎ7 5 = 0 (Osborne, 2010).  
Urine concentrations of Chlorides, Potassium, Sodium and Osmolarity were 
transformed using 5 = 0.43, 0.3, 0.383  0.64  respectively. Urine Calcium had 
5 = 0  and thus was transformed using the natural log. Urine Phosphorus and 
Magnesium were transformed using the log10. Urine Glucose was transformed using 
quantile normalisation, after all the transformation methods described above failed 
to normalise the trait values. The residuals of both the transformed and 
untransformed phenotype data were used in the downstream GWA and heritability 
analysis. 
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2.2.4 GREML analysis  
The heritability is the genetic component of the phenotypic variance. For a 
vector  of  trait values, the mixed effects model for fitting the polygenic effect of 
genome-wide SNPs is given as  
 =  + >? +                                                         (2.4) 
where  is an  × 1 vector of phenotypes,  is an  ×  design matrix of  + 1 fixed 
effects, and   a  × 1  vector of fixed effects, @  is an  × A  design matrix for 
polygenic effects and B  is an A × 1  vector of random polygenic effects of A 
genome-wide SNPs assumed to be multivariate normal, CD!E0, #F%)G . And   is 
an  × 1 vector of residual effects assumed to be multivariate normal, CD!(0, #$%"). 
Under this model, the vector of traits is assumed to be normally distributed,  
!(, H). And the variance, D, for a trait is defined as 
 
D = +#F% + I#$%                                                       (2.5) 
where ) and " are the incidence matrix for the total additive genetic variance #F% and 
residual environmental variance #$% respectively. Both #F% and #$%are estimated with 
GCTA (Yang et al., 2011) using Restricted Maximum Likelihood (REML) where the 
Genetic Relationship Matrix, ), is fitted.  
The matrix ) is expressed as  
+ = >>′A                                                                  (2.6) 
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where ) is the genetic relationship matrix (GRM) between pairs of individuals which 
is estimated as the proportion of the genome-wide autosomal SNPs shared Identical 
by State (IBS) across all A markers weighted by their allele frequency (Yang et al., 
2010); @  is a matrix that indicates which marker alleles each sampled individual 
carries and has been centred and standardized at each locus (VanRaden, 2008); A is 
the total number of markers used. The genomic relationship coefficient for two 
individuals 0 and  is therefore estimated as follows 
+3N = 1A × O (P3Q − 2/Q)(PNQ − 2/Q)2/Q(1 − /Q)RQST                              (2.7) 
where P3Q is the genotype code at locus V for individual 0 and takes the values 0, 1 
and 2 for WW, W, and  genotypes respectively, /Q  is the frequency of allele  at 
locus V. 
The narrow sense heritability, h2 is then calculated by  
     ℎ% = XYZXYZ[X\Z                                                        (2.8) 
This gives an estimate of the heritability that is explained by genome-wide SNP 
markers (Yang et al., 2011). 
The GREML analysis of the GS dataset was performed using the transformed 
data. Two sets of analysis were performed for each category of the dataset. The first 
was an analysis that excluded one of each pair of relatives (individuals with estimated 
kinship > 0.025) and computed a global estimate of heritability. The second analysis 
fitted separate relationship matrices for all the 22 different chromosomes 
(autosomes) simultaneously in the GREML analysis to try and estimate the local 
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contribution of each chromosome to the total heritability. The model for the 
chromosome GREML is given as 
 =  + O >3?3%%3ST +                                           (2.9) 
2.2.5 Mixed effects linear model to test for association 
The association between SNPs and a trait was tested using a mixed effects 
linear regression model,     
̂ = 1. + ; + >? +                                             (2.10) 
where _ is a vector of the residuals for the trait after adjusting for the covariates, . 
is the mean effect which is fixed; ` is a vector of allelic substitution effect, which is 
fixed with a design matrix  (the matrix  takes the values 0, 1, or 2 for the WW, W 
and   genotypes respectively); B is a vector of random polygenic effects with a 
design matrix @; B is assumed to be multivariate normal, B~ CD!E0, )#F%G;  is the 
residual environmental effect, also assumed to multivariate 
normal, ~CD!(0, "#$%).  
) was calculated in the GenABEL package in R (Aulchenko et al., 2007) using 
the “ibs” function. The ) matrix was subsequently used in the “polygenic” function 
(Thompson and Shaw, 1990) to estimate the heritability for the kidney disease traits 
already adjusted for the fixed effects (sex, age, clinic location and creatinine). The 
results from the polygenic function were saved as R objects which were later 
employed in the “mmscore” function (Chen and Abecasis, 2007) in GenABEL to 
estimate the association between SNPs and traits by the mixed effects linear 
regression model described in equation (2.10).  
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2.2.6 Zoom in around top GWAS hits 
A further exploratory analysis that focused on the top GWAS hit SNPs for the 
kidney function traits was performed by selecting SNPs within 500kb on both sides 
of those SNPs and fine mapping using LocusZoom (Pruim et al., 2010). LocusZoom is 
an online plotting tool that provides detailed regional plots around GWAS hits. The 
plots list genes in the region, local LD between SNPs and recombination rates.  
2.2.7 Regional GREML analysis  
Consider a vector  of phenotype values with length , the mixed effects 
model for fitting the effects of 7  genomic regions and A  background polygenic 
markers is given as  
 =  + b3?3 + >?c +                                       (2.11) 
where  is an  × 1 vector of phenotypes,  is an  ×  design matrix of  + 1 fixed 
effects, and  a  × 1 vector of fixed effects, de is an  × f design matrix relating 
phenotype measures to f  SNPs in region 0  and Be  is an f × 1  vector of random 
genetic effects due to region 0 assumed to be multivariate normal, CD!E0, #gh% )BeG. 
@ is an  × A design matrix for A background polygenic effects of SNPs outside the 
region and Bi is an A × 1 vector of random polygenic effect of these SNPs excluded 
from the regions assumed to be multivariate normal, CD! j0, #gk% )Bil. And  is 
an  × 1 vector of residual effects assumed to be multivariate normal, CD!(0, #$%"). 
Under the model, the vector of phenotypes   is assumed to be normally 
distributed, !(, H) where the variance is 
D = #gh% +gh + #gk% +gk + #$%I                                     (2.12) 
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 The regional GREML analysis was performed using REACTA (Cebamanos et al., 
2014). This program performs a regional GREML analysis across the whole set of 
autosomal SNPs by breaking up the genome into smaller windows of N SNPs, which 
overlap by X SNPs. For this study, the analysis was carried out using a window size of 
100 SNPs, and consecutive windows overlapped by 50 SNPs. For each SNP window, 
the local GRM for that window was analysed simultaneously with a whole genome 
GRM that excludes the SNPs in the region.   
 Results 
2.3.1 PCA places GS: SFHS individuals in European ancestry 
The generation of spurious genomic associations in disease studies arising 
from population stratification is a well-known fact in GWAS literature (Aulchenko, 
2011; Freedman et al., 2004). Techniques exist to deal with this problem with 
genomic control (Aulchenko, 2011) being the most widely employed. But these have 
their limitations (Price et al., 2006). In this study, population substructure was 
checked for by computing the first two principal components from a covariance 
matrix of study participants calculated using all the genome-wide markers.  
Figure 2.1a shows the results of this analysis. The plot shows most individuals 
in the GS: SFHS data clustering together on the first PC axis with very few individuals 
breaking away from the cluster. The second PC, however, shows a big gap between 
seven individuals (shown in red) and the rest of the population. Further investigation 
of these individuals revealed that they belong to the same family that spans three 
generations from grandparents to grandchild. There is not much substructure in the 
GS: SFHS population apart from the one produced by this family. Keeping them in the 
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data for GWA analysis shouldn’t cause any problems because the mixed model used 
fitted a GRM to account for background genetics and this should adequately deal 
with any problems that keeping these individuals might cause. 
The analysis to check for ancestry firmly placed the GS: SFHS individuals 
amongst individuals of European ancestry (Figure 2.1b). Both the first and second 
principal components clearly separated the GS: SFHS individuals from the African and 
Asian populations, confirming the European ancestry of the GS: SFHS individuals. The 
populations from the Americas (ASW, MXL, PUR, CLM) were spread in between the 
European (CEU, TSI, FIN, GBR, IBS), Asian (CHB, JPT, CHS) and African (YRI, LWK, ASW) 
populations. 
2.3.2 Data transformations improve model fit 
By transforming data, we do two things. Firstly, we change the nature of the 
relationship between the data variables. This affects our interpretation of results 
because it may change the effect sizes in whichever direction, up or down. Second is 
that we alter the mean-variance relationship which again makes results 
interpretation difficult. Albeit transformations attempt to minimize violation of 
model assumptions which can improve the results from the analyses by minimizing 
our chances of committing either Type I or II errors (Osborne, 2010).    
The results for the non-linear transformations of the data using λ values from 
the Box-Cox analyses are shown in Figure 2.2. 
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 Figure 2.1. Plot of the first two principal components of covariance matrix of study individuals. a. plot 
for the GS: SFHS data only. The outlier points shown in red are individuals from the same family 
spanning 3 generations. The plot shows there is not much genetic substructure in the GS data; 
b is a plot of the GS: SFHS individuals with the individuals from 14 ancestral populations from 
the 1000 Genomes project. The GS: SFHS individuals clustered together with individuals of 
European ancestry (dashed circle). They were clearly separated from the African Asian 
ancestral populations on both PC axes with the populations from the Americas spread in 
between.   
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 This is a plot of model diagnostics before and after Box-Cox transformations 
for urine chlorides, potassium, sodium and osmolarity. The results in Figure 2.2 show 
some improvement in two of the model assumptions. First is the assumption of 
a.  
         
b.  
        
c.  
         
d.  
             
Figure 2.2. Model diagnostics plots before and after Box-Cox transformations. From a to d is urine chlorides, 
potassium, sodium and osmolarity respectively. Each phenotype has got 4 model diagnostic plots. 
The first two tests for the assumption of normality in the distribution of residuals before and after 
Box-Cox transformations. The other two plots show the mean – variance relationship before and 
after transformation. The Box-Cox transformation significantly improves the model fit and 
minimizes violations of model assumptions 
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normality in the distribution of residuals which is shown in the figure by the Q-Q 
plots. The Q-Q plots in the transformed data show the plotted points falling closely 
on the diagonal line. The improvement is quite obvious in urine potassium (Figure 
2.2b) where the Q-Q plot of the residuals in the untransformed data shows that the 
residuals are skewed in such that the larger values are more extreme than would be 
expected under a normality, thus skewing the data to the left. This is corrected by 
the Box-Cox transformation (Figure 2.2b). 
The second improvement is the assumption of constant variance with 
increasing mean. The plots for Box-Cox transformed data shows parallel dispersal of 
points as we would expect for the assumption of no relationship between the 
variance and the mean. The plot for urine sodium (Figure 2.2c) shows a distortion of 
the dispersion by a single outlier point. 
The log10 transformed phenotypes also showed some improvement over the 
untransformed data with respect to the assumptions of normality in distribution of 
residuals and constant variance with increasing mean, Figure 2.3. None of the 
transformation tested improved the distribution properties for glucose and therefore 
quantile normalisation was applied in further analyses.   
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Figure 2.3. Model diagnostics plots before and after log10 transformations. From a to d is urine calcium, 
glucose, magnesium and phosphorus respectively. The log10 transformation improves the model fit 
especially for calcium but doesn’t do as well as the Box-Cox transformations in magnesium and 
phosphorus. The quantile normalisation of urine glucose offered some improvement on the residual 
distribution of the trait. 
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2.3.3 GREML analysis to estimate heritability 
The results for the GCTA analysis are shown in Table 2.2 and plots for the 
chromosomal heritability of the traits are shown in Figure 2.4 and Figure 2.5. The 
heritability estimate of a trait gives an idea of whether the trait is significantly 
affected by genes or not. Higher estimates are an indication of significant 
contribution by genes to trait variation. The whole genome estimates of heritability 
were obtained for the kidney phenotypes by analysing all common SNPs in the 
genome at once using restricted maximum likelihood analysis. This gave rather small 
estimates of heritability for most of the traits.  
Table 2.2. The heritability estimates of the two categories of GS: SFHS data.  The trait name, 
the heritability estimates for traits, and the sum of chromosomal heritability estimates of 
traits. The standards errors are in parentheses. NC is for likelihood not converged.   
Traits Heritability Estimates 
 
Whole Genome h2 % (SE) Sum of Chromosomal h2 % (SE) 
Calcium 5.76 (6.2) 20.74 (7.00) 
Chlorides 1.25 (5.51) 9.70 (6.11) 
Glucose 0.00 NC 
Potassium 0.00 NC 
Magnesium 10.50 (5.73) 16.29 (6.00) 
Sodium 10.52 (5.73) 14.92 (5.87) 
Osmolarity 4.22 (5.52) 13.07 (6.02) 
Phosphorus 0.00 NC 
 
When the SNPs were binned by chromosomes and local (chromosomal) 
estimates of heritability were calculated and summed, all the traits had an increase 
in the heritability estimates (Table 2.2). The likelihood failed to converge for the 
chromosomal estimates for some traits after 1000 iterations and they have NC (Not 
Converged) entered in Table 2.2. The standard errors of the estimates are large, but 
this is likely to improve with the increase in sample size. The regional heritability 
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analysis further reduced the local bin sizes from whole chromosomes to 100 SNP bins 
overlapping by 50 SNPs. The results are shown in Figure 2.4b and Figure 2.5b. The 
results for regional heritability analysis for most of the traits showed some 
consistency with the chromosomal heritability results.  
2.3.4 Mixed model GWA analysis identify genome-wide significant loci 
The most important result from this analysis is that there are significant 
GWAS hits in most of the kidney traits in areas of the genome that have genes within 
1MB (Table 2.3 and Table 2.4). The majority of these hits, however, are significant at 
the suggestive level and do not reach genome-wide significance. But concerns over 
the overly stringent threshold of genome-wide significance (p-value < 5 × 10&( )  
have been raised previously (Sham and Purcell, 2014). Although the reason for this 
threshold is mainly statistical and may lack any biological significance, its usage 
presents the possibility of true associations of biological relevance being missed by 
GWA studies. Looking at SNPs that are significant at the suggestive level (p-value <
1 × 10&m) is now common practice to mitigate this concern. But beyond this point, 
there is not much motivation to look any further.   
Another important observation from these analyses is that the data 
transformations greatly reduced the SNP effect sizes (Table 2.3 and Table 2.4). This 
doesn’t come as surprise because transformations obviously change the scale of the 
data and in effect should change the scale of the effect sizes. Data transformation, 
however, improved the evidence of association by giving low association p-values. 
The GWA results for the traits are shown in the Manhattan plot in Figure 2.4c and 
Figure 2.5c.  
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a.  
             
b.  
                   
c.  
         
Figure 2.4. Whole genome and regional analysis of urine calcium and magnesium. a plots of chromosomal 
heritability, with the heritability of chromosomes expressed as percentage. b plots of regional 
GREML analysis. The Likelihood ratio test statistic (LRT), regional heritability (RG h2), heritability 
of rest of genome excluding region (WG h2) and total heritability (Total h2) are plotted. The red 
horizontal line is Bonferroni-corrected threshold for genome-wide significance (LRT=18.6, p-
value < 1.6278e-05). Chromosomes are indicated by blue steps plot. c Manhattan plots showing 
genome-wide associations. The points are plots of -log10 of association p-values of genome-wide 
SNPs. Red line is genome-wide significance (GWS) threshold (p-value < 1e-08) and green line is 
threshold for significance at the suggestive level (p-value < 1e-05). For calcium the Manhattan 
plot shows a GWS peak on chromosome 3 where one SNP reaches genome-wide significance. 
The regional GREML plot shows the most significant region on chromosome 3 (LRT = 16.553, p-
value =2.37e-05). The chromosomal heritability plot points to chromosome 3 as explaining the 
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a.  
                
b.  
                  
c.  
     
Figure 2.5. Whole genome and regional analysis of urine chlorides, sodium and osmolarity. a is plots chromosomal heritability, with the heritability of chromosomes 
expressed as percentage. b is plots regional of GREML analysis. The Likelihood ratio test statistic (LRT), regional heritability (RG h2), heritability of rest of 
genome excluding region (WG h2) and total heritability (Total h2) are plotted. The red horizontal line is Bonferroni-corrected threshold for genome-wide 
significance (LRT=18.6, p-value < 1.6278e-05). Chromosomes are indicated by blue steps plot. c is the Manhattan plots showing genome-wide associations. 
The points are plots of -log10 of association p-values of genome-wide SNPs. Red line is genome-wide significance (GWS) threshold (p-value < 1e-08) and 
green line is threshold for significance at the suggestive level (p-value < 1e-05). For all the three traits, the Manhattan plot shows association at the 






















































































































































































































































































































































































































































































































LRT RG h2 WG h2 Total h2 Chr
Investigating the genetic control of complex traits 










Figure 2.6. The genome-wide evidence for SNP association for urine glucose, potassium and 
phosphorus. The points are plots of -log10 of association p-values of genome-wide SNPs. 
Red line is genome-wide significance (GWS) threshold and blue line is threshold for 
significance at the suggestive level (p-value < 1e-05). For all the three traits, the Manhattan 
plot shows association at the suggestive level as no SNP reaches genome-wide significance. 
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Table 2.3. The markers most strongly associated with the 8 urine traits analysed using a 
mixed model GWAS for the trait transformed GS: SFHS dataset. The trait name, 
genomic inflation factor, top SNPs, chromosomal position of SNPs, the effect of the 
minor allele, p-value corrected for genomic inflation, and genes within 1MB of SNP.  
Traits λ SNP Chr. effect P Genes within 1MB 
Calcium  1.000 rs4574243 3 0.043 9.3e-09 RBMS3 
rs6934483 6 0.033 5.9e-06 HULC, SLC35B3, LOC100506207 
Chlorides 1.005 rs12197896 6 -0.428 7.2e-07 - 
rs7567950* 2 0.661 1.6e-06 - 
rs11588628 1 0.053 5.0e-06 KAZN, TMEM51, FHAD1, CELA2A, 
AGMAT, C1orf126, EFHD2, 
DNAJC16, CTRC, CELA2B, CASP9 
rs3804538 6 0.273 1.2e-05 ADAT2, LOC285740, PEX3, 
FUCA2, PHACTR2, LTV1, 
ZC2HC1B, AIG1, PLAGL1, 
LOC100507489 
Glucose <1 rs3756804 6 0.196 1.8e-06 CLIC5, ENPP4, ENPP5, RCAN2, 
CYP39A1 
rs12293191 11 0.121 1.9e-06 CCDC86, ZP1, PRPF19, PTGDR2, 
TMEM109, TMEM132A, CD6, 
CD5, SLC15A3, VPS37C, PGA3 
Potassium <1  rs9518824 13 0.079 8.3e-08 CCDC168, TPP2, METTL21C, 
TEX30, KDELC1, ERC5, BIVM-
ERCC5, METTL21EP 
rs3797064 5 0.098 3.4e-06 PDZD2, GOLPH3, MTMR12, ZFR, 
MIR4279 
rs1796120 7 -0.079 1.0e-05 C1GALT1, COL28A1, 
LOC100131257, MIOS, RPA3, 
LOC729852, RSPH10B2, 
RSPH10B, CCZ1B 
Magnesium <1   rs2541872** 18 0.045 1.4e-06 CDH7 
rs4606726** 16 -0.043 2.2e-06 GP2, UMOD, PDILT, ACSM2A, 
ACSM2B, ACSM1, THUMPD1, 
ACSM3, ERI2, LOC81691 
rs16837959** 2 -0.055 8.3e-06 TMEM237, MPP4, ALS2, 
ALS2CR11, CDK15, STRADB, 
TRAK2, ALS2CR12, CASP8, 
CASP10 
Sodium 1.000 rs12365770 11 0.174 2.1e-06 CNTN5 
rs7567950* 2 0.447 3.3e-06 - 
rs12634170 3 -0.179 3.3e-06 NMNAT3, RBP1, RBP2, COPB2, 
MRPS22, CLSTN2, PISRT1 
rs12604137 18 0.170 3.6e-06 CCBE1, RAX, CPLX4, LMAN1, GRP, 
SEC11C, OACYLP, ZNF532, 
PMAIP1 
Table continues 
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rs8161 6 0.177 6.3e-06 ADAT2, PEX3, FUCA2, 
LOC285740, PHACTR2, LTV1, 
ZC2HC1B, PLAGL1, AIG1, 
LOC100507489 
Osmolarity 1.001 rs12551209** 9 1.342 4.2e-06 GGTA1P, DAB2IP, STOM, GSN, 
RAB14, CNTRL, C5, TTLL11 
rs12782067 10 0.986 6.4e-06 UPF2, DHTKD1, SEC61A2, 
CDC123, NUDT5, PROSER2, 
PROSER2-AS1, ECHDC3, USP6NL 
rs8001997 13 1.042 6.7e-06 MYCBP2, MYCBP2-AS1, FBXL3, 
CLN5, IRG1, BTF3P11, KCTD12, 
SCEL, MIR3665, SLAIN1 
rs4147996* 17 2.117 6.8e-06 - 
Phosphorus <1  rs1414850** 9 0.044 4.9e-07 KLF9, TRPM3, SMC5, MIR204, 
LOC100507299, LOC100507244, 
MAMDC2 
rs7623722** 3 -0.028 5.3e-06 LINC00693, RNMS3, ZCWPW2, 
AZI2 
* Rare SNPs (1% < MAF < 5%) 
** SNP association disappears in untransformed data 
 
 
Table 2.4. The markers most strongly associated with the raw measurement of urine traits 
analysed using a mixed model GWAS for the GS: SFHS dataset.  The trait name, 
genomic inflation factor, top SNPs, chromosomal position of SNPs, the effect of the 
minor allele, p-value corrected for genomic inflation, and genes within 1MB of SNP. 
Traits λ SNPs Chr effect P Genes within 1MB 
Calcium  <1  rs4574243 3 0.725 1.7e-06 RBMS3 
rs12341976** 9 -0.679 7.6e-06 PBX3, MAPKAP1, GAPVD1 
rs4742914** 9 0.668 1.8e-05 NIPSNAP3A, NIPSNAP3B, 
LOC286367, ABCA1, SMC2, 
OR13 Family of genes 
Chlorides 1.005 rs7567950* 2 43.158 1.6e-06 - 
rs12197896 6 -26.22 3.3e-06 - 
Glucose 1.015 rs11597250* 
** 




8 378.17 2.9e-11 PAG1, FABP5, ZNF704, PMP2, 
FABP9, FABP4, FABP12 
rs960491*   19 314.02 4.4e-11 DOT1L, LINGO3, PLEKHJ1, 
IZUMO4, AP3D1, SF3A2, AMH, 
MIR4321, JSRP1, OAZ1 
rs17013067* 
** 
4 270.18 2.7e-10 IBSP, MEPE, HSP90AB3P, SPP1, 
PKD2, DMP1, DSPP, SPARCL1, 
NUDT9, ABCG2, HSD17B11 
rs2389225* 
** 
13 211.35 4.3e-08 ABCC4, CLDN10, CLDN10-AS1, 
DZIP1, DNAJC3 
Table continues 
Investigating the genetic control of complex traits 
The genetic control of kidney function   49 
 
Potassium <1  rs9518824 13 12.58 4.8e-07 CCDC168, TPP2, METTL21C, 
TEX30, KDELC1, ERC5, BIVM-
ERCC5, METTL21EP 
rs1348259** 5 15.155 4.1e-06 LINC00052, NTRK3, AGBL1 
  rs1796120 7 -13.38 1.1e-05 C1GALT1, COL28A1, 
LOC100131257, MIOS, RPA3, 
LOC729852, RSPH10B2, 
RSPH10B, CCZ1B 
Magnesium <1  rs1441827** 15 0.736 1.4e-06 ALDH1A2, AQP9, MYZAP, 
GCOM1, POLR2M, CGNL1 
rs6953804** 7 -0.470 8.8e-06 CARD11, SDK1, GNA12, AMZ1, 
TTYH3, IQCE, LFNG, MIR4648, 
BRAT1 
Sodium 1.00 rs7567950* 2 30.98 7.9e-07 - 
rs12365770 11 11.688 1.0e-06 CNTN5 
rs12634170 3 -
11.715 
3.0e-06 NMNAT3, RBP1, RBP2, COPB2, 
MRPS22, CLSTN2, PISRT1 
rs8161 6 11.704 4.6e-06 ADAT2, PEX3, FUCA2, 
LOC285740, PHACTR2, LTV1, 
ZC2HC1B, PLAGL1, AIG1, 
LOC100507489 
rs12604137 18 10.891 5.2e-06 CCBE1, RAX, CPLX4, LMAN1, 
GRP, SEC11C, OACYLP, ZNF532, 
PMAIP1 
Osmolarity 1.00 rs8001997 13 16.071 2.5e-06 MYCBP2, MYCBP2-AS1, FBXL3, 
CLN5, IRG1, BTF3P11, KCTD12, 
SCEL, MIR3665, SLAIN1 
rs4147996* 17 32.547 2.7e-06 - 
rs699608 12 15.365 4.1e-06 PPM1H, AVPR1A, C12orf61, 
MIRLET7I, MON2 
rs12782067 10 14.516 6.7e-06 UPF2, DHTKD1, SEC61A2, 
CDC123, NUDT5, PROSER2, 
PROSER2-AS1, ECHDC3, USP6NL 
Phosphorus 1.004 rs9468226* 
** 
6 17.749 7.9e-07 LOC100507173, HIST1H2AL, 
LOC100131289, HIST1H2BL, 
OR2B2, HIST1H2AI, ZNF184 
rs3980449** 11 7.578 9.8e-07 PAMR1, FJX1, TRIM44, SLC1A2, 
CD44, LDLRAD3, MIR3973 
rs10508250** 10 10.443 1.8e-06 TRPM3, KLF9, SMC5, MIR204, 
SMC5, LOC100507299, 
LOC100507244, MAMDC2 
rs9933070 16 9.914 1.9e-06 XYLT1 
* Rare SNPs (1% < MAF < 5%) 
** SNP association disappears in transformed data 
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The genome-wide association approach to studying complex traits has taken 
centre stage in genetics research during the last decade (Björkegren et al., 2015; 
Burton et al., 2007; McCarthy et al., 2008; Seng and Seng, 2008) and has had an 
enormous impact particularly on the field of human genetics (Bush and Moore, 
2012). Despite the number of problems catalogued on GWAS, such as multiple 
testing, low power to detect effects and the winner’s curse (Shriner et al., 2007; Wray 
et al., 2013), the approach still enjoys much usage in the study of genetic control of 
 
Figure 2.7. LocusZoom plot around the top hit SNP for urine calcium on chromosome 3. The plot 
shows that the two highly associated variants are strongly correlated in terms of LD (LD > 
0.8). The top SNP rs4574243 lies in the RBMS3 (RNA Binding Motif, Single Stranded 
Interacting Protein 3) gene is implicated in DNA replication, gene transcription, cell cycle 
progression and apoptosis. Diseases associated with RBMS3 are osteonecrosis of the jaw 
and osteoporosis.  
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complex traits (Welter et al., 2014) which only highlights the fact that the GWA 
approach has come to stay. This study, therefore, aimed to investigate, using the 
GWA approach, if the kidney phenotype measurements taken for individuals of the 
GS: SFHS are under significant genetic control.  
Before attempting to answer that question, the ancestry of the study 
individuals was checked by contrasting them against the background of the several 
ancestral populations from the 1000 Genomes Project. The results from the principal 
components (PC) analysis shown in Figure 2.1b show that the individuals analysed 
are of European ancestry since they clustered together with 1000 genomes 
populations from Europe. A further investigation of the GS: SFHS population alone 
(Figure 2.1a) to check for genetic substructure showed seven individuals clustering 
away from the rest of the population on the second principal component axis. The 
pedigree information showed that they are individuals of the same family spanning 
three generations from grandparents to grandchild. Those individuals were kept in 
downstream mixed-model GWA analysis which fitted a GRM to account for any 
potential confounding due to the genetic substructure. The genomic inflation 
parameters (lambda) reported for the traits in Table 2.3 and Table 2.4 were all 1 or 
acceptably close to 1. This suggests there is no strong influence of genetic 
substructure or other design factors on the association test statistic (Aulchenko, 
2011).  
The GWA analysis results for the kidney phenotypes studied show some 
associations of SNPs at the suggestive level with one SNP (rs4574243) on 
chromosome 3 reaching genome-wide (GW) significance (p-value < 9.378709 ×
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10&n) for urine calcium in the transformed data (Table 2.3 and Figure 2.4a). A follow-
up analysis on the top GWAS hits for these traits revealed that most of them lie in 
regions of the genome that have several genes nearby. However, the functional 
relevance of these genes to the phenotypes of interest remains to be explored. A 
quick look up, nonetheless, for the RBMS3 gene found in the region of the SNP that 
reached genome-wide significance for urine calcium (Figure 2.4a), showed that the 
gene has been implicated in osteonecrosis of the jaw (Nicoletti et al., 2012), and also 
reported to interact with ZNF516 to influence bone mineral density (Yang et al., 
2013). A SNP in the RBMS3 gene region was found to be associated with trochanter 
bone mineral density in males in the Framingham heart study (Kiel et al., 2007). This 
link of RMBS3 with osteoporosis phenotypes might explain its association to urine 
calcium concentration.  
The GWA analysis for the untransformed data saw 4 SNPs for urine glucose 
reaching genome-wide significance (Table 2.4). All these SNPs were rare (1% < MAF 
< 5%) and the signal disappeared in the transformed data. The SNP effect sizes in the 
transformed data were greatly reduced (Table 2.3). Both the Box-Cox and log10 
transformations involve raising the values of the data points to a certain exponent 
and this will change the scale of the data which invariably will change the scale of the 
effect sizes. However, how much information is lost by this change is not known. For 
most of the traits, the significance of the SNP association is improved by data 
transformation because transformation improved model fit.  
Top hit SNPs that were rare (1% < MAF < 5%) had relatively bigger effect sizes 
than the common SNPs (Table 2.3 and Table 2.4). Natural selection will drive the 
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frequencies of variants with relatively large effects on disease risk down (Bodmer and 
Bonilla, 2008). The consequence of this low SNP MAFs is that such rare variants may 
be missed in GWA studies because they will fail to pass the commonly used MAF 
threshold (5%) set in initial QCs. Again, for studies like this which include rare variants 
in GWA analysis, even if they show up in association signals, they will most likely be 
overlooked in follow-up studies. The reason being that the GWA field is chiefly driven 
by the ‘common disease – common variant’ hypothesis (Cirulli and Goldstein, 2010) 
and also the lack of power to replicate rare associations. Although rare variants could 
have a prominent claim as key drivers of some common diseases (Bodmer and 
Bonilla, 2008; Pritchard, 2001). In spite of this, variants having large effect sizes 
doesn’t guarantee any functional relevance since association doesn’t necessarily 
imply causation. This was the case for most of the rare variants identified in  Table 
2.3 and Table 2.4, which had no genes within 1MB of those GWAS hits. I must admit, 
however, that the further analysis employed in this study to search for genes within 
1MB genomic regions of the GWAS hits is not an exhaustive solution since the 
variants could be exerting their influence on genes or causal variants several 
megabase-pairs away in the genome. Also, not all causal variants have to be genes; 
regulatory elements that can affect phenotypes can be far away from genes.  
The modest heritability estimates obtained from the GREML analysis using 
GCTA (Table 2.2), suggest that the kidney phenotypes may not be under a significant 
genetic control of common SNP variants. The standard errors of most of the 
heritability estimates show that they are not significantly different from zero. But this 
initial assertion would require further analysis with a larger sample size to confirm it 
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since standard error decreases with sample size. The local chromosomal estimates 
of heritability were calculated and summed up for each phenotype and all the traits 
curiously had a significant increase in the heritability estimates (Table 2.2). This could 
be due to the sum of the local chromosomal estimates of variance being driven up 
by the covariance between the chromosomes. This covariance between 
chromosomes may not be driven by LD since LD may be limited between SNPs on 
different chromosomes. But in a data with lots of family structure like the GS: SFHS, 
individual chromosomes will each reflect the family structure to some extent. So, the 
family component of the heritability may be included in the individual chromosomal 
heritabilities and so may be counted multiple times when you sum their effects.    
The results for the regional heritability analysis for most of the traits showed 
some consistency with the chromosomal heritability results and with the GWAS 
results. This kind of analysis improves the resolution of the heritability down to the 
very few SNPs in the regions that may be driving the underlying genetic variance. It 
can, therefore, give evidence in support of some of the associations found in the 
GWA analysis of traits. For instance, the plots shown in Figure 2.4 and 2.5, for the 
urine traits, show that regions of top GWAS hits have relatively high estimates of local 
heritability compared to other genomic regions. For instance, in calcium, the 
Manhattan plot shows an association peak on chromosome 3 and the regional 
heritability plot also shows the most significant region on chromosome 3 (LRT = 
16.553, p-value 2.37 × 10&m), which is just shy of genome-wide significance (p-value 
1.6278 × 10&m) after multiple testing correction for the 6143 regions tested in the 
regional heritability analysis. The plot from the chromosomal heritability analysis for 
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urine calcium also points to chromosome 3 as having a local heritability of 4.65% (SE 
= 4.07) explaining nearly a quarter (22.43%) of the total chromosomal heritability 
20.74% (SE = 7). 
In summary, mixed model GWAS has allowed us to scrutinize kidney disease 
endophenotypes in the GS: SFHS data, expanding on the myriad of GWA studies on 
complex traits that have resulted since the first GWAS a decade ago. There have been 
very sparse GWAS reports on these kidney disease endophenotypes which make 
these findings uniquely important. Many of the GWAS hits for these traits lie within 
areas of the genome that have genes close by which presents a useful avenue to be 
explored in future studies. Data transformation improved evidence of SNP 
associations in most traits. The heritability estimates calculated from the analysis 
suggest that these kidney disease endophenotypes are under modest genetic control 
common genetic variants. The study would have benefitted from larger sample size 
because that would have increased the power to detect more SNP associations and 
reduce the standard errors of the heritability estimates. However, for now, 
understanding the implications of these findings in the context of kidney disease 
development should offer some useful leads in the fight against the disease. 
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3 Use of a Bayesian mixture model (Bayes R) to investigate 
the genetic control of complex traits  
 
 Introduction 
The genome-wide association (GWA) analysis of complex traits has made a 
lot of advances in human genetics and has been employed to estimate SNP 
heritability and map genetic loci of interest in many traits. The approach also offers 
itself to the investigation of the underlying genetic architecture of traits, and to 
predict the genetic or breeding value of individuals (Gianola, 2013; Moser et al., 
2015) through the polygenic risk score analysis (Wray et al., 2007). 
The general framework for the GWA analysis is to regress the measured 
responses or phenotypes of study individuals on whole-genome markers’ codes, 
mostly derived from genotyped SNPs of those individuals, to determine the 
association between SNPs and a trait. From a frequentist standpoint, evidence of an 
association between phenotypes and genotyped SNPs is assessed with p-values 
calculated for the null hypothesis of no association (Stephens and Balding, 2009).  
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The conventional GWA model treats the effects of the markers as fixed and 
does not analyse them simultaneously. Thus, at each instance of marker effect 
estimation, the model ignores the effects of all other markers in the background. This 
analysis of markers in isolation often leads to an increase in the residual variance and 
a decrease in the power to capture true associations (de los Campos et al., 2010; 
Hoggart et al., 2008).  
Other factors such as the minor allele frequency (MAF) and the number of 
participants in the study also affect the power of the test for association (Stephens 
and Balding, 2009). SNPs with very low MAF are considered rare and are usually 
removed from GWA analysis during data quality control to improve power and 
reduce the risk of finding spurious associations.  
There is also the problem of multiple testing which arises statistically due to 
the test for SNP associations to phenotypes not being done simultaneously. Stringent 
p-value thresholds are set to account for the problem of multiple testing in GWA 
analysis which in itself presents the risk of true associations being discarded while 
overestimating the effects of SNPs that pass the stringent threshold.  
The overestimation of the SNP effects is due to the so-called “winner’s curse” 
or Beavis effect (Beavis, 1997). The winner’s curse arises in GWA analysis because 
the analysis involves numerous markers (mostly in the hundreds of thousands), 
which generally have very small effects. Consequently, there is a low power to detect 
markers that are significant, thus the effects of those markers that come out as 
significant tend to be overestimated.  
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One direct effect of the winner’s curse in GWA studies is the non-
reproducibility of GWAS hits in studies that aim to replicate GWAS results. In 
addition, in most complex traits, the markers that pass the significance threshold 
explain just a fraction of the heritability, and this led to claims that a proportion of 
the heritability was missing (Maher, 2008) for most traits. There has since been 
evidence to suggest that the heritability is not missing (Yang et al., 2015) but perhaps 
only hidden because of an even lower power to detect associations of markers of 
small effects (Gibson, 2010; Park et al., 2010).  
From what has been said thus far, it can be argued that models that treat the 
SNP effects as random and analyse them all simultaneously (Meuwissen et al., 2001; 
VanRaden, 2008; Yang et al., 2010) should perform better than the conventional 
approach of treating the effects as fixed and analysing SNPs one after the other. Thus 
models that treat the SNP effect as random have been developed and these models 
fit a genomic relationship matrix (GRM) to account for all SNP effects simultaneously 
(Fernando and Grossman, 1989; Habier and Fernando, 2013; VanRaden, 2008). One 
of such methods is the Genomic Best Linear Unbiased Predictor (GBLUP), which 
draws its theoretical foundations from an equivalent model (BLUP) that is utilised by 
animal breeders. GBLUP fits a GRM in place of the pedigree-based numerator 
relationship matrix used in BLUP. The GRM is generated by scaling the covariance of 
genomic values between two individuals to be equivalent to the pedigree-based 
elements of the numerator relationship matrix (VanRaden, 2008). Two scaling factors 
were developed by VanRaden (2008) but several scaling factors have since been 
developed (Wang et al., 2017). Other methods that utilise the GRM in a genome-wide 
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analysis setting involve the use of a restricted maximum likelihood estimation of 
genetic and residual components of the phenotypic variation (Speed et al., 2012; 
Yang et al., 2010).    
The GBLUP model assumes that all SNPs have small effects and these effects 
are drawn from the same normal distribution (Strandén and Garrick, 2009; 
VanRaden, 2008). This essentially means that all SNPs have an equal chance of 
contributing to the trait variation. This assumption suffers setbacks in at least two 
ways. First, it is not prudent to blindly assume a priori that all genetic loci will be 
associated with a trait and thus should have an effect. This is because, in truth, not 
all loci will be associated with a trait or will be in LD with the true underlying causal 
loci for a trait. Second, some quantitative traits have been shown to have a few loci 
with moderate to large effects on those traits, which means those loci can’t be 
treated the same as every other locus. There is, therefore, some benefit to be gained 
by fitting models that adequately account for the background effects of polygenic 
loci as well as the loci with moderate to large effects.  
After dealing with all problems described above such as low power to detect 
effects, multiple testing and the winner’s curse, there is one last hurdle to overcome 
in a GWA analysis. And that is GWA models typically having more predictors, in most 
cases hundreds of thousands of markers, than phenotype records, which introduces 
the problem of high dimensionality.  
Bayesian models have been presented as being better equipped than GBLUP 
to adequately deal with the challenges that conventional GWA analysis face. 
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Bayesian models allow for SNP effects to be sampled from more than one distribution 
which eliminates the problem of assuming that all genetic loci will have an effect on 
a trait. They also deal with the problem of dimensionality by introducing sparseness 
into the model. They do this by either shrinking the effects of those SNPs with very 
small effects to zero as in Bayesian LASSO (Tibshirani, 1994) or by choosing a subset 
of the markers to have an effect. Meuwissen et al. (2001) advanced the second 
approach by proposing Bayesian methods, BayesA and BayesB which sample SNP 
effects from prior distributions that accounts for the different SNP effect sizes. These 
methods fit a hierarchical model that samples the genetic variances of the markers 
from an inverse chi-squared conditional prior distribution (Meuwissen et al., 2001). 
BayesA and BayesB led to the proliferation of other Bayesian methods over the years 
each unique in the prior distribution it samples the SNP effects from in the GWA 
analysis. Gianola et al. (2009) came up with the term ‘Bayesian alphabet’ to refer to 
the growing number of Bayesian methods employed in GWA analysis named after 
letters of the English alphabet (Gianola, 2013). 
An extension to the BayesB model was proposed by Erbe et al. (2012) to 
improve the sampling of SNPs with zero and nonzero effects, that is which SNP is in 
or out of the subset of SNPs chosen to be having an effect on the trait. They proposed 
a hierarchical model that sampled the SNP effects from a mixture of 4 normal 
distributions, one with zero contribution to the total genetic variance and the other 
three with an increasing contribution to the genetic variance. In keeping with the 
tradition of the Bayesian alphabets, the new method was named BayesR. 
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In this chapter, I explore the BayesR method in some detail and apply it to 
simulated phenotypes in a simulation study to assess the performance of this BayesR 
method as compared to that of GBLUP. I also apply this model in the subsequent 
chapter on urine phenotypes measured from individuals from the Scottish 
population. The underlying genetic architecture of these traits was investigated using 
the method and an estimate of the additive genetic variance explained by the 
genome-wide SNPs was obtained. 
 Methods 
3.2.1 Mixture models in the GWA setting 
Mixture models are useful in determining the inner structure of data with 
hidden clusters when no information is available on how the clusters might have 
been formed (Picard, 2007). These models are composed of a finite or infinite 
number of components that can describe different attributes of data (Marin et al., 
2005). Each component may or may not come from the same type of distribution.  
In a GWA setting, the different components of the model can describe 
different classes of markers that have different effect sizes on traits. Consider 
a  vector `  containing the allelic substitution effects of /  genotyped SNPs for a 
measured phenotype. In a mixture model context, the density function for the 
realisation of ` given all unknown parameters u(`|w) is assumed to be a mixture of 
x parametric distributions such that   
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y(;|z) = O {Ny(;||N),}NST        O {N = 1,   
}
NST     x > 1,                      (3.1)  
where w  is a vector of all unknown parameters of the model,   is the mixing 
proportion or the weight of component . If all the y(;||N) are normal distributions, 
then | represents the unknown mean and variance.  
Primarily, such models aim to recover unobserved clusters in the data by 
attempting to label each data point as belonging to a particular cluster. In a GWA 
study, these could be two-cluster labels of whether a locus has an effect on a trait or 
not. This clustering on locus effects can be more than two such as a locus having no 
effect, a small effect, or a large effect. If a locus is classified as belonging to one 
component of the mixture distributions, then it will be classified as zero for all others. 
If these class labels were known, then the estimation of the mixture parameters 
would be easy since the parameters of each mixture distribution y(;||N) could be 
estimated directly from the data points from a component   (Picard, 2007). The 
labels are unobserved; however, and thus estimation of mixture parameters can only 
be based on the observed data points.  
Fitting mixture distributions can be done using a number of approaches, such 
as graphical methods, the method of moments, maximum likelihood and Bayesian 
approaches (Picard, 2007). Bayesian inference offers the opportunity for probability 
statements to be directly made about the unknown parameters (i.e. the mixing 
proportions, the mean, the additive genetic variance and error variance), and the 
priors used in the analysis (Marin et al., 2005). BayesR fits a mixture of four normal 
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distributions and implements a Gibbs sampler that iteratively estimates the model 
parameters.  
3.2.2 The Bayesian mixture model 
BayesR was developed by Erbe et al. (2012). The BayesR model starts with the 
general setting similar to the one described in the equation 3.1 above and assumes 
a mixture of four normal distributions with means equal to zero and variances that 
account for increasing proportions of the additive genetic variance as the conditional 
priors for the distribution of SNP effects 
/E;Q{N#F%G = {T!E0, 0 × #F%G + {%!E0, 10& × #F%G + {!E0, 10& × #F%G
+ {!(0, 10&% × #%).                                                                             (3.2) 
Here, {N are the mixing proportions and #F% is the additive genetic variance explained 
by all the SNPs. Thus, under this model, if a SNP effect is drawn from the first 
component of the mixture, it will be zero with a zero variance. This incorporates 
sparseness into the model since a large proportion of the SNPs are expected to have 
no effect on traits and thus go into this distribution. SNP effects drawn from the 
second component will be normally distributed with mean zero and variance 
= 10& × #F%.  
In the implementation of the model, uninformative flat priors for the mixing 
proportions are generally assumed (Erbe et al., 2012), although the model can 
accommodate informative priors. The prior distribution of the proportions of SNP in 
each component is a Dirichlet distribution, with parameter vector   =
(T, %, , ) = 1. This defines a uniform prior for the mixture distributions and 
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thus each SNP will have an equal chance of being in any of the distributions. The 
posterior distribution of the mixing proportions is  ~ ,07( + ), where  is a 
vector containing the number of SNP in each mixture distribution estimated from the 
data (Erbe et al., 2012). The   estimates are obtained by first calculating four 
likelihoods assuming a particular SNP is in one of the four mixture distributions at a 
time with a corresponding probability (Erbe et al., 2012). The mixture distribution to 
sample the SNP effect from is then selected based on these probabilities for the 
current iteration (Erbe et al., 2012).  
The genetic variance #F% and the error variance #$% have a starting value of 
0.01. The priors for both #F%  and #$%  are assumed to be from a scaled inverse chi-
squared distribution parameterised by the number of chi-squared degrees of 
freedom () and the scaling parameter(%). The priors used for the two hyper-
parameters for the scaled inverse chi-squared distribution are -2 and 0 respectively.  
Updated estimates of the pre-specified parameters (#F% ,  {N, #$% ), and an 
estimate of the other unknown parameters, the overall mean . and the SNP effects 
;  are estimated using a Gibbs sampling scheme that samples values from each 
parameter’s conditional posterior distribution (conditional on other parameters). 
BayesR uses a Gibbs sampling method analogous to the scheme described for BayesA 
(Meuwissen et al., 2001) with an addition of a polygenic effect, and with the SNP 
effects coming from four normal distributions with different variances (Erbe et al., 
2012). 
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3.2.2.1 The Gibbs sampler used 
My implementation of the BayesR model was performed with a Fortran 
program written by Moser et al. (2015) and compiled locally using the Intel Fortran 
compiler. The Gibbs sampler used as described in the supplementary text of Moser 
et al. (2015) is given as follows: 
The sampler first samples the overall mean from the full conditional posterior 
distribution 
.|. ~ ! &T O 3 − O P3Q;QcQST 

3ST ,
#$%                               (3.3) 
where 3  is the observed phenotype for individual 0 ,   is the total number of 
individuals, . is the overall mean, P3Q is the number of copies of the effect allele of 
SNP V which takes the values 0, 1, or 2, and ;Q the allelic substitution effect of SNP V. 
The starting values for the ;  and #$% are 0 and 0.01 respectively. 
It then calculates the probability that a SNP V  is in component   of the mixture 
distribution. The log likelihood of SNP V being in component  is  
:;(V, ) = log({N) − 12#$% O 3%

3ST − .Q,N OEP3Q3G
%
3ST  −
12 9:;D,           (3.4) 
where 3  is the phenotype of individual 0  corrected for the overall mean and the 
effects of all markers in the model, except marker V. 
3 = 3 − . − O P3;cQ  
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and  
.QN = ∑ P3Q33ST∑ P3Q% +3ST #$%#N%
 
logV is the log likelihood of the reduced model including only the effect of the marker 
V and a residual effect 
9:;D = 9:;(#$%) + log #N%#$% O P3Q%

3ST + 1.                               (3.5) 
Then the probability of marker V being in component  is 
PrEPQ∈NG = 1 O exp(0, 9) − (0, ) .}NST                                  (3.6) 
The sampler assigns marker V  to component   based on a value sampled from a 
uniform distribution. 
The third step is to sample the allelic substitution effect for marker V from mixture 
component  from the full conditional posterior distribution. 
;QN|. ~!E.QN, N%G, 
where 
N% = #$%∑ P3Q%3ST + #$% #N%⁄  
and .QN is sampled as above. 
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The sampler repeats for all genotyped SNPs, the steps of calculating probability and 
assigning a marker to a mixture component and then sampling the marker effects 
from the assigned mixture component. 
After assigning all markers to a mixture distribution, the additive genetic variance is 
then sampled from the full conditional posterior distribution 
#F%|. ~I − %  + AF, AF ∑ ;Q% + %cQST + AF  ,                      (3.7) 
where AF is the number of SNPs included in the current model,  is the number of 
chi-squared degrees of freedom and % is the scaling parameter of the scaled inverse 
chi-squared distribution. These parameters have values of -2 and 0 respectively. The 
residual variance is also inverse chi-square distributed and is sampled from the full 
conditional posterior distribution 
#$%|. ~I − % ¡ + , ∑ (3 − . − ∑ P3Q;Q)cQST % + ¡%3ST ¡ +  .               (3.8) 
The sampler then updates the mixing proportions by sampling from the posterior 
{|. ~,070¢ℎ91(T + , % + ,  + ,  + ), 
where T, … ,  are the number of markers in each component. 
New genetic variances of the mixture components #N% are computed 
#N%~
⎩⎪⎨
⎪⎧ {T × 0 × #F%{% × 10& × #F%{ × 10& × #F%{ × 10&% × #F%
 . 
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It becomes clear from the last step that the additive genetic variances of the 
mixture components are not estimated in this implementation of BayesR. The default 
implementation makes use of arbitrary values of 0, 10&, 10&, 10&% as scaling to get 
the additive genetic variances for markers assigned to the mixture components 
respectively. The total additive genetic variance for a mixture component , #N%  is 
then computed by scaling the total additive #F% with the total number of markers 
assigned to that component {N  and the arbitrarily assigned scaling value for the 
component.  
To investigate the robustness of BayesR I tested a variant of the model in a 
simulation study in which I used the true scaling values obtained from variances 
simulated for SNPs in each mixture component instead of the arbitrary values. These 
scaling values are 0, 4 × 10&m, 6 × 10&, 0.025 for low heritability traits, 0, 10&, 6 ×
10&, 0.01  for moderate heritability traits and 0, 1.25 × 10&, 5 × 10&, 6.25 ×
10& for high heritability traits. These true values were used as scaling values for the 
additive genetic variances for SNPs assigned to the mixture components respectively. 
Also, I ran a model that changed the starting values for the Dirichlet distribution for 
the proportions of SNP in each mixture component from the default values of  =
(T, %, , ) = 1 to  = (1,1,1,10).       
The order in which the markers are resampled is randomly permuted in each 
iteration to improve the mixing. The analysis was done using a Markov Chain Monte 
Carlo (MCMC) chain length of 50,000 with the first 20,000 chains being discarded as 
burn-in. Every 10th iteration after burn-in was kept to create visual plots of the 
sampling.  
Investigating the genetic control of complex traits 
Bayesian mixture model to investigate complex traits  69 
 
3.2.3 Simulation of phenotypes 
In order to evaluate the model performance and also the accuracy of the 
model parameters estimated by BayesR, I performed a simulation study. Phenotypes 
were simulated using available genotypic information of the 2,896 individuals with 
urine phenotype measurements in the Generation Scotland: Scottish Family Health 
Study (GS: SFHS) (Smith et al., 2012). A quality control (QC) that removed SNPs with 
MAF < 0.01 and SNPs that were out of Hardy-Weinberg equilibrium at p-value <
0.00001 was performed. A total of 555,091 SNPs remained after QC.  
Three phenotypes with high, moderate and low heritability of 80%, 50% and 
10% respectively were simulated. For simulating the SNP effects, I assumed they 
came from four normal distributions with zero means and variances that were equal 
to their contribution to the total additive genetic variance. The first distribution 
contributed nothing to the additive genetic effect. For the second distribution, 5,000 
SNPs were randomly sampled to form the background polygenic effect, then another 
500 SNPs were randomly sampled to have moderate SNP effects in the third 
distribution. A further 20 SNPs were sampled randomly to have large SNP effects in 
the final distribution. The small effect sizes were drawn from a  !(0,0.5) , 
!(0,0.25), and !(0,0.02) respectively for the high, moderate and low heritability 
phenotypes. The moderate effect sizes were drawn from a !(0,0.2), !(0,0.15) and 
!(0,0.03) for the high, moderate and low heritability phenotypes. The large effect 
sizes were drawn from a !(0,0.1), !(0,0.1) and !(0,0.05) for the high, moderate 
and low heritability phenotypes respectively. 
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The effect ;Q of a SNP V from a distribution component  under a heritability 
class was calculated from the additive genetic variance #N%  contribution from the 
respective distribution as follows: 
#NQ% = 2/QE1 − /QG;Q%,                                              (3.9) 
;Q = ¨ #NQ%2/QE1 − /QG,                                               (3.9©) 
where /Q is the frequency of the effect allele of the SNP V. 
 A random environmental variance was simulated for each individual for the 
phenotypes. The environmental variances were derived from !(0, #$%) where #$% is 
0.2, 0.5 and 0.9 for the high, moderate and low heritability traits. The final simulated 
phenotype for an individual  0  was then calculated as follows                                         
3 = O P3Q;QmQST + O P3Q;Q
m
QST + O P3Q;Q + 3 ,
%
QST                       (3.10) 
where P3Q is the number of copies of the effect allele of SNP V and ;Q is the effect of 
SNP V. Thus, the final phenotype for each heritability class was the sum of the additive 
genetic variance from the three distributions and the residual variance, with an 
expected mean of zero and a variance of 1. Fifty replicates were analysed for each of 
the three heritability classes with a different set of SNPs sampled for each replicate.   
3.2.4 GBLUP 
The simulated phenotypes were also analysed using a GBLUP model. The 
model below was fitted to the data 
 = 1. + ? + ,                                                   (3.11) 
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where   is a vector of  observations for the phenotype, ª is the overall mean effect 
which is fixed; considering a vector of A genome-wide SNPs,  is an  × A design 
matrix that assigns phenotypes to marker effects; B is a vector of A marker effects 
assumed to be multivariate normal,  ?~CD!E0, )#F%G;  is a vector of  residual 
effects, ~CD!(0, "#$%)  with "  being an  ×   identity matrix. )  is the GRM, 
calculated from genome-wide SNPs that is scaled to be analogous to the pedigree-
based numerator relationship matrix used in BLUP (VanRaden, 2008). 
+ = >,>«A                                                                (3.12) 
The elements in column  V E¬3QG  of @  can take the values E0 − 2/QG, E1 −
2/QG,  E2 − 2/QG  for the homozygote genotype with the reference allele, the 
heterozygote genotype and the homozygote genotype with the effect allele; /Q is the 
reference allele frequency at locus V; * is a diagonal matrix that scales ). The scale 
used in this model is the locus specific scale described by VanRaden (2008)  
QQ = 12/QE1 − /QG                                                    (3.13) 
3.2.5 Prediction analysis to assess model performance 
One of the benefits of a GWA analysis model is its ability to predict breeding 
values or risks when there are no phenotype data available. Prediction usually 
informs economically important decisions, especially in animal breeding which 
makes it imperative that some form of quality assessment of the model is done 
before its implementation.  
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To assess how good a model is for prediction of new phenotypes, based on 
the data available, it is common to perform a -fold cross-validation, where the data 
is split into  subsets. The analysis then uses each of the  subsets as a validation set 
to predict phenotypes using information from the other  − 1 subsets of the data.  
Two parameters are measured in the validation set to assess predictive 
performance, and these are accuracy and bias. Accuracy is the correlation of the 
estimated breeding values (EBVs) with the true breeding values (TBVs). I, therefore, 
calculated accuracy as the correlation between the simulated breeding values and 
the EBVs. I selected 30 of the simulated phenotypes, 10 from each heritability class 
for the prediction analysis. For each replicate, phenotypes were randomly split into 
five subsets to be used in a 5-fold cross validation analysis to evaluate the predictive 
performance of the BayesR and GBLUP models. 
 Results 
One major drawback of the standard GWA analysis is that each marker is 
analysed one at a time ignoring the background effect of all other markers. This has 
been pointed out as problematic (de los Campos et al., 2010; Hoggart et al., 2008) 
and the way around this problem is the use of methods that analyse all markers at 
the same time. 
I tested two models that analysed markers all at once using phenotypes I had 
simulated under three different heritability classes. The first model is a Bayesian 
mixture model that assumes a mixture of four normal distributions with zero means 
as the prior distributions for sampling the effect of a particular SNP. These 
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distributions are such that they contribute increasing proportions of the total 
additive genetic variance. The model samples the estimates of four parameters from 
their conditional posterior distributions using a Gibbs sampling scheme. These 
parameters are the additive genetic variance, the residual variance, the overall mean 
and the number of SNPs that go into each of the mixture distributions. 
3.3.1 BayesR parameter trace  
A Gibbs sampler uses a Markov Chain to make Monte Carlo approximations 
of the posterior distribution of parameters by drawing a large number of samples 
from it. To visualise how the parameters are sampled from the posterior distribution 
by the MCMC algorithm I produce trace plots of how the chain treads through the 
parameter space. These plots provide evidence of how the Markov chain converges 
to the posterior distribution. A good MCMC algorithm allows the parameters to have 
sufficient state changes along the chains. This is indicative of proper mixing, which 
means the algorithm jumps around well in the parameter space.  
I ran an MCMC chain of 50,000 cycles for each BayesR model. The first 20,000 
cycles of the chain were discarded as burn-in. Plots of the posterior samples of the 
additive genetic variance, the error variance and the number of SNPs sampled  
for each mixture component were generated to visualise the sampling.  
The plots in Figure 3.1 to Figure 3.4 were generated by drawing from every 
10th sample after burn-in to give a total of 3,000 posterior samples. The plots in Figure 
3.1 show that there are no mixing problems for the sampling of both the genetic and 
error variance for any of the heritability traits under any of the BayesR models. In the 
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low heritability traits, the trace for the posterior number of SNPs (Figure 3.2) shows 
that for the 1  2  components, the algorithm stays trapped in certain 
parameter states for longer periods at a time before jumping to other states. The 
trace of the two component distributions mirrors each other. 
 
Figure 3.1. Trace-plots of the posterior estimates of the genetic and error variance for each 
heritability trait for the 4 BayesR models. The MCMC chain was run for 50,000 cycles with 
the first 20,000 cycles discarded as burn-in. The trace-plots are therefore based on 3000 
sampled posterior parameters estimated drawn at every 10th cycle after burn-in. The plots 
show that the MCMC algorithm had no mixing problem when sampling the two 
parameters. 
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This means the two parameters are correlated and this is what potentially 
leads to the bad mixing. Perhaps this correlation is being driven by the fact the SNPs 
in these distributions contribute nothing and very little (about 10-4 on average per 
SNP) to the additive genetic variance respectively.  
The mixture model is a combination of the four components and thus without 
sufficient evidence to distinguish the 1  2, the algorithm wouldn’t be able to 
correctly classify SNPs in those two distributions. So, at one realisation it will put a 
particular group of SNPs in one distribution and at another realisation it will place 
 
Figure 3.2. Trace-plots of the posterior estimates of the number of SNPs in each component of the 
mixture distributions for the low heritability traits for the 4 BayesR models. The MCMC 
chain was run for 50,000 cycles with the first 20,000 cycles discarded as burn-in. The trace-
plots are therefore based on 3000 sampled posterior parameters estimated drawn at every 
10th cycle after burn-in. The plots for the 3  4 components show that the MCMC 
algorithm had no mixing problems.  
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those SNPs in the other distributions. The 3  4 components however, show 
very good mixing (Figure 3.2).  
The trace of the moderate (Figure 3.3) and high heritability traits (Figure 3.4) 
show a correlation between the parameter spaces for the first 3 components of the 




Figure 3.3. Trace-plots of the posterior estimates of the number of SNPs in each component of the 
mixture distributions for the medium heritability traits for the 4 BayesR models. The MCMC 
chain was run for 50,000 cycles with the first 20,000 cycles discarded as burn-in. The trace-
plots are therefore based on 3000 sampled posterior parameters estimated drawn at every 
10th cycle after burn-in. The plots 4 components show that the MCMC algorithm had no 
mixing problem. The 1, 2  3 components show bad mixing for the sampling.  
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3.3.2 Estimates of model parameters by the two models 
Estimates of the additive genetic and residual variances from this model were 
compared to those obtained from a GBLUP model. These results are summarised in 
Figure 3.5 and Table 3.1.   
I simulated 50 replicates of three different phenotypes with differing 
heritability values from low to high having 10%, 50% and 80% heritability, 
represented by h10, h50 and h80 in the results, respectively.  
 
Figure 3.4. Trace-plots of the posterior estimates of the number of SNPs in each component of the 
mixture distributions for the high heritability traits for the 4 BayesR models. The MCMC chain 
was run for 50,000 cycles with the first 20,000 cycles discarded as burn-in. The trace-plots are 
therefore based on 3000 sampled posterior parameters estimated drawn at every 10th cycle 
after burn-in. The plots 4  components show that the MCMC algorithm had no mixing 
problem. The 1, 2  3 components show bad mixing for the sampling. 
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The additive genetic effects for these traits were simulated using a random 
sample of SNPs across the genome totalling 5,520. These SNPs were split across three 
normal distributions with zero means and varying proportions of contribution to the 
total additive genetic variance of each simulated phenotype. The remaining SNPs 
were assumed to have no effect on the traits and thus contribute nothing to the total 
additive genetic variance. These zero effect SNPs constituted another distribution for 
 
Figure 3.5. Comparison of the heritability estimates of the simulated phenotypes obtained from 
the two models. BayesR with a default variance value for SNPs in the mixture components 
(BayesR_AV), BayesR with true values of SNP variance simulated for the three heritability 
traits (BayesR_TV), and BayesR under the first two instances but with starting values for 
the Dirichlet priors changed (BayesR_AV_cD and BayesR_TV_cD). The dashed lines are 
simulated heritability values for the different traits. The heritability estimates for the 
BayesR models with Dirichlet priors changed were inflated for the low heritability traits. 
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each of the simulated traits to give a total of four normal distributions as conditional 
priors for sampling the effects of SNPs. This simulation was in line with the basic 
assumption of BayesR. 
The BayesR model was implemented in four different ways. First was a BayesR 
model with arbitrarily set values for scaling the variance for SNPs in the mixture 
components, represented in the results as BayesR_AV. The second was a BayesR 
model which utilised true scaling values for the SNP variance simulated under the 
three heritability classes (BayesR_TV), and the last two were BayesR models with 
similar variance scaling values to the first two instances but with starting values for 
the number of SNPs that goes into the mixture components changed i.e. the Dirichlet 
priors were changed (BayesR_AV_cD and BayesR_TV_cD). 
The results reported in Table 3.1 and in Figure 3.5 show that the BayesR_AV 
and BayesR_TV models underestimated the heritability of h10 traits by about 35% 
and 22% respectively, on average. However, the heritability of the h10 traits analysed 
with BayesR models with Dirichlet priors changed were overestimated on average. 
The heritability for the h50 and h80 traits were estimated fairly accurately by all 
models, although some models slightly underestimated or overestimated them by 
between 1 – 5%.  
A total of 5,000, 500 and 20 SNPs were simulated to have an effect in 
the 2, 3  4 components of the mixture distributions respectively. It can be 
seen from Table 3.1 that analysing the low heritability traits (h10) with the default 
implementation of BayesR (BayesR_AV) underestimated the number of SNPs that 
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went into the 2  3  components by almost half whilst overestimating the 
number that went into the 4 component by more than double on average.  
Table 3.1. The posterior estimates of model parameters by the BayesR models for the three 
heritability classes. The model name, simulated trait name, heritability (calculated 
using the posterior estimates of the genetic and residual variances), estimated total 
number of SNPs, estimated number of SNPs for the second mixture component, 
estimated number of SNPs for the third component of the mixture distributions and 
the estimated number of SNPs for the fourth component of the mixture 
distributions. The values reported are the mean and standard deviation in the 
parenthesis of each estimate across the replicates of each heritability class. 
The  2, 3  4  components are simulated to each contribute to the total 
additive genetic variance. 
Model Trait % 
heritabilit
y 








h10 6.51 (1.37) 3402 (749) 3031 (796) 319 (46) 50 (7) 
h50 50.61 (4.25) 5260 (1228) 4804 (1348) 444 (125) 11 (5) 
h80 78.3 (3.96) 7019 (1026) 6704 (1138) 311 (113) 4 (2) 
BayesR_AV_c
D 
h10 18.2 (1.86) 1810 (512) 1580 (511) 137 (17) 94 (5) 
h50 52.4 (5.69) 5590 (845) 5300 (899) 239 (70) 44 (7) 
h80 80 (2.98) 7540 (610) 7350 (664) 161 (53) 28 (3) 
BayesR_TV 
h10 7.73 (1.69) 7540 (2645) 6930 (2762) 591 (136) 21 (3) 
h50 51.8 (4.25) 1920 (105) 1180 (203) 726 (148) 13 (5) 
h80 79 (4.26) 4890 (996) 3950 (1304) 923 (316) 11 (7) 
BayesR_TV_cD 
h10 15.7 (1.42) 6640 (1587) 6280 (1605) 316 (63) 41 (3) 
h50 52 (4.99) 1680 (146) 1070 (195) 566 (92) 44 (7) 
h80 79.7 (2.86) 5250 (385) 4670 (475) 540 (102) 45 (6) 
 
When the Dirichlet priors were changed, a similar trajectory was observed 
with the number that went into the 4  component more than quadrupled on 
average for the low heritability traits. In the moderate heritability traits (h50), these 
two implementations of the BayesR model estimated the number of SNPs that got 
sampled into the 2  3 components fairly well on average but underestimated 
and overestimated the numbers that went into the 4  component for the 
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BayesR_AV and BayesR_AV_cD models by half respectively. Both models 
overestimate the number of SNPs that are sampled into the 2 components and 
underestimate the 3 numbers. The 4 numbers are grossly underestimated for h80 
in the BayesR_AV model and overestimated by half in the BayesR_AV_cD. 
Further implementations of the BayesR model involved the use of the true 
scaling values obtained from the additive genetic variance simulated for SNPs in the 
various components of the mixture. Table 3.1 shows that this implementation of the 
model may not be very different from the default implementation. The only thing 
that stands out is the gross underestimation of the number of SNPs that are placed 
in the 2 component of the mixture distributions for the moderate heritability traits.  
Two things become obvious from these results. The first is that using arbitrary 
or true scaling values of genetic variance of SNPs for the mixture components in 
BayesR, on the average, underestimates the additive genetic variance of low 
heritability traits (Figure 3.5) except when the values for the Dirichlet priors are 
changed in which case it overestimates it. Second is that there is not much difference 
in the estimation of the number of SNPs with effects under the different models of 
BayesR. The importance of this is that there is not much benefit to be gleaned when 
the BayesR model is fitted with true prior values as opposed to arbitrary values which 
most likely will be the case in analysing real phenotypes.  
3.3.3 Selection of effect SNPs by the two models 
The heritability and the number of effect SNPs estimated by the models are 
remarkably not far off from the true numbers simulated on average. But more 
importantly, are the models finding the same effect SNPs that were simulated and 
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are they being placed in the right component class? To answer this question, nine 
simulated traits for each heritability class were chosen to investigate if the BayesR 
models pick simulated effect SNPs and if they place SNPs into the correct mixture 
distribution. The nine simulated traits selected for each heritability class were those 
with the lowest, middle and maximum values for estimated heritability, the total 
number of effect SNPs and number of SNPs in the  4  distribution in the h50 
heritability traits. In total, 27 simulated traits were selected across the three 
heritability classes.  
For each of the chosen simulations, I ranked all SNPs based on the estimated 
effect sizes and picked the top-ranked SNPs based on the total number of SNPs 
reported to have an effect by the models. I used the absolute values of the effect 
sizes for ranking SNPs without regard to their sign. I compared the RS-IDs of the top 
SNPs to those in the list of SNPs simulated to have an effect. The common SNPs 
between the two lists were counted for all the 5520 SNPs simulated to have an effect 
and another count that involved only the 20 SNPs simulated to have large effects. 
The same analysis was done for the GBLUP model and the results are shown in Figure 
3.6. 
The total number of overlaps between estimated and simulated SNPs with 
effect was on average very low across models and traits. The numbers improved 
when moving from low heritability traits to high heritability traits. BayesR on average 
performed better than GBLUP in the high heritability traits. The BayesR models on 
average were able to recover almost all the 20 SNPs with large effects in the medium 
and high heritability traits. GBLUP only managed to recover half of these large effect 
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SNPs on average in the medium and high heritability traits. The benefit of using the 
true SNP variances in a BayesR model was observed only in low heritability traits, 
whereas in the medium and high heritability traits it drove the numbers of true effect 
SNPs captured down. So again, there is no real benefit in using the true values of the 
SNP variances.  
 
 
Figure 3.6 Models choice of SNPs with effect over nine traits. The upper panel gives information 
on the top 20 SNPs and the lower panel is the total number of SNPs simulated to have an 
effect. The x-axis is the three different heritability traits. The BayesR models perform 
better than the GBLUP model in the moderate and high heritability traits. Both models 
perform similarly in the low heritability traits. In total, only a handful of the SNPs 
simulated to have an effect were picked up by the models. But on average the BayesR 
models were able to pick up nearly all the 20 SNPs simulated to have the largest effects 
in the moderate and high heritability traits 
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3.3.4 Genetic architecture of traits  
One of the selling points of BayesR is that it lends itself to the study of the 
genetic architecture of traits. The whole genome architecture of the simulated traits 
was investigated to assess the performance of BayesR in dissecting the genetic 
architecture of traits.  Where genetic architecture refers to the number of loci that 
affects a trait and the effect sizes of these loci. The results for the genetic architecture 
of the simulated traits are given in Figure 3.7 as proportions of the additive genetic 
variance explained by SNPs with effect. These are averaged over the 50 simulations 
for each heritability class. 
 
Figure 3.7. The whole genome architecture of the different heritability traits estimated using the 
different BayesR models. The proportion of additive genetic variance explained by SNPs 
with effect. The plot facets represent the three distributions describing the SNP effects. 
The dashed lines are the proportions of genetic variance simulated for the three traits; they 
are colour coded to correspond with the respective heritability traits. The medium and high 
heritability traits are estimated to have polygenic architecture. The two BayesR models 
with the Dirichlet prior changed on a whole gave better estimates of the proportion of 
variance explained than the other two models.  
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The h10 trait was simulated such that SNPs in the 2, 3  4 components 
of the mixture distributions accounted for 20%, 30% and 50% of the additive genetic 
variance respectively. BayesR_AV estimated these to be 37.8%, 37.9% and 24.2% on 
average respectively. When the Dirichlet prior was changed for the 4 component, 
the estimates were 16.82%, 14.30% and 68.46% on average. In the model that used 
the true SNP variances, changing the Dirichlet prior improved the estimates of the 
genetic variances in the mixture components. 
The h50 trait was simulated to have a polygenic architecture (bigger 
contribution to the total additive genetic variance from the low variance SNP 
distribution) and consequently, the  2, 3  4  components of the mixture 
distributions explained 50%, 30% and 20% of the additive genetic variance 
respectively.  
The BayesR models estimated these proportions fairly well. The models with 
the changed Dirichlet priors outperformed the models that used the default 
uninformative priors. The BayesR models were able to estimate the proportions of 
the 2 distribution close enough but the 3 proportions were slightly overestimated 
whereas the  4  proportions were underestimated in the models with default 
uninformative Dirichlet priors. 
The h80 trait also followed a polygenic architecture and the 2, 3  4 
components of the mixture distributions were simulated to account for 62.5%, 25% 
and 12.5% of the additive genetic variance respectively. BayesR models could 
accurately determine the genetic architecture for the high heritability traits. Similar 
Investigating the genetic control of complex traits 
Bayesian mixture model to investigate complex traits  86 
 
results were observed in the high heritability traits as in the moderate heritability 
traits. The 4 proportions of the variance were underestimated in the models with 
uninformative Dirichlet priors. 
3.3.5 Investigating the relationship between MAF, effect sizes and posterior 
inclusion probability 
I investigated the MAF spectrum for the SNPs with estimated effect, the 
relationship between the MAF, the effect sizes and the posterior inclusion probability 
using the BayesR_AV model for the nine selected traits as described in the section 
above. The SNPs with effects are well distributed across the MAF spectrum for all the 
heritability traits (Figure 3.8i – iii).  
There seems to be no apparent relationship between the MAF of SNPs and 
the SNP effects, and the posterior probability of a SNP being included in 2, 3 :7 4 
components of the mixture distributions, Figure 3.9 – Figure 3.10.  
I further investigated whether the SNPs with effect detected in the BayesR 
model are located within regions where I simulated SNPs to have an effect. I 
employed a rolling non-overlapping window approach along defined regions of 1000 
SNPs spanning the whole genome. So, for each region of 1000 SNPs, I calculated the 
sum of the absolute values of their simulated effects. I compared these sums to the 
sums of the absolute values of estimated SNP effects obtained using the BayesR 
model. The results of this analysis are shown in Figure 3.11 for the three different 
heritability traits. The sums of the estimated SNP effects are lower in magnitude and 
are spread uniformly across the genome as compared to the sums of simulated 
effects. 
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Figure 3.8. The minor allele frequency spectrum of SNPs sampled to have an effect on traits.  The 
panels represent a total of nine traits chosen for each heritability level. The selection 
criteria used is such that the top panels (i) are chosen based on the estimated 
heritability, the middle panels (ii) are based on the number of SNPs sampled for the 4 
distribution and the lower panels (iii) are based on the total number of SNPs sampled 
for the traits. The plots show that there is no apparent relationship between MAF and 
estimated SNPs with effects. BayesR does not discriminate on what SNP to sample to 
have an effect based on its MAF but samples across the whole MAF spectrum. 
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Figure 3.9. The relationship between minor allele frequency (MAF) of genome-wide SNPs and the 
estimated SNP effects (i) and posterior inclusion probability for the 2  distributions 
(PIP2) (ii).  Three traits were selected for each heritability. The plots show that there is 
no relationship between MAF of SNPs and the SNP effects or the PIP2.  
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Figure 3.10. The relationship between minor allele frequency (MAF) of genome-wide SNPs and 
the posterior inclusion probability for the 3  4 distributions (PIP3 and PIP4). Three 
traits were selected for each heritability. The plots show that there is no relationship 
between MAF of SNPs and the PIP3 or the PIP4.  
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3.3.6 Models prediction 
To evaluate the accuracy of phenotype prediction from genotype data using 
the BayesR and GBLUP models, I performed a cross-validation analysis using 30 of 
the simulated sets of phenotypes, 10 from each of the three heritability classes. The 
data within each replicate of the simulation were randomly split into five subsets to 
be used in 5-fold cross-validation analysis. The default BayesR model was used in this 
prediction analysis. For both models, the accuracy of prediction was based on the 
estimated effects of all markers. The accuracy of the prediction reported in Table 3.2 
is the correlation between the simulated breeding values (TBVs) and estimated 
breeding values (EBVs).  
Figure 3.11. Comparison between the simulated SNP effects and the BayesR estimates of SNP effects. 
The plots are sum of effects in 1000 SNP windows across the genome. The estimated SNP 
effects shown in red are lower on average across the regions than the simulated SNP effects. 
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Accuracy is a function of the heritability of the trait (Canela-Xandri et al., 
2015), and the genetic architecture of the trait (Daetwyler et al., 2010; Hayes et al., 
2010). For the two models, prediction accuracy, as expected, increased with 
increasing heritability. Theoretically, the maximum value attainable for prediction 
accuracy is the square root of the heritability (Canela-Xandri et al., 2015). For the 
GBLUP model, the accuracies were between 31% and 93% of the theoretical 
maximum for the traits. The BayesR model produced accuracies between 41% and 
46% of the theoretical maximum attainable for the traits.  
Bias is the other parameter of interest in prediction analysis, results given in 
Table 3.2. The two models produced slightly biased EBVs for the low heritability trait. 
The EBVs obtained for the moderate and high heritability traits using both models 
are unbiased, with slopes of about 1.  
Table 3.2. The prediction analysis of the BayesR model and GBLUP for the 10 replicates of 
the three heritability classes.  The columns are the simulated heritability class, model 




Traits Accuracy Bias Accuracy Bias 
h10 0.101 (0.015) 5.452 (1.192) 0.136 (0.018) 4.167 (0.747) 
h50 0.658 (0.004) 0.965 (0.035) 0.321 (0.034) 0.969 (0.066) 
h80 0.823 (0.002) 1.025 (0.011) 0.365 (0.013) 0.992 (0.027) 
 Discussion 
This chapter aimed to evaluate the potential of BayesR as a model to 
adequately provide estimates of complex traits parameters such as the genetic and 
residual variances and also truly capture the underlying genetic architecture of these 
complex traits. I conducted a simulation study using three different heritability 
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classes. I then proceeded to provide a comprehensive analysis and comparison of 
BayesR and GBLUP to analyse GWA-type datasets of complex traits.  
In Bayesian inference, unknown parameters are treated as random variables 
coming from a specified prior distribution. The posterior distribution of a parameter 
sums up the information about the parameter conditional on the observation of the 
data (Held and Bové, 2014). BayesR assumes the prior distribution of marker effects 
in a GWA analysis is a mixture of four normal distributions. The justification for this 
prior distribution is that the majority of the SNPs will not be in LD with a QTL and thus 
will have no effect, while a handful of SNPs will be in LD with a QTL and have an effect. 
Consequently, the first component of the mixture distribution contains SNPs with 
zero effects. The remaining three distributions sample SNPs effects that contribute 
to increasing proportions of the additive genetic variance in traits.  
The BayesR model performed well in estimating the heritability of traits 
spanning three different genetic architectures (Figure 3.5). The three different 
heritability traits simulated were low, moderate and high heritability traits with 
heritability of 0.1, 0.5 and 0.8 respectively. The moderate and high heritability traits 
were simulated such that the distributions had decreasing proportions of the additive 
genetic variance moving from the second component 2 to the fourth component 
4 of the mixture distributions. The low heritability trait was on the other hand, 
simulated to have increasing proportions of the additive genetic variance moving 
from the second to the last distribution. The BayesR model was able to dissect the 
genetic architecture of these traits (Figure 3.7). On the whole, the model correctly 
shows traits that have a polygenic architecture, perhaps because the model primarily 
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assumes polygenicity in the way it defines the second component 2 of the mixture 
distributions to have a large number of SNPs individually contributing a small effect. 
GBLUP does not offer such partitioning of the genetic variance to indicate how SNPs 
with effect contribute to the traits.  
BayesR detects almost all the SNPs simulated to have the largest effect in the 
moderate and high heritability traits (Figure 3.6). This is almost twice as good as 
GBLUP that could only manage to detect half of those on average. The power to 
detect a SNP as significant in a GWA analysis depends on the variance explained by 
the SNP. In GBLUP this consequently depends on the LD between the SNP and the 
causal SNP, the effect of the causal SNP and its frequency (Yang et al., 2010). 
Depending on the MAF and the effect size, causal variants may explain little variance 
and thus may not be picked up by GWAS models even though they may be in high LD 
with genotyped SNPs, however the variance explained by these SNPs aggregate to 
form part of the total variance explained and thus the GBLUP model will provide good 
estimates of the additive genetic variance (Figure 3.5). With that being said, LD also 
presents another problem to GBLUP models such that granted a causal SNP has a 
large MAF and a big effect and thus explains a large enough variance to be picked by 
the model and this SNP is in strong LD with multiple genotyped SNPs then its effect 
may be replicated (Speed et al., 2012). Speed et al. (2012) explore the possibility of 
this happening in detail and provide an analytical approach to deal with replicated 
effects of causal SNPs due to LD. The overall additive genetic variance estimate may 
not be affected by this because the overestimation of the effect in some part of the 
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genome due to high LD will be compensated for by the underestimation of the effect 
in other parts of the genome due to low LD.  
There was no apparent relationship between MAF and estimated SNP with 
effects for BayesR (Figure 3.8). Similarly, this was observed for all genome-wide SNPs 
(Figure 3.9 and Figure 3.10). BayesR provides an estimate of the total number of SNPs 
that affects a trait. These estimates for the number of SNPs shown in Table 3.1 and 
the estimates of the additive genetic variance are not very far off the actual numbers 
simulated for all the traits.  But looking at the results shown in Figure 3.6, the SNPs 
the model estimated to have an effect were only a small minority of the SNPs 
simulated to have an effect. This means although the estimates are correct, the 
model picks the wrong SNPs. The question then is, do the results that we get out of 
the models reflect what was simulated other than the sense that the models pick up 
something close to what is simulated? The SNPs estimated to have an effect could 
more or less explain the variance I simulated and I, therefore, decided to investigate 
if they lie within regions of simulated SNPs (Figure 3.11). This was done by 
aggregating the SNP effects across the genome in 1000 SNP bins. The plot for the 
simulated SNP effects appeared in spikes across the genome showing regional 
clustering of SNPs selected to have an effect with some regions having no effect 
(Figure 3.11). The plot for the estimated effect, on the other hand, was smoothed 
across the whole genome with one or two spikes in some regions. This observation 
may be down to three reasons. The first is that SNPs may be spending more time in 
the zero-effect distribution (based on the PIPs) than in the distributions with effect 
over all realisations. The Gibbs sampler at each sampling round estimates the effect 
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of a SNP and then classifies the SNP based on the effect it has estimated and place 
the SNP in the appropriate distribution. At the end of the chain, the mean effect 
across all realisations is calculated for each SNP and if SNPs are sampled most of the 
time to have no effect, then this will downwardly impact the effect estimate in the 
end. The second reason is that the washout of the estimated effect observed in 
Figure 3.11 might be due to the effect of LD: i.e. the split of the effect between all 
SNPs in LD with the effect SNP. This is because if two SNPs are perfect proxies for 
each other (i.e. LD of 1) and one is causal, the model may not be able to distinguish 
between them and at each one sampling stage, the model may give one SNP a 
posterior inclusion probability of 1 for having an effect and the other SNP a PIP of 
zero and at the end of the MCMC chain, the effect may be split over both. With that 
being said, the BayesR model works such that if the SNP effect is not well estimated 
consistently over realisations, then the model has no way of knowing the correct 
class for a SNP. The standard error of an estimate gives an indication of how good an 
estimate is. All SNPs with effect estimates that are less than their standard errors 
won’t be correctly classified by the model and thus may not be picked by the model. 
The BayesR model’s ability to detect effect SNPs is not entirely dependent on LD at 
least not in the same sense that LD affects GBLUP (as explained above); the BayesR 
model performs better than GBLUP at correctly picking out SNPs with large effect. 
The last reason, therefore, for the observations in Figure 3.6 and Figure 3.11 may be 
that the population size is quite small which will greatly impact the standard errors 
of the effect estimates. The standard error increases with decreasing sample size. So, 
although all the SNPs with effect on aggregate explain the total additive genetic 
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variance, their individual effects may not be picked up in any GWA model, at least 
not at any genome-wide significance, except for the few large ones. Thus, the effects 
of background polygenic markers with small effects may be poorly estimated and 
thus be missed by the models. BayesR still edges GBLUP in its ability to capture the 
SNPs with large effect.  This shows that if there is sufficient information for the 
BayesR model to act on (for instance large sample size or effect size), it will have 
sufficient power to correctly pick loci that have an effect on traits. Therefore, 
increasing the sample size will improve the individual locus effect estimates we get 
out of this model. 
The usefulness of a GWA model can be assessed by its ability to predict 
unobserved phenotypes of individuals using their genotypes. The accuracy of the 
prediction reported as the correlation between the simulated breeding values (TBVs) 
and estimated breeding values (EBVs), is used to assess predictive performance of 
models. The accuracy of prediction depends on a number of factors, one is SNPs that 
are in LD with causal loci and also the availability of SNPs that adequately capture the 
relationship structure between the training dataset and the test dataset (Habier and 
Fernando, 2013; Habier et al., 2008). Thus, having a lot of related individuals in your 
data improves accuracy. Nearly a third of the individuals (797) used in the study were 
close relatives with relationship greater than 3rd degree cousins. Out of these 
individuals, about 658 had relationships at the level of grandparent – grandchild and 
above. There was, therefore, sufficient relationship amongst study individuals to 
provide good prediction accuracies. And this was observed for GBLUP which gave 
very good accuracies for the moderate and high heritability traits. These accuracies 
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were better than the ones obtained with BayesR (which do not take advantage of 
familial relationships in the data) for the same traits. BayesR, however, provides 
slightly better prediction accuracies than GBLUP for the low heritability traits (Table 
3.2).  
Besides, family relationships in the data, the size of the training set used in 
the analysis and the marker density also impacts prediction accuracy (Makowsky et 
al., 2011). With a training set size of 470,000 individuals, which is the largest human 
training set ever used, Canela-Xandri et al. (2015) obtained accuracies that were 
between 68% and 86% of the theoretical maximum. By the deterministic formula for 
computing the prediction accuracy of additive genomic values (Daetwyler et al., 
2008, 2010), my training set size of 2312 individuals and 5520 independent effect loci 
would generate prediction accuracies of about 0.2005, 0.4161 and 0.5009 for the 0.1, 
0.5 and 0.8 heritabilities respectively, not taking family relationships into account. 
These accuracies will be between 56% and 63% of the theoretical maximum. BayesR 
produced accuracies that were between 41% and 46% of the theoretical maximum 
attainable for the traits, which goes to show that BayesR performs very well. 
Both models produce unbiased estimates of breeding values for the 
moderate and high heritability traits, but slightly biased EBVs for the low heritability 
traits (h10). Thus, for the h10 traits estimated breeding values are lower than the 
true breeding values. Bias is the slope of the regression of the TBVs on the EBVs. A 
predictor is unbiased if it has a slope of 1. When a predictor is biased, then the 
breeding values it estimates are expected to change when more information is 
accumulated. Therefore, the scale of the EBVs will be stretched towards the TBVs as 
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more information (more sample) is accumulated in the prediction analysis for the 
h10 traits. 
I will comment on the general applicability of BayesR to real phenotypes by 
stating that the default implementation that makes use of arbitrary values of 
0, 10&, 10&, 10&% as values for scaling the additive genetic variances for markers 
assigned to the mixture components works very well and in my case, there was no 
real advantage in knowing and using the true SNP variances in the model. Also, I 
further tested the robustness of the BayesR model by changing the starting values 
for the Dirichlet priors from  = (T, %, , ) = 1 to  = (1,1,1,10). This again 
showed BayesR gives good estimates of the parameters and is not strongly 
influenced by the starting values of the priors used.  
Another point I will make here is that, the phenotypes were simulated based 
on the assumption of BayesR: the effect of genetic markers are sampled from four 
normal distributions. This simulation assumption is quite simplistic and does not 
cover a wide enough range of complex trait architectures as may occur in real 
phenotypes. And also, the simulation may seem to give BayesR an unfair advantage 
over GBLUP when comparisons are drawn. An ideal scenario will be to draw 
additional comparisons between BayesR and GBLUP by simulating phenotypes under 
the GBLUP assumption: every genetic marker has an equal chance of contributing to 
the genetic variance. This will essentially mean simulating phenotypes where each 
genetic marker has an effect on the phenotype. However, the effects of genetic 
markers for such a phenotype will be completely washed-out across the genome, 
which will make mapping efforts basically impossible, and also such a phenotype will 
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not be representative of real-life scenarios. Therefore, although the simulated 
phenotypes may not be exhaustive enough in terms of the range of phenotype 
architectures possible and may be biased towards BayesR, it is a good start point. 
This is because it helps put in context what we should expect to find if indeed real 
phenotypes are controlled by genetic markers with effects sampled from more than 
one distribution.    
To sum up, I have performed a simulation study that assessed the 
performance of two GWA models, GBLUP and a Bayesian mixture model. Both 
models provide good estimates of the additive genetic variation explained by SNPs. 
The Bayesian model edges GBLUP in capturing SNPs with effect, however, GBLUP 
provides better prediction accuracies. The Bayesian model presents a unique 
opportunity to dissect the genetic architecture of traits; that is the number of loci 
affecting trait variation, their contribution to the additive genetic variance, and 
distribution of allelic effects. The estimates from the Bayesian model like any other 
GWA model will improve with the availability of more data. Therefore, although 
some statistical methods will have better power than others in capturing variants 
associated with complex traits, increasing the sample size will continue to be the best 
strategy in the quest to dissect the genetic architecture of complex traits. 
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4 Use of a Bayesian mixture model (Bayes R) to investigate 
the genetic control of urine phenotypes 
 
 Introduction 
The body’s metabolites and proteins are largely excreted through the urine. 
The urine concentration of electrolytes and proteins, therefore, provides insights into 
the functioning and metabolic capabilities of various body organs. These electrolytes 
are used by clinicians in the diagnosis of kidney disease.  
Unearthing genetic loci associated with these urine electrolytes will offer 
insights into the genetics of renal function and into the genetic predisposition of 
populations to chronic kidney disease.      
Bayesian approaches have been presented as better suited to deal with the 
numerous weaknesses catalogued for conventional GWAS (Meuwissen et al., 2001). 
In the previous chapter, BayesR was shown in a simulation study to have an edge 
over GBLUP in mapping loci with large effect leading us to conclude that BayesR is a 
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better alternative for uncovering genetic markers in traits and for predicting 
unobserved phenotypes. 
In this chapter, I present a genome-wide association study of urine 
electrolytes using a Bayesian mixture model (Erbe et al., 2012). A total of nine 
phenotypes comprising of measured urine electrolytes from about 3,000 individuals 
from the Generation Scotland: Scottish Family Health Study (Smith et al., 2012) were 
used. This study was designed with the aim of investigating the underlying genetic 
architecture of these urine phenotypes and to provide estimates of the additive 
genetic variance explained by the genome-wide SNPs. 
 Methods 
4.2.1 Genetic architecture of urine traits 
The BayesR model assumes a mixture of four normal distributions with zero 
means as the conditional priors for the distribution of SNP effects. This assumption 
is intuitively based on the fact that most of the SNPs will not be in LD with a QTL and 
thus will have no effect, while a minority of SNPs will be in LD with a QTL and have 
an effect. As a result, the first component of the mixture distribution contains SNPs 
with zero effects and the remaining three distributions contain SNPs with non-zero 
effects. The SNPs in each of the mixture have effects that are drawn from 
distributions that explain increasing proportions of the additive genetic variance in 
traits. 
The proportion of the additive genetic variance that is explained by each 
mixture distribution was used to investigate the genetic structure across the urine 
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phenotypes. Most quantitative traits are assumed to be polygenic such that a large 
proportion of the total genetic variance is explained by a large number of SNPs each 
explaining a very small amount of the genetic variance. This polygenic background 
underlies a few SNPs with moderate to large effects. The BayesR model is designed 
to be able to capture this structure in traits.   
The architecture was explored in two ways. First was the whole-genome 
architecture which considered how all the genome-wide markers contribute to the 
total additive genetic variance. This was investigated by considering the proportion 
of the additive genetic variance explained by all the SNPs that are in each of the 
mixture distributions.  
I also assessed the contribution of SNPs on each autosomal chromosome to 
the additive genetic variance. This chromosomal contribution to the genetic 
architecture was determined by calculating the proportion of the additive genetic 
variance explained by SNPs assigned to a particular mixture distribution on a 
chromosome. The proportion of genetic variance ¡ is calculated for chromosome 0 
of a trait as follows, 
¡3 = O O °N#±N% ²⁄NSTQST ,                                                     (4.1) 
where  is the number of SNPs on the chromosome 0, °N is the posterior probability 
of inclusion of a SNP to distribution mixture , #±N% is the additive genetic variance 
explained by distribution mixture , ² is the sum of the product of the total variance 
explained by all the SNPs and the posterior probability of inclusion of all SNPs. For A 
genome-wide SNPs,  ² is calculated as follows 
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² = O O °N#±N%NSTRQST                                                   (4.2) 
4.2.2 Genome-wide evidence for association 
The evidence for an association of a SNP with a trait is given by the posterior 
inclusion probability (PIP) value for that SNP for the four mixture distributions. The 
PIP for the first mixture distribution provides evidence in support of no association 
of a SNP with a trait. That is because SNPs sampled for that distribution are assumed 
to have zero effects. The evidence in support of association, therefore, is one minus 
the PIP of the first distribution. This value was obtained for all the SNPs and then 
used to generate association plots.   
4.2.3 Zoom in around top hit SNPs 
I extracted SNPs that flanked top hit SNPs by 500kb on both sides for further 
analysis to explore the LD structure in those regions, the recombination rates and to 
discover potential gene candidates within that region. 
 Results 
4.3.1 BayesR estimates of parameters 
Table 4.1 summarizes the estimates of these parameters for each of the nine 
urine phenotypes. The heritability values were calculated using estimates of the 
additive genetic variance and the residual variance. The traits all have low heritability 
values. The number of SNPs that are sampled into each of the mixture distributions 
is also reported for each trait. For all the traits, more than 99% of the SNPs were 
sampled to have no effect on the trait and thus placed in the first mixture 
distribution.  
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The number of SNPs sampled to have an effect on the traits varies from just 
over 2000 for urine creatinine to more than 4,000 for urine potassium. 
Table 4.1. The posterior estimates of model parameters by BayesR for the urine traits. The 
columns show the traits, heritability estimates from GBLUP and BayesR, estimated 
total number of SNPs having an effect on the trait, estimated number of SNPs for the 
first, second, third and fourth mixture components. 
 
4.3.2 The genetic architecture of urine phenotypes 
The GBLUP model estimates the total variance explained by all SNPs and 
provides an estimate of the effect for all SNPs but does not give any indication of how 
many SNPs truly affect a trait. BayesR, on the other hand, gives estimates closer to 
the true distribution of SNP effects by specifying a mixture of four normal 
distributions. The model estimates the variance explained by each component of the 
mixture distributions in addition to estimating the number of SNPs sampled into each 
distribution. This is the benefit of the BayesR model – it provides a neat way for 
studying the underlying genetic architecture of traits. 
Trait GBLUP BayesR 
 
h2 (%) h2 (%) No. SNP nk1 nk2 nk3 nk4 
Calcium 5.76 4.16 3631 551460 3286 294 50 
Chloride 1.25 5.5 2786 552305 2330 405 50 
Glucose 0 4.28 2728 552362 2353 309 65 
Potassium 0 4.2 4484 550607 4195 246 49 
Magnesium 10.5 4.5 2854 552237 2443 354 57 
Sodium 10.52 5.2 3579 551512 3219 309 51 
Osmolarity 4.22 5.2 2972 552119 2572 346 54 
Phosphorus 0 4.6 2788 552303 2425 303 60 
Creatinine 6.14 3.5 2283 552807 1842 379 62 
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In this study, the genetic architecture of the traits was investigated first at the 
whole genome level and subsequently at the chromosome level for the urine traits. 
The whole genome architecture for a trait was calculated by dividing the additive 
genetic variance explained by each mixture distribution by the total additive genetic 
variance.   
For estimating the chromosomal architecture, first, the proportion of the 
additive genetic variance explained by each chromosome was calculated by summing 
the product of the additive genetic variance contributed by a mixture distribution 
and the posterior probability of inclusion of SNPs allocated to that mixture 
distribution per chromosome. This was then divided by the sum of the product of the 
total variance explained and the posterior probability of inclusion of all SNPs on the 
chromosome.  
The results for the whole genome architecture of traits are shown in Figure 
4.1. The results closely mimicked the chromosomal architecture for all the traits; 
which are urine Calcium (uCa), urine Chloride (uCl), urine Creatinine (uCr), urine 
Glucose (uG), urine Potassium (uK), urine Magnesium (uMg), urine Sodium (uNa), 
urine Osmolarity (uO) and urine Phosphorus (uP).  
All the traits have a polygenic architecture. This means most of the additive 
genetic variance is explained by SNPs with small to moderate effects. These SNPs are 
sampled into the second and third components of the mixture distribution of SNP 
effects. These two distributions explain a larger proportion of the additive genetic 
variance of these traits than 4. The fourth mixture distribution samples SNPs with 
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large effects and this distribution explains a lesser proportion of the additive genetic 
variance in the urine traits.  
 
The results for the chromosomal architecture are shown in Figure 4.2 – Figure 
4.4. Again, all the traits are polygenic across all the chromosomes. The proportions 
of variation explained by the chromosomes were mostly driven by the length of the 
chromosomes (Figure 4.2 – Figure 4.4). 
 
Figure 4.1. The whole-genome architecture of the nine urine traits determined using BayesR. The 
proportion of additive genetic variance explained by SNPs with effect. The plot bars are colour 
coded to correspond to the proportions of genetic variance explained by the three mixture 
distributions that contain the SNPs with effect. The proportions were calculated by dividing 
the additive genetic variance explained by each mixture distribution by the total additive 
genetic variance explained by all SNPs. All the traits have an underlying polygenic architecture 
with mixture distributions that samples small and medium effects SNPs, 2  3 , 
explaining a larger proportion of the additive genetic variance.  
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Figure 4.2. The genetic architecture explained by SNPs with effect on each chromosome for urine 
calcium, chloride and magnesium. The proportion of additive genetic variance explained 
by each chromosome and the proportion of additive genetic variance explained by SNPs 
sampled with effect on these chromosomes are plotted. The plot bars are colour coded 
to correspond to the proportions of genetic variance explained by the three mixture 
distributions that contains the SNPs with effect. 
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Figure 4.3. The genetic architecture explained by SNPs with effect on each chromosome for urine 
creatinine, osmolarity and glucose. All the three traits follow a polygenic genetic 
architecture. 
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Figure 4.4. The genetic architecture explained by SNPs with effect on each chromosome for urine 
sodium, potassium and phosphorus. All the three traits follow a polygenic genetic 
architecture. 
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4.3.3 Genome-wide evidence for association 
The BayesR model calculates the posterior probability of including (PIP) a SNP 
in each of the four components of the mixture distribution. The PIPs of the four 
mixture distributions sum up to unity for each SNP. The first component of the 
mixture distribution samples SNPs that have no effect on the trait. The PIP of a SNP 
for this zero-effect distribution is, therefore, evidence of no association of that SNP 
to the trait. Thus, evidence for association of a SNP to a trait is given by 1 minus the 
PIP of that SNP for the first distribution. The values obtained from these calculations 
were used to generate the genome-wide association plots shown in Figure 4.5 – 
Figure 4.7. 
The genome position around the top associated marker for each trait was 
explored in an analysis to identify genes nearby. Figure 4.8 – Figure 4.11 show the 
results of this analysis. The genome regions explored are 500Kb upstream and 
downstream of the top associated SNPs for the urine traits.  
The top SNPs for most traits are located within genomic regions where there 
are genes close by. Urine creatinine had no gene within the genome region of the 
highest associated SNP. Table 4.2 summarises the direct gene ontology (GO) class for 
some of the genes identified to be lying close to the genomic position of the highest 
associated SNPs for some urine traits. The genes were explored to find possible 
associations to kidney disease. The highest associated SNP for urine osmolarity, 
rs795521, was mapped to the KLF12 gene on chromosome 13 (Figure 4.10). Diseases 
associated with the KLF12 gene may include Wegener’s Granulomatosis (Wieczorek 
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et al., 2010), which can cause rapidly progressive glomerulonephritis in the kidney 







Figure 4.5. The genome-wide evidence for SNP association for urine calcium, chlorides and 
magnesium. The posterior inclusion probability (PIP) plotted as evidence in support of 
association for each genome-wide SNP was calculated as one minus the posterior 
probability of including a SNP in the first component of the mixture distribution. The first 
component of the mixture distribution is assumed to have zero effect on a trait. The most 
significant SNP for urine calcium is on chromosome 14, for chloride is on chromosome 13 
and for magnesium is on chromosome 4. 
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Figure 4.6. The genome-wide evidence for SNP association for urine creatinine, osmolarity and 
glucose. The most significant SNP(s) for urine creatinine is on chromosome 5, for 
osmolarity is on chromosome 13 and for glucose is on chromosome 6. 
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Figure 4.7. The genome-wide evidence for SNP association for urine sodium, potassium and 
phosphorus. The most significant SNP for urine sodium is on chromosome 6, for potassium 
is on chromosome 22 and for phosphorus is on chromosomes 9. 
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Figure 4.8. Zoom in around 500kb upstream and downstream of the top-hit SNP for urine calcium 
(a) and chloride (b). The plots are based on the calculation of one minus the posterior 
inclusion probability of a SNP in the first component of the mixture distribution. The spikes 
in the plots represents recombination rate within the genomic region. The plot points are 
SNPs in the region and are colour-coded based on their LD with the top-hit SNP which is 
shown as a purple diamond. Nearby genes within the genomic region are written at the 
bottom panels of plots. For urine calcium, the GPR33 and AKAP6 genes have direct GO 
classes of positive regulation of cytosolic calcium ion concentration and positive regulation 
of release of sequestered calcium ion into cytosol respectively. 
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Figure 4.9. Zoom in around 500kb upstream and downstream of the top-hit SNPs for urine 
magnesium (a) and creatinine (b). The top hit SNP for urine magnesium is in moderate 
LD with a handful of SNPs within the genomic region and these are bounded by 
recombination hotspots. The SH3RF1 gene lies downstream of this top SNP and it has a 
direct gene ontology (GO) class of metal ion binding. The urine creatinine top hit SNP is 
weakly correlated with other SNPs and there are no nearby genes within the genomic 
region.  
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The highest associated SNP for urine sodium, rs7750062, was mapped within 
0.32Mb of the TBX18 gene (figure 4.12). The TBX18 (T-Box 18) gene is involved in 
renal development and diseases associated with the gene include congenital 
anomalies of the kidney and urinary tract 2 and bilateral multicystic dysplastic kidney 
(Vivante et al., 2015). Congenital anomalies of the kidney and urinary tract are the 
commonest cause of chronic kidney disease in people within the first three decades 
of their life (Vivante et al., 2015).  
Table 4.2. The Gene Ontology (GO) class for the nearby genes located within genomic regions 
of top-hit SNPs for urine traits. The columns show the trait name, the gene symbol, 
the gene name, the direct GO class of gene and the GO reference. 
Urine Trait Gene Gene name GO class (direct) Reference 
Calcium GPR33 Probable G-protein 
coupled receptor 33 
positive regulation of 
cytosolic calcium ion 
concentration 
GO_REF:0000033 
 AKAP6 A-kinase anchoring 
protein 6 
positive regulation of 
release of sequestered 




zinc finger protein 
280A and B 
metal ion binding GO_REF:0000037 
 GNAZ Guanine nucleotide-
binding protein G(z) 
subunit alpha 
Metal ion binding GO_REF:0000037 
 GUCA2B Guanylate cyclase 
activator 2B 
Digestion, excretion and 






ate synthase A 
metal ion binding GO_REF:0000037 
 CLDN19 Claudin-19 calcium-independent 









Osmolarity KLF12 Krueppel-like factor 
12 
metal ion binding GO_REF:0000037 
Magnesium SH3RF1 E3 ubiquitin-protein 
ligase SH3RF1 
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Figure 4.10. Zoom in around 500kb upstream and downstream of the top-hit SNP for urine 
osmolarity (a) and glucose (b). The top hit SNP for urine osmolarity is moderately 
correlated with SNPs within two recombination hotspots. The KLF12 gene has a direct GO 
class of metal ion binding. Diseases associated with KLF12 may include Wegener’s 
Granulomatosis, which can cause rapidly progressive glomerulonephritis in kidney leading 
to chronic kidney failure. The top SNP for urine glucose is weakly correlated with the other 
SNPs in the region and that means it is individually driving the genetic association within 
those regions.  
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Figure 4.11. Zoom in around 500kb upstream and downstream of the top-hit SNP for urine 
phosphorus (a) and sodium (b). The top hits of both traits are in high LD with one SNP 
and is moderately correlated with other SNPs and these are bounded by two 
recombination hot spots for urine sodium. For urine sodium, the TBX18 gene lies 
upstream of this top SNP and has a direct GO class of renal system development. 
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A top hit SNP in urine potassium, rs4660630, was mapped close to the 
GUCA2B (within 0.23Mb) and CLDN19 (within 0.346Mb) genes on chromosome 1 
(Figure 4.12). The GUCA2B gene also known as uroguanylin is involved in electrolyte 
homeostasis (Forte et al., 1996; Kinoshita et al., 1997) and may be implicated in 
kidney disease (Rahbi et al., 2012). Variations in uroguanylin were associated with 
urinary volume and sodium and potassium secretion (Guo et al., 2007). The CLDN19 
gene was found to be expressed in renal segments that are mainly involved in 
paracellular cation transport (Lee et al., 2006) which may suggest their possible 
involvement in that process. Lee et al., (2006) reported a decreased expression and 
delocalization of CLDN19 in polycystic kidneys suggesting a possible link between the 
gene and kidney disorders.  
  Discussion 
I used a Bayesian mixture model (BayesR) to perform a genome-wide 
association (GWA) analysis on measures of urine electrolytes from about 3,000 
individuals from the Generation Scotland: Scottish Family Health Study. The general 
premise of a GWA analysis is to set measured values of a trait of interest in study 
individuals as a function of whether an individual has one of three possible genotypes 
at a genome position. These genotypes are codes of allele counts derived from a 
genome-wide array of SNPs. The import of a GWA analysis is to test for association 
between these SNPs and the phenotype of interest.  
This can be done in several ways. The most commonly used approach is to fit 
one SNP at a time in a multiple regression model. The Bayesian mixture model I used 
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fits all SNPs simultaneously to estimate their effect on the trait. But instead of 





Figure 4.12. Zoom in around 500kb upstream and downstream of the first (a) and second (b) top-
hit SNPs for urine potassium. In the lower panel, the top SNP is in high LD with one SNP 
within two recombination hotspots. There are lots of genes nearby the top hits. The 
ZNF280A and ZNF280B, GNAZ, and RIMKLA genes have a direct GO class of metal ion 
binding. The GUCA2B may be implicated in the regulation of salt and water homeostasis 
in the intestines and kidneys. A decreased expression and delocalization of CLDN19 gene 
was reported by Lee et al., (2006) in polycystic kidneys suggesting a possible link between 
the gene and kidney disorders 
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drawn from the same normal distribution, the model assumes that the majority of 
the SNPs do not have an effect on the trait and also their effects are drawn from a 
mixture of four normal distributions with increasing contribution to the total additive 
genetic variance.     
The BayesR model, therefore, provides an estimate of the total number of 
SNPs having an effect on a trait. It has been established long before GWA analysis 
that quantitative traits may be controlled by multiple genetic loci and methods that 
try to map these loci had already been developed (Haseman and Elston, 1972). 
Subsequently, GWA studies in complex traits, starting with the Wellcome Trust Case 
Control Consortium (WTCCC) (Burton et al., 2007), confirmed this polygenic 
architecture for human complex traits and suggested that complex traits may be 
affected by thousands of genetic loci individually contributing a small effect (Stranger 
et al., 2011; Visscher et al., 2012, 2017). For the urine traits studied, BayesR 
estimated the number of effect SNPs to be between 2283 and 4,484 SNPs. This means 
over 99% of the SNPs tested have no effect on these traits. When the BayesR model 
was used to analyse binary traits from the WTCCC, over 96% of the SNPs were found 
to have zero effect on the traits (Moser et al., 2015). These effect SNP numbers 
obtained from BayesR support the widely held belief that complex traits may be 
under the control of thousands of genetic loci (Visscher et al., 2017). And the direct 
implication of these results is that it won’t be long for most loci affecting most 
complex traits to be mapped, since true effect SNPs of most complex traits may be 
just a few thousand loci. These loci-mapping efforts will be greatly aided by the 
recent advancement in the field of whole genome sequencing, and improved 
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analytical methods and also significantly increased study sample size such as the UK 
Biobank (Sudlow et al., 2015).  
The BayesR estimates of heritability obtained for the urine traits were 
generally low but not zero as were obtained for some of the urine traits using GBLUP. 
Urine glucose had moderate heritability with much of the additive genetic variance 
explained by SNPs sampled in the large effect component of the mixture distribution.  
All the urine traits have a polygenic architecture (Figure 4.1). This polygenic 
architecture was also observed in the chromosomes for the traits. The proportions 
of additive genetic variance explained by the chromosomes were positively 
correlated with chromosome size in all traits (Figure 4.2 – Figure 4.4). 
Figure 4.5 to Figure 4.7 show that the BayesR model can identify SNPs that 
have effects on traits, but often the evidence of association (1 minus PIP of k1 
component of mixture distribution) was low but not zero. The overarching aim of a 
GWA analysis is to understand the underlying biology of traits, especially diseases, in 
the hope of gaining a better understanding of disease aetiology which may translate 
to improved prevention and treatment. To this end, I mapped the highest associated 
SNPs to genomic regions to identify genes close by and explore possible links 
between these nearby genes and the urine traits that have been measured in my 
study population.  
All the highest associated SNPs for the urine traits, except urine creatinine, lie 
in genomic regions which harbour genes (Figure 4.8 to Figure 4.12). One may expect 
SNPs that are associated with complex traits to lie within genes, but there is also 
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enough information to suggest that a lot of the variants affecting complex traits 
reside outside genes in regulatory sequences that control gene expression (Pai et al., 
2015). This was the case for most of the highest associated SNPs for the urine traits. 
The SNPs reside either within genes or in intergenic sequences within the genomic 
regions. For some of the traits, there were possible functional links between the 
genes nearby associated SNPs and the urine traits tested. For instance, one 
associated SNP in urine potassium is situated close to the CLDN19 gene which has 
been implicated in kidney disease related phenotypes (Lee et al., 2006). These genes 
and others identified for the other urine traits could serve as candidate genes in 
future efforts aimed at finding gene targets for kidney disease therapy.    
I conclude by saying that, BayesR is a good analytical tool for studying the 
genetic architecture of complex traits. The method gives an estimate of the number 
of loci affecting a trait which potentially becomes useful to efforts in trying to map 
causal loci of complex traits. The BayesR genome-wide evidence of association given 
by the posterior inclusion probabilities was mostly low for a lot of the urine traits. 
This indicates that BayesR like many other analytical methods is susceptible to low 
power due to the small sample size. The results from BayesR analysis, therefore, can 
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5 Regional Heritability analysis of complex traits using 




Before the introduction of SNPs in genetic research, the best linear unbiased 
predictor (BLUP) was the standard method for genetic evaluation, particularly in 
livestock research (Robinson, 1991). BLUP made use of a relationship matrix that 
contained identity by descent (IBD) coefficients, calculated using pedigree 
information of study individuals. The BLUP analytical method was later implemented 
in a genome-wide analysis setting using an identity by state (IBS) relationship matrix 
that was calculated using genome-wide SNPs (Meuwissen et al., 2001; VanRaden, 
2008). This genomic implementation of BLUP was named GBLUP. Efficient ways for 
calculating these genomic predictors were proposed by VanRaden (2008), who 
proposed two genomic relationship matrices (GRMs) in which the covariance of 
genomic values between two individuals are scaled to be analogous to the pedigree-
based relationship matrix used in BLUP.  
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These GRMs by VanRaden (2008) became widely accepted by genetic 
researchers and used in a restricted maximum likelihood method known as GREML 
to calculate the total genetic variance or the heritability (Yang et al., 2010). The 
GREML method played a pivotal role in uncovering some of the so-called missing 
heritability of complex traits (Clarke and Cooper, 2010; Maher, 2008; Manolio et al., 
2009; Speed et al., 2012; Yang et al., 2011). More than half a decade and several 
analytical methods later (Chen et al., 2015; Gonzalez-Recio et al., 2015; Hemani et 
al., 2013; Reynolds and Finkel, 2015; Yang et al., 2015; Zhu et al., 2015; Zuk et al., 
2012), the heritability was believed to be hidden (Yang et al., 2015) rather than 
missing. 
The heritability may be missing or hidden, and in both cases, this points to 
one fact: that current analytical approaches in genetic variance estimation can 
account for only a fraction of the total contribution of genetic factors to the variation 
observed in phenotypes. There is, therefore, the need for continual efforts in 
uncovering the total heritability. 
One of the numerous arguments made to account for the missing heritability 
is that true causal variants of traits may be rare (Pritchard, 2001) and thus may be in 
incomplete linkage disequilibrium (LD) with genotyped SNPs (Yang et al., 2010). 
There is, therefore, some benefit to be gained in terms of improving the heritability 
estimates and uncovering gene variants involved in the control of traits by fitting 
GWA models that adequately capture rare genetic variants (Cirulli and Goldstein, 
2010; Gonzalez-Recio et al., 2015).  
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I am proposing a genome-wide analytical approach that draws its theoretical 
basis from a variant of the GREML approach that uses both local and genome-wide 
relationship matrices to provide regional estimates of the heritability across locally 
defined regions in the genome (Nagamine et al., 2012). What is unique in this 
approach is that it utilises a relationship matrix that is based on local haplotype blocks 
defined by recombination boundaries in the genome. 
Compared with SNPs, haplotype analysis has an advantage because 
haplotypes can be functional units (Vormfelde and Brockmöller, 2007) and thus 
haplotype analysis can capture the joint effects of closely linked cis-acting causal 
variants (Balding, 2006). Haplotypes provide a better strategy in capturing true 
genomic relationship amongst individuals in the presence of rare variants and thus 
should provide real benefit over SNPs in recovering much of the missing heritability 
and identifying novel trait-associated variants. This is because although rare variants 
are not in LD with genotyped variants and thus difficult to capture in GWAS, these 
rare variants may be in LD with some haplotypes and thus can be captured using 
haplotype methods. 
I hypothesize that this approach will complement already existing GWAS 
analytical approaches by capturing regions in the genome contributing to the 
phenotype that existing GWAS methods fail to capture. In this chapter, I report the 
implementation of this approach on simulated data and explored its performance in 
detail. Results from the simulation study support my hypothesis and I have confirmed 
there are real benefits to be gained from this approach by applying it to real data 
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obtained from about 20,000 individuals from the Generation Scotland: Scottish 
Family Health Study (GS: SFHS). 
 Methods 
5.2.1 SNP-based regional GREML model  
The general statistical setting of a regional GREML analysis has been 
described already in the methods section in chapter 2. This type of SNP-based 
regional GREML analysis was first reported by Nagamine et al. (2012). The regional 
GREML analysis approach I employ here differs from the analysis done by Nagamine 
et al. (2012) in the way the regions are defined. Their analysis defined local regions 
by breaking the genome into smaller user-defined windows of   SNPs, which 
overlapped by P SNPs. My model, however, defines local regions naturally based on 
recombination boundaries in the genome.  
The regional GREML model fits two genetic relationship matrices (GRMs): one 
local GRM for the region and a whole genome GRM for the remaining SNPs in the 
genome that are outside the region. Both GRMs are kinship matrices calculated as 
the proportion of the genome-wide autosomal SNPs shared identity by state (IBS) 
between pairs of individuals. The SNP IBS matrices are calculated as follows, 
following the second scaling factor proposed by VanRaden (2008)  
+ = >>′A                                                                   (5.1) 
where A is the total number of local or genome-wide autosomal SNPs, and @ is a 
matrix of genotype codes for the sampled individuals which has been centred by loci 
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means and normalised by the standard deviation of each locus. @ is calculated as 
follows for individual 0 at locus V 
>3Q = (P3Q − 2/Q)³2/Q(1 − /Q)                                                 (5.2) 
where P3Q is the genotype code at locus V for individual 0 and takes the values 0, 1 
and 2 for AA, Aa and aa genotypes respectively, /Q is the frequency of allele ‘a’ at 
locus V . The SNP-based kinship for individuals 0  and   is therefore calculated as 
follows 
+3N = 1A × O (P3Q − 2/Q)(PNQ − 2/Q)2/Q(1 − /Q)RQST                             (5.3) 
5.2.2 Haplotype-based regional GREML model  
The haplotype-based regional GREML model follows on theoretically from the 
SNP-based analysis and utilises haplotypes instead of SNPs as the genetic markers for 
the local analysis. The analysis fits two GRMs, a haplotype-based regional GRM and 
a SNP-based genome-wide GRM. The haplotype-based GRM is similar to the SNP-
based GRM defined in the previous section. For a locally defined region containing ℎ 
haplotypes, the haplotype-based kinship for individuals 0  and   is calculated as 
follows 
3́N = 1ℎ × O (3Q − 2/Q)(NQ − 2/Q)2/Q(1 − /Q)µQST                                (5.4) 
where 3Q is the diplotype code (coded as the number of copies of haplotype V) for 
individual 0  and takes the values 0, 1 and 2 for the ℎ¶ℎ¶, ℎ¶ℎQ , ℎQℎQ  diplotypes 
respectively where 1 ≠ V, /Q  is the haplotype frequency for haplotype V. 
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5.2.3 Phenotype simulations 
Five phenotypes were simulated using available genotypic information of 
approximately 20,032 individuals from the Generation Scotland: Scottish Family 
Health Study (GS: SFHS) (Smith et al., 2012). A total of 593,932 genotyped SNPs were 
used, and missing genotypes were filled in by imputed data. About 555,091 SNPs 
remained after a QC that removed SNPs of MAF < 0.01 and SNPs that were out of 
Hardy-Weinberg equilibrium at p-value < 1e-5.  
The five phenotypes were simulated to have a total variance of 1. This is 
composed of 0.6 environment variance and a genetic variance of 0.4. The genetic 
variance was partitioned into two components, a polygenic variance of 0.3 and a QTL 
variance of 0.1. A common polygenic variance was simulated for all five phenotypes 
from 20,000 markers randomly selected across the genome. Half of the 20,000 
markers were randomly assigned negative effects and the other half were randomly 
assigned positive effects. The polygenic SNP effects were assumed to be normally 
distributed with zero mean and variance equal to the polygenic variance 0.3.  
For each phenotype, 20 regions or haplotype blocks were randomly selected, 
one on each chromosome (except chromosomes 6 and 8 because of the unusually 
high LD in the MHC regions on chromosome 6 and inversion duplication regions on 
chromosome 8), to simulate quantitative trait loci (QTL). This gave a total of 20 QTLs 
for each phenotype. The regions were delimited by natural boundaries which are 
recombination hotspots where the estimated recombination frequency do not 
exceed 10 centiMorgans per Megabase (10cM/Mb) based on the Genome Reference 
Consortium Human Build 37 (International Human Genome Sequencing Consortium, 
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2004). The number and type of marker used to simulate the QTL are what defined 
the five phenotypes. The five phenotypes are, a 1-SNP QTL within the haplotype 
block, a multiple-SNP (5 SNPs) QTL within the haplotype block, two types of 1-
haplotype QTL within the haplotype block and multiple (5) haplotype QTL within the 
haplotype block. These are described below. 
For the haplotype QTL phenotypes, a haplotype block is treated as a single 
genetic locus having multiple alleles. Each haplotype within a block is considered as 
an allele of that locus. Each study individual will carry two alleles or diplotypes for 
each locus or haplotype block. The genotype data used to simulate the phenotypes 
was phased using SHAPEIT (Delaneau et al., 2012) and haplotypes for study 
individuals were extracted. The multiple haplotype QTL phenotypes were simulated 
by randomly sampling two rare haplotypes and three common haplotypes within 
each haplotype block to give a total of five haplotypes per block. The two types of 1-
haplotype QTL phenotypes were simulated by randomly sampling a rare haplotype 
per haplotype block for one type and for the other type a common haplotype was 
randomly sampled within each haplotype block. 
The polygenic effect and the QTL effects were calculated as follows 
#Q% = 2 O /Q;Q%QST , 
;Q = ¨ #Q%2 ∑ /QQST ,                                                 (5.5) 
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where #Q% is the contribution of a QTL to the polygenic variance, ;Q is the effect of a 
SNP V or haplotype V randomly sampled to have polygenic or QTL effect, /Q  is the 
frequency of haplotype V or the effect allele of the SNP V,  is the number of alleles 
at a genetic locus. For a diallelic locus such as those for genotyped SNPs,  = 2. Each 
QTL explained a variance of 0.005. For the single QTL phenotypes, each QTL marker 
had a variance of 0.005. The multiple QTL phenotypes also had a variance of 0.005 at 
each locus, and each QTL marker explained a variance of 0.001.    
Common environmental effects were randomly sampled for the five 
phenotypes from a normal distribution !(0, #$%) where #$% is 0.6. This together with 
a genetic variance of 0.4 gave a total variance of 1 for each phenotype. The final 
simulated phenotype for an individual 0 was then calculated as follows  
(f0;9 ·¸)3 = O P3Q;Q%QST + O P3Q;Q + 3,
%
QST                          (5.6) 




ST                   (5.7) 
where P3Q is the number of copies of haplotype V or the effect allele of SNP V and ;Q 
is the effect of haplotype V or SNP V. Twenty replicates were analysed for each of the 
five phenotypes with a different set of QTL markers sampled for each replicate.   
5.2.4 Model implementation    
The regional GREML model is a mixed effects model that fits both fixed and 
random effect terms. In this simulation study, the mean is fitted as a fixed effect and 
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the polygenic, QTL and residual terms are fit as random effects. The model fits two 
GRMs to account for the local QTL variance and whole genome polygenic variance.  
The five phenotypes were analysed using two models, a SNP-based regional 
GREML model (Sbm) (for the SNP QTL phenotypes) and haplotype-based regional 
GREML model (Hbm) (for the haplotype QTL phenotypes). To test for the specificity 
of the analytical models, I applied the haplotype-based regional GREML model to SNP 
QTL phenotypes and the SNP-based regional GREML model to the haplotype QTL 
phenotypes. I also performed an Hbm analysis in which the natural haplotype block 
sizes were restricted to 20 or fewer SNPs per haplotype block. This was to investigate 
whether the regional effect will be well captured by the haplotype-based model 
when shorter haplotypes are used. 
The SNP-based model GRMs were calculated using the REACTA software 
(Cebamanos et al., 2014). The haplotype-based model GRMs were calculated using a 
locally written Fortran programme. The GRMs were then utilised in REACTA to 
estimate the regional genetic variance and polygenic variance using a restricted 
maximum likelihood. For each phenotype, I analysed 220 regions in total to map the 
20 simulated QTLs. This involved analysing the region containing the QTL and 10 
adjacent regions (five in either direction).  
 Results  
I performed a regional GREML analysis that fits two GRMs (one for the region 
and one for the rest of the genome) per region across multiple genomic regions 
defined by recombination hotspots. I tested two types of regional GREML models on 
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20 replicates of five simulated phenotypes. One model fitted a regional SNP GRM 
(SNP-based model) and the other fitted a regional haplotype GRM (Haplotype-based 
model), each together with a genome-wide SNP GRM. The phenotypes were 
simulated to have 20 regional QTL effects and genome-wide polygenic effects. The 
regional QTL effects of the five phenotypes were simulated using SNPs as causal 
variants for two of them and haplotypes for the remaining three.  
The likelihood ratio test (LRT) was used to test the hypothesis, H0: that the 
genetic variance explained by the region is not significant, against the alternative, H1: 
that the region accounts for a significant proportion of the genetic variance. A large 
LRT statistic is an evidence against the null hypothesis, and therefore means the 
region explains a significant proportion of the genetic variance.  
The LRT averaged over the 20 replicates of the five phenotypes are shown in 
Figure 5.1 and Figure 5.2. Figure 5.1 shows the average LRT for the QTL regions and 
10 adjacent regions. The results show that both models could estimate the simulated 
regional effects with statistical significance and therefore can capture true causal loci 
in traits. The LRTs were higher on average for the SNP-based model (Sbm) compared 
to the haplotype-based model (Hbm).    
The models, however, fail to capture the simulated regional effects when the 
simulated phenotype does not match the analysis model (Figure 5.3a and 5.3b). 
These figures show the results for the situation where the SNP QTL phenotypes were 
analysed with the haplotype-based model and the haplotype QTL phenotypes were 
analysed with the SNP-based model.  Both models fail in such situations. Figure 5.3a 
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and 5.3b show that the models are complementary to each other since they capture 
effects due to different types of genetic variants (i.e. tagged by SNPs or haplotypes).  
i.                                                    ii.  
 
Figure 5.1. Plots of Likelihood ratio test (LRT) statistics at each QTL loci and 10 adjacent regions 
averaged for the 20 simulations of each of the five QTL phenotypes. Plot (i) is SNP QTL 
phenotypes analysed using the SNP-based model and plot (ii) is the haplotype QTL 
phenotypes analysed using the Haplotype-based model. Both models can capture the 
simulated QTL effects for their respective phenotypes. 
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The LRT statistics decayed with increasing region size (the number of markers 
in the region) for the two models even when the models matched the simulated 
phenotypes (Figure 5.4a). The rate of decay was more pronounced in the haplotype-





Figure 5.2. Plots of average LRT statistics over replicates of QTL loci across the chromosomes for the 20 
simulations of each of the five QTL phenotypes. The red dashed lines are genome-wide 
significance at alpha of 0.05 and the black dashed lines are Bonferroni significance threshold 
(for 220 regions). The upper panel (i) is plot of SNP QTL phenotypes analysed using the SNP-
based model and the lower plot (ii) is a plot of haplotype QTL phenotypes analysed using the 
Haplotype based model. Both models, on average, captures the effects SNP and haplotype 
QTLs at loci very well.  
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Figure 5.3a. Plots of average LRT statistics over replicates of QTL loci across the chromosomes for the 20 
simulations of each of the two SNP QTL phenotypes. The red dashed lines are genome-wide 
significance at alpha of 0.05 and the black dashed lines are Bonferroni significance threshold (for 
220 regions). The upper plot (i) is the 1-SNP QTL phenotype and the lower plot (ii) is the multiple 
SNP QTL phenotype. The two phenotypes are analysed using both the SNP based model (SSbm) 
(blue line) and the Haplotype based model (Hbm) (red line). The Haplotype based model fails to 
capture the simulated effects for the SNP QTLs. 
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i.          ii.  
             
iii.  
 
Figure 5.3b. Plots of average LRT statistics over replicates of QTL loci 
across the chromosomes for the 20 simulations of each of the 
three haplotype QTL phenotypes. The red dashed lines are 
genome-wide significance at alpha of 0.05 and the black dashed 
lines are Bonferroni significance threshold (for 220 regions). The 
plot (i) is the 1-rare haplotype QTL phenotype, the plot (ii) is the 
1-common haplotype QTL phenotype and the plot (iii) is the 
multiple haplotype QTL phenotype. The three phenotypes are 
analysed using both the SNP-based model (blue line) and the 
Haplotype based model (red line). The SNP-based model fails to 
capture the simulated effects for the haplotype QTLs. 
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Figure 5.4a. Plots of LRT statistics against QTL region size for the 20 simulations (not averaged) of 
each of the two SNP QTL phenotypes. The red dashed lines are genome-wide significance 
at alpha of 0.05 and the black dashed lines are Bonferroni significance threshold (for 220 
regions). Plot (i) is the 1-SNP QTL phenotype and the lower plot (ii) is the multiple SNP 
QTL phenotype. In both phenotypes the LRT statistic reduced with increasing region size.  
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i.             ii.    
                    
iii.  
Figure 5.4b. Plots of LRT statistic against QTL region size for the 20 
simulations of each of the three haplotype QTL phenotypes. 
The red dashed lines are genome-wide significance at alpha of 
0.05 and the black dashed lines are Bonferroni significance 
threshold (for 220 regions). The plot (i) is the 1-rare haplotype 
QTL phenotype, the plot (ii) is the 1-common haplotype QTL 
phenotype and the plot (iii) is the multiple haplotype QTL 
phenotype. For all the three phenotypes the LRT statistic 
reduced with increasing region size.  
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 For the SNP QTL phenotypes, the variance estimated by the Sbm in regions 
where I simulated effects were significantly different from zero (except two regions 
in both phenotypes) (Figure 5.5a). The variance was however overestimated for 
some regions, although there is no apparent relationship between the LRTs and the 
estimated variance (that is the estimated variance does not get closer to the 
simulated as the LRT increases). 
  The regional variance estimates for the haplotype QTL phenotypes, on the 
other hand, improved with increasing LRTs (Figure 5.5b). The plots show that once 
the LRT passes the Bonferroni-corrected threshold for genome-wide significance (red 
horizontal dashed lines), the variance estimates approached the simulated value of 
0.005 (blue vertical line). 
Plots shown in Figure 5.6a show no relationship between region size (number 
of markers in the region) and the estimated regional variance for the SNP QTL 
phenotypes. The estimated regional variances for the haplotype QTL phenotypes, 
however, are inflated when region size has more than 5,000 different haplotypes, 
Figure 5.6b.  
I further investigated whether the LRT statistics and the estimated regional 
variances are influenced by the allele frequencies of the QTLs. I show in Figure 5.7 
that there is no relationship between allele frequencies and LRTs. The haplotypes 
simulated to have an effect in regions with an overestimated regional variance are 
marked with different colours on these plots. These haplotypes are shown to have 
rare haplotype frequencies and relatively low LRTs (Figure 5.7i and ii). Figure 5.7 
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shows that the QTLs for the 1-SNP QTL phenotypes and 1 common haplotype QTL 
phenotypes are well distributed across the MAF spectrum, whereas the QTLs for the 




ii.     
 
 Figure 5.5a. Plots of LRT statistic against estimated regional variance for the 20 simulations of the 
single SNP QTL phenotype. The red dashed lines are genome-wide significance at alpha 
of 0.05, the black dashed lines are Bonferroni significance threshold (for 220 regions) and 
the blue vertical line is the simulated regional variance of 0.005. The plot (i) is the 1 – SNP 
QTL phenotype and the lower plot (ii) is the multiple SNP QTL phenotype. The estimated 
regional variance clustered closely around the simulated value for most of the regions. 
The variances of a few regions were overestimated in both phenotypes.   
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Figure 5.5b. Plots of LRT statistic against estimated regional variance for 
the 20 simulations of each of the three haplotype QTL 
phenotypes. The red dashed lines are for genome-wide 
significance at alpha of 0.05, the black dashed lines are Bonferroni 
significance threshold (for 220 regions) and the blue vertical line 
is the simulated regional variance of 0.005. The plot (i) is the 1-
rare haplotype QTL phenotype, the plot (ii) is the 1-common 
haplotype QTL phenotype and the plot (iii) is the multiple 
haplotype QTL phenotype. The estimated regional variance 
clusters closely around the simulated value for the regions that 
pass the Bonferroni threshold. 
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Figure 5.6a. Plots of region size against estimated regional variance for the 20 simulations of the 
two SNP QTL phenotype. The blue vertical line is the simulated regional variance of 0.005. 
The plot (i) is the 1-SNP QTL phenotype and the lower plot (ii) is the multiple SNP QTL 
phenotype. The two plots show there is no apparent relationship between estimated 
regional variance and region size. 
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Figure 5.6b. Plots of region size against estimated regional variance for 
the 20 simulations of the three haplotype QTL phenotype. 
The blue vertical line is the simulated regional variance of 
0.005. The plot (i) is the 1-rare haplotype QTL phenotype and 
the plot (ii) is the 1-common haplotype QTL phenotype. On 
these plots, the blue square point is the region with the 
largest overestimated variance, the green triangle points are 
regions with overestimated variance, red points are all other 
regions and purple points are regions with least variance 
estimates. The plot (iii) is the multiple haplotype QTL 
phenotype. The plots show that the estimates of the regional 
variances are likely to be inflated when the region size gets 
beyond 1000 haplotypes. 
Investigating the genetic control of complex traits 
Haplotype-based regional GREML analysis of complex traits  145 
 
i.                 ii.  
                   
iii.  
 
Figure 5.7. Plots of LRT statistic against QTL marker frequencies. The red 
dashed lines are genome-wide significance at alpha of 0.05 and 
the black dashed lines are Bonferroni significance threshold (for 
220 regions). The plots (i) and (ii) are 1 rare and 1 common 
haplotype QTL phenotypes respectively. On these plots, the blue 
square point is the region with the largest overestimated 
variance, the green triangle points are regions with 
overestimated variance, red points are all other regions and 
purple points are regions with least variance estimates. The plot 
(iii) is the 1-SNP QTL phenotype analysed using the SNP based 
model (blue points) and the haplotype-based model (red points). 
The three plots show that there is no relationship between QTL 
marker frequencies and the LRT statistic.  
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When the region sizes used in the haplotype-based model were reduced in 
an analysis that restricted the natural haplotype block sizes to 20 or fewer SNPs per 
haplotype block, the haplotype-based model underestimated the regional variance 
at larger regions but did not offer any discernible improvement in the LRT statistics 
(Figure 5.8). 
 Discussion 
I have proposed and implemented a genome-wide analytical method that 
analyses blocks of genomic regions using a regional GREML model (Cebamanos et al., 
2014). The uniqueness in this method is that, genomic regions in my data are defined 
naturally by recombination hotspots drawn from a reference human genome and, I 
fit a regional GREML model that fits a haplotype-based GRM (Hbm) (Shirali et al., 
2018). I also fit another regional GREML model that fits a SNP-based GRM (Sbm) to 
draw comparisons with the haplotype method.  
I hypothesised that the haplotype-based model will complement 
conventional GWAS methods which are predominantly SNP-based. I investigated this 
hypothesis in a simulation study in which I simulated 20 replicates each of two types 
of SNP QTL phenotypes and three types of haplotype QTL phenotypes.  
The results show that the two models can capture the effects of causal 
variants within genomic loci that are associated with the phenotype analysed. The 
usefulness of the SNP-based GREML model in analysing real phenotypes had been 
demonstrated and widely implemented in GWA research (Canela-Xandri et al., 2015; 
Cebamanos et al., 2014; Yang et al., 2010, 2011).  
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Figure 5.8. Plots for the 1-rare haplotype QTL phenotype analysed using the haplotype-based model 
(red points) and a hybrid variant of the haplotype-based model (blue points). The hybrid 
model broke larger regions (regions with more than 20 SNPs) into smaller regions of 20 or 
less SNPs and used that to determine the haplotypes. Each blue point represents the 
estimated variances or LRT for best sub-window within the bigger window. (i) is a plot of 
region size over estimated regional variance for the 20 simulations of the phenotype and 
(ii) is the plot of LRT statistic over QTL region size for the 20 simulations of each of the 
phenotype. The plot (i) shows that the hybrid model underestimates the regional variance 
at larger regions. The LRT statistics however do not improve very much over the default 
haplotype-based model.   
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Figure 5.9. Histogram of counts of pairwise relationships for haplotype GRM for region with 
overestimated variance. (i) the diagonal relationships indicating relationship between 
individuals and themselves. (ii) the off-diagonal relationships indicating the relationship 
between an individual and everybody else. The lower plot shows there are lots zero kinships 
among individuals in the largest haplotype block. 
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The usefulness of the more novel haplotype-based GREML model (Shirali et 
al., 2018) for the analysis of real data is of particular interest because the results from 
this simulation study show that this model is capable of capturing causal loci with 
statistical significance which is very reassuring in terms of applying the model to real 
data and finding real effects.  
The results also show that the two models are very specific to the type of 
marker effect they can capture. Figure 5.3a and b show that the haplotype-based 
model can specifically target haplotype effects which are mostly missed by SNP-
based analysis and vice versa. These results, therefore, support my hypothesis that 
haplotype-based GREML models will complement SNP-based GREML models.  
The GREML models use the covariance of genomic values calculated from 
SNPs that are identity by state (IBS) between pairs of study individuals. This IBS matrix 
is used to estimate the fraction of the phenotype variance explained by genotyped 
genomic markers (mostly SNPs) (Yang et al., 2010). The way haplotypes are defined 
in my setting makes it possible that in the same region, pairs of individuals may be 
related in the SNP-based GRM but not related in the haplotype-based GRM. This can 
generate major disparity between a SNP-based GRM and haplotype-based GRM 
within the same region in terms of which cluster of individuals are genetically similar 
and how different these cluster of individuals are from the rest of the population. 
The GREML model works by projecting the marker-derived genetic relationships 
between individuals onto their phenotypic differences to estimate the genetic 
variance (Yang et al., 2010). Thus, mismatching the simulated phenotype and the 
model will mean the relationship matrix won’t reflect well the phenotypic differences 
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between the individuals. One would then observe very low or zero genetic variance 
estimates and highly insignificant LRT statistics as observed in the simulation study. 
This will also be expected when using real phenotypes.   
The results shown in Figure 5.4a and b show that the LRT statistic decayed 
with increasing region size for both analytical models (even when phenotype 
simulation matches the analytical model). The rate of decay, however, was relatively 
higher in the haplotype-based analysis model. This observation may be explained by 
the structure of the GRMs. The pairwise genetic relationships provide the 
information for estimating the genetic variance and therefore there must be some 
genetic similarity between a subset of individuals in a region for the model to 
estimate the genetic variance within that region with statistical significance. If many 
pairs of individuals have “zero” (i.e. very small) kinships in a region then the genetic 
variance within that region cannot be estimated relatively with much statistical 
significance. The results showed the number of markers within regions increased by 
one or two orders of magnitude in the haplotype-based model compared to the SNP-
based model. In large regions (with many markers) there are lots of very rare markers 
in the haplotype-based analysis. Therefore, since there won’t be adequate sharing of 
the rare haplotypes in these very large regions between individuals, there won’t be 
a generation of higher kinships in the haplotype-based GRMs. For instance, if you 
have a pair of individuals sharing one rare haplotype, then they would have a very 
high pairwise relationship estimate and their relationship with other individuals will 
be very small as well if there is no haplotype sharing. In such a GRM, there will be 
lots of near-zero pairwise relationships (Figure 5.9) and clusters of high pairwise 
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relationships which will affect the estimate of the variance and thus impact the LRT 
statistics. 
The regional variances in the longer haplotype blocks were overestimated by 
the haplotype-based analysis model. These regions are known to potentially harbour 
lots of rare haplotypes, which could mean the haplotypes that are chosen as QTLs in 
the simulation are more likely to be rare. One could imagine that individuals who 
share a QTL haplotype would have greater genetic similarity and be unrelated to 
everyone else in the regional relationship matrix. The phenotype will be associated 
with this cluster of individuals and not associated with the rest and this should drive 
down the estimate of the variance and not overestimate it. However, because the 
long haplotypes blocks harbour lots of rare haplotypes, these haplotypes may be in 
long-range LD with variants in other regions (Sabeti et al., 2002) and thus explain 
some of the variance in other regions, whereas the shorter haplotypes will be 
common and won’t be in long-range LD with variants in other regions. This view is in 
line with the neutral theory of molecular evolution (Kimura, 1983), where because it 
takes new variants such a long time to rise to high frequencies in the population, 
recombination would cause a considerable decay of the LD around them by the time 
they are common. Again, the GREML model normalises the marker genotypes and 
assumes that the effect size per normalised genotype follows a normal distribution.  
This indirectly assumes that a variant with lower MAF will have a larger allele effect 
and thus by design the model is likely to overestimate its effect. Although this model 
assumption is in harmony with a model of negative selection (Loewe, 2008) where 
selection acts on variants with larger effect sizes to keep them at lower frequencies, 
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the effect sizes may be largely overestimated in some cases which may drive down 
the LRT statistic. I, therefore, observed very low test statistics for the long haplotype 
blocks (Figure 5.4b).   
I attempted to mitigate this low test statistics by implementing a hybrid-Hbm 
that limited the haplotype window sizes to 20 SNPs or less. The results for this are 
shown in Figure 5.8 where the LRT for the sub-window explaining most of the 
variance within the bigger window is plotted. The hybrid model underestimated the 
variance for the size-limited haplotype windows and offered no improvement to the 
test statistics. The most obvious reason for this may be that breaking the large 
regions also breaks up the long haplotypes structures in such a manner that the 
resulting relationships estimated with the shorter haplotypes do not exactly match 
the ones obtained from long haplotypes used to simulate the phenotypes. For 
example, if you take a large haplotype window, the similarities between shared 
haplotypes may be driven by a combination of alleles at several SNPs along the 
haplotype. Therefore, breaking the window up such that a lot of individuals do not 
get the combination of the alleles in that haplotype driving the variance, makes 
detecting its effect difficult. I must mention here that, for any large window there 
were at least two sub-windows whose variance sum up approximately to give the 
total variance simulated. I reported the sub-windows with the highest test statistic 
because the sub-windows are most likely to be correlated and thus the sum of the 
variance and the covariance of all the sub-windows will end up overestimating the 
variance.   
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This may be an obvious problem for the Hbm, but this is not sufficient to 
downplay the usefulness of this analytical method in a real phenotype setting. In the 
real world, one could imagine most haplotype analyses going wrong because the 
haplotypes are not actual haplotypes; instead, they are imputed from genotype data. 
But this does not apply here because in this simulation study the imputed haplotypes 
are used for both simulation and analysis. Granted, it may be difficult to account for 
any uncertainty that arises during phasing when assessing the overall significance of 
any finding from this method, but when LD between markers is high the level of 
uncertainty is quite low (Balding, 2006). Therefore, for the large haplotype windows, 
one way to deal with the problem of low LRT is to use a recombination frequency of 
5cM/Mb for these windows instead of the usual 10cM/Mb. This lower threshold 
generates windows with relatively high LD (Figure 5.10) and shorter haplotype 
lengths which can improve the test statistics.  
In conclusion, I have implemented a regional GREML analysis that analyses 
regions in the genome delimited by natural recombination boundaries and shown 
that haplotype-based methods (Hbm) can capture portions of the genetic variance 
that may be missed by conventional SNP-based analysis when the simulated effect is 
not SNP. The Hbm, however, struggles to accurately capture causal effects at regions 
with very long haplotypes (haplotypes consisting of more than 20 SNPs) and I suggest 
utilising lower recombination threshold in such regions to alleviate this issue.  The 
results from this simulation study show the usefulness of these models and I, 
therefore, implement these methods in the next chapter to analyse real phenotype 
data from GS: SFHS and UK Biobank data. 
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Figure 5.10. Plots of LD structure within largest haplotype window. (i) is the LD structure within a 
recombination threshold of 10cM/Mb. (ii) is the LD structure of the same region delimited by a 
recombination threshold of 5cM/Mb. The use of 5cM/Mb broke the window into 6 sub-windows 
and shown here is 5 plots (the third sub-window had just one SNP, so no plot is shown for it). From 
the plots it obvious that the LD structure large window improves when the recombination threshold 
is lowered.    
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Figure 5.11a. Plots of Likelihood ratio test (LRT) statistic of QTL loci across the chromosomes for the 
20 simulations of 1-SNP QTL phenotypes. The upper plot (i) is analysis done using the SNP-
based model and the lower plot (ii) is analysis done using the Haplotype based model. The 
Haplotype based model fails to capture the simulated effects for the SNP QTLs.  
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Figure 5.11b. Plots of Likelihood ratio test (LRT) statistic of QTL loci across the chromosomes for the 20 
simulations of multiple-SNP QTL phenotypes. The top plot (i) is analysis done using the SNP-based 
model and the lower plot (ii) is analysis done using the Haplotype based model. Here again the 
haplotype-based model fails to capture the QTL effects simulated for multiple SNP QTL phenotypes.  
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Figure 5.11c. Plots of Likelihood ratio test (LRT) statistic of QTL loci across the chromosomes for the 20 
simulations of 1-common haplotype QTL phenotypes. The upper panel (i) is analysis done 
using the SNP-based model and the lower plot (ii) is analysis done using the Haplotype based 
model. In this phenotype the SNP-based model fails to capture the simulated QTL effects. 
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Figure 5.11d. Plots of Likelihood ratio test (LRT) statistic of QTL loci across the chromosomes for the 20 
simulations of 1-rare haplotype QTL phenotypes. The upper panel (i) is analysis done using the SNP-
based model and the lower plot (ii) is analysis done using the Haplotype based model. The 
haplotype-based model can capture the simulated QTL effect irrespective of the haplotype 
frequency. 
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Figure 5.11e. Plots of Likelihood ratio test (LRT) statistic of QTL loci across the chromosomes for 
the 20 simulations of multiple-haplotype QTL phenotypes. The upper panel (i) is analysis 
done using the SNP-based model and the lower plot (ii) is analysis done using the 
Haplotype based model.
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6 Regional heritability analysis of height and major 
depressive disorder phenotypes of GS: SFHS and UK 




GWA studies of height have been hugely successful with a lot of significant 
associations being found (Lin et al., 2017). That have offered some useful insights 
into the biology of height. The same cannot be said for major depressive disorder 
(MDD), however, for which uncovering genomic associations have proven difficult so 
far (Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium 
et al., 2013).  
The SNP heritability of MDD is estimated to be between 21% (Cross-Disorder 
Group of the Psychiatric Genomics Consortium et al., 2013) and 32% (Lubke et al., 
2012), and this implies that there is some genetic contribution to the disease 
aetiology. The failure of GWAS to identify significant genomic loci for MDD has been 
put down to sample size and heterogeneity of the trait (Levinson et al., 2014). Large 
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sample size is needed before we can expect to identify multiple associations for 
MDD. Inferring from schizophrenia, Levinson et al. (2014) reasoned that an excess of 
75,000 to 100,000 MDD cases is needed in a GWA study before we can expect to get 
some real answers.  
More recent GWA studies of MDD have seen substantial sample size increases. 
A GWA study that analysed 322,580 UK Biobank individuals for three depression-
related phenotypes found 14 independent loci significantly associated with MDD 
(Howard et al., 2018). Another study performed a GWA meta-analysis of 135,458 
MDD cases and 344,901 controls and identified 44 independent loci significantly 
associated with MDD (Wray et al., 2018). These studies seem to provide support for 
the assertion that MDD GWA studies with sufficiently large sample sizes will detect 
multiple significant associations. 
Increased sample size has offered some progress but that is not the only way 
forward for MDD GWA mapping. MDD is a very heterogeneous phenotype, and thus 
every MDD case will have a set of genetic and non-genetic risk factors exclusive to 
them (Levinson et al., 2014). The heterogeneity due to unique non-genetic risk 
factors reduces power to detect causal variants in GWA analysis across multiple 
cohorts (Wray and Maier, 2014). Also, the unique genetic risk factors will mean that 
at the population level, a lot of the genetic variants driving the disease will be rare. 
These potentially causal rare variants will be in weak linkage disequilibrium (LD) with 
genotyped SNPs and thus GWA analysis of SNPs will not have sufficient power to 
detect them. The answer to uncovering genetic risk loci for MDD, therefore, does not 
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lie in large sample size GWA studies alone, other analysis strategies to unearth MDD 
risk loci need to be developed.     
Haplotypes are sets of linked SNP alleles on the same chromosome. For a trait 
like MDD which may be driven by lots of rare variants, seeking associations with 
haplotypes might be a better approach than seeking associations with SNPs in 
uncovering loci with effect. This is because although rare variants will be in weak LD 
with genotyped variants, they might be in strong LD with haplotypes. A genome-wide 
haplotype-based association analysis of MDD in 18,773 individuals identified two 
haplotypes to be significantly associated with MDD (Howard et al., 2017). There is, 
therefore, some promise in GWA study of MDD by employing haplotypes.  
The usefulness of other mapping methods like the regional GREML analysis in 
uncovering significant loci in MDD has also been shown (Zeng et al., 2017a, 2017b), 
where gene loci significantly associated with MDD were identified. 
This study, therefore, performs a regional GREML analysis of MDD and height in 
about 20,000 GS: SFHS individuals using natural haplotypes blocks defined by 
recombination hotspots in the genome. The aim is to be able to capture novel genetic 
variants that may be having an effect on these traits and improve the estimates of 
the genetic components of the variation in these traits. I also compare the results to 
the results of analyses of height and MDD done using a mixed linear model, GBLUP 
and BayesR. The study will then seek replication of any association results obtained 
in the GS: SFHS in the UK Biobank Leeds subpopulation cohort which is the largest 
sub-cohort of UK Biobank. 
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 Methods 
6.2.1 Study cohorts 
6.2.1.1 Genotyping, quality control and phasing of Generation Scotland: Scottish 
Family Health Study dataset 
The data from the Generation Scotland: Scottish Family Health Study 
comprised of 23,960 participants recruited from Scotland (Smith et al., 2006). The 
DNA from about 20,032 of the participants had been analysed using the Illumina 
HumanOmniExpressExome8v1-2_A chip (~700K genome-wide SNP chip) (Smith et al., 
2012).  
Quality control (QC) excluded SNPs and individuals with a call rate less than 
98%, SNPs with minor allele frequency (MAF) less than 1% and SNPs that were out of 
Hardy-Weinberg equilibrium (p-value < 0.000001). A total of 555,091 autosomal 
SNPs passed quality control for downstream analysis. Phasing of the GS: SFHS data 
was done using SHAPEIT2 (Delaneau et al., 2013). Haplotype blocks were defined 
using recombination hotspots with a recombination rate of 10cM/Mb inferred from 
the Reference Consortium Human Build 37 (International Human Genome 
Sequencing Consortium, 2004). Haplotypes within blocks were determined using the 
phased data.  
6.2.1.2 Genotyping, quality control and phasing of UK Biobank dataset 
The full UK Biobank (Sudlow et al., 2015) dataset contains genotype 
information for about 488,377 participants. The genotypes of about 50,000 
participants were assayed using the UK BiLEVE Axiom array (Wain et al., 2015) by 
Affymetrix (807,411 SNPs). The remaining participants in the cohort were genotyped 
using the UK Biobank Axiom array (825,927 SNPs) (Bycroft et al., 2017). 
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The cohort of participants from Leeds, the largest recruitment centre (in 
terms of number of participants) of the UK Biobank, were used as replication cohort 
to assess those genomic regions that were identified as associated for MDD within 
the GS: SFHS by the haplotype-based analysis model with p-value < 5 × 10&m. Pre-
QC of the data excluded individuals identified as non-white British using genotypes 
rather than self-reported ancestry. It also removed outliers based on heterozygosity 
and missingness and sex mismatch between self and inferred sex. Individuals who 
had withdrawn consent were also excluded. A second QC removed individuals and 
SNPs with a call rate less than 98%, SNPs with a MAF less than 1% and SNPs that were 
out of Hardy-Weinberg equilibrium (p-value < 0.000001). A total of 38,010 individuals 
and 621,890 SNPs passed QC and were used for downstream analysis. The data had 
been phased using a SHAPEIT3 (Marchini, 2015). 
6.2.2 Phenotype definition 
MDD status for GS: SFHS participants was assigned following an initial mental 
health screening questionnaire with the questions: “Have you ever seen anybody for 
emotional or psychiatric problems?” or “Was there ever a time when you, or 
someone else, thought you should see someone because of the way you were feeling 
or acting?” Participants who answered yes to one or more of the screening questions 
were further interviewed by the structured clinical interview for the diagnosis of 
mood disorders (SCID) (First et al., 2002). A total of 18,725 participants (2,603 MDD 
cases and 16,122 controls) were retained for analysis for MDD. 
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A total of 19,944 participants from the GS: SFHS were analysed for height. The 
phenotypes were controlled for sex, age, age2, and first 20 principal components 
calculated from the genomic covariance matrix of study participants. 
A broad MDD phenotype was defined for UK Biobank participants in which 
depression cases were diagnosed for participants who answered yes to either of 
these questions: “Have you ever seen a GP for nerves, anxiety, tension or 
depression?” or “Have you ever seen a psychiatrist for nerves, anxiety, tension or 
depression?” A total of 13,723 cases and 24,287 controls were defined for the UK 
Biobank cohort.  
6.2.3 Regional GREML analysis 
Regional GREML analysis using fixed region sizes in the genome has been 
shown to be a good mapping method for finding local genetic effects (Nagamine et 
al., 2012). The model uses both local and genome-wide GRMs in the analyses to map 
genetic loci with effect. A regional GREML method that uses recombination hotspots 
to define natural region sizes in the genome has been successfully used in the analysis 
of MDD to map genetic loci (Zeng et al., 2017a, 2017b).  
This study utilizes a regional GREML model that defines natural regions 
delimited by recombination hotspots to analyse height and MDD. Two types of 
regional GREML models are fitted in turn to the phenotypes. The first model uses 
SNPs to construct local genetic relationships between study individuals and the 
second model defines local relationships amongst individuals using haplotypes.   
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The significance of a region was tested with the likelihood ratio test (LRT). The 
model fits the effects of markers in each region as random and the effects of all SNPs 
in the background outside a region analysed also as random. The LRT tests for the 
significance of a random regional effect by comparing a model with both the regional 
and whole-genome effects fitted against a model in which only the whole-genome 
effect is fitted. 
The p-values obtained from LRTs were used to generate genome-wide 
association plots for both models for each phenotype. The genome-wide significance 
threshold was calculated to be LRT = 23.88 (p-value < 1.02 × 10&¹) for the SNP-
based model and LRT = 22.54 (p-value < 2.04 × 10&¹ ) for the haplotype-based 
model using a Bonferroni correction for testing 48,772 and 24,513 regions 
respectively (a lesser number of regions were tested for the Hbm because I skipped 
regions with one SNP). The suggestive significance of a region was set at an LRT = 
16.5 (p-value < 5 × 10&m).      
6.2.4 Mixed linear model, GBLUP and BayesR analysis of height and MDD 
The height and MDD phenotypes from the GS: SFHS were analysed using the 
three GWAS models described in the previous chapter: the mixed linear model 
analysis, the genomic best linear unbiased predictor (GBLUP) and BayesR. The p-
values of association and 1 minus the posterior inclusion probabilities (PIP) of the 
zero-effect distribution were used to generate genome-wide association plots for the 
two phenotypes. The genome-wide significance threshold was set at p-value  <
5 × 10&(. 
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6.2.5 SNP-based association test of SNPs in most significant regions identified by 
the Haplotype-based model for MDD 
A linear mixed effects model was used to test for phenotype association with 
the SNPs in the genome-wide significant regions identified by the haplotype-based 
regional GREML analysis. The effects of the regional SNPs and covariates such as sex, 
age, age2 and the first 20 principal components calculated from the genomic 
covariance matrix of study participants were fitted as fixed, and the background 
polygenic effect was fitted as random in the linear mixed effects model association 
analysis using GCTA (Yang et al., 2011).   
 Results 
6.3.1 Regional GREML analysis of GS: SFHS 
The heritability estimates for height and MDD are 81.4% and 13.8% 
respectively (Table 6.1). The chromosome number and the heritability estimates for 
the genome-wide significant regions are shown in Table 6.1. For the two traits, there 
were no overlaps between regions identified as significant by both models. This 
reaffirms my hypothesis that the haplotype-based model is complementary to the 
SNP-based models in mapping out associated genomic loci. 
The regional GREML results for height and MDD are presented as plots of 
minus-Log10 of LRT p-values (Figure 6.1 and Figure 6.2). The plots for the analysis 
using the two models, SNP-based and haplotype-based models are shown. The 
results for the mixed linear model analysis (MLMA) and BayesR are also shown in 
Figure 6.1 and Figure 6.2 for the two traits. 
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The results for height show that 14 regions passed the Bonferroni-corrected 
genome-wide significance threshold in the analysis using the SNP-based regional 
GREML model. No region was genome-wide significant for height when analysed with 
the haplotype-based model, but three regions were significant at the suggestive 
level. There are five genome-wide significant regions for height analysed with the 
MLMA. The BayesR analysis of height showed several regions with PIPs > 0.5, with 
about seven regions having PIPs > 0.9.   
Table 6.1. The heritability estimates of traits under the two models. The columns are the type 
of heritability estimate, chromosome (Chr) number, heritability estimates and 
standard errors for the height and MDD under the two models. 
  Height MDD 
Heritability Chr Sbm Hbm Sbm Hbm 
Total h2  81.36 (0.9) 81.35 (0.9) 13.82 (1.3) 13.81 (1.3) 
h2 GW significant 
regions for MDD 
3    1.5 (0.3) 
20   0.35 (0.26)  
h2 GW significant 
regions for height 
6 0.16 (0.1)    
20 0.32 (0.2)    
3 0.19 (0.1)    
4 0.5(0.24)    
18 0.24 (0.12)    
2 0.26 (0.15)    
6 0.6 (0.28)    
6 0.43 (0.18)    
15 0.72 (0.43)    
13 0.14 (0.15)    
15 0.19 (0.1)    
6 0.29 (0.22)    
15 0.1 (0.1)    
6 0.37 (0.18)    
From the plots in Figure 6.1, it can be seen that the association hits are more 
enriched in the SNP-based analyses than in the haplotype-based analysis for height. 
This can be explained by the fact that height is a trait driven by a lot of common 
genetic variants which may be in LD with genotyped SNPs on SNP chips 
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(disproportionately enriched for common SNPs) and thus SNP-based analyses should 
capture the effect of most of the genetic variants in height.      
For MDD, one region passed the Bonferroni-corrected genome-wide 
significance threshold for the analysis done with the SNP-based regional GREML 
model. Again, one region passed the genome-wide significance threshold when MDD 
was analysed with the haplotype-based model, however, 20 regions were significant 
at the suggestive p-value. There are six regions that are significantly associated with 
MDD at the suggestive level when analysed with the MLMA. The most significant 
region for MDD was on chromosome 10 for the BayesR analysis. This same region 
was found to be the most significant for MDD for the MLMA. The SNP driving this 
association is rs1331328 with p-value < 1.01 × 10&¹ for the MLMA and PIP > 0.332 
for the BayesR analysis. The SNP was again found to be lying in a region that was 
nearly genome-wide significant at the suggestive level for (p-value < 6.16 × 10&m)  
MDD in the SNP-based GREML analysis. The SNP lies in the CACNB2 gene which has 
been reported to be associated with five major psychiatric disorders including major 
depressive disorder (Cross-Disorder Group of the Psychiatric Genomics Consortium, 
2013). The gene has also been reported as an emerging pharmacological target for 
mental disorders (Soldatov, 2015). The gene region was however not replicated in 
the haplotype-based GREML analysis. 
The association hits for MDD are more enriched as one moves from the SNP-
based analyses to the haplotype-based analysis. This can be down to the fact that the 
genetic variation in MDD may be driven by rare genetic variants which may be in LD 
with haplotypes and thus their effects are captured by haplotype-based models. 
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Figure 6.1. The genome-wide evidence of haplotype block association for height.  Analysis done with 
i. mixed linear model (MLM) ii. BayesR iii. SNP-based regional GREML model and iv. 
Haplotype-based regional GREML model. The points on the BayesR plot are plots of the 
posterior inclusion probability of SNPs. The points on the remaining plots are plots of -log10 
of the p-values of SNP tested for MLM analysis and regions tested for the regional GREML 
analyses. The red dashed lines are the Bonferroni-corrected genome-wide significance 
threshold and the green dashed lines are suggestive significance threshold calculated to be 
p-value < 5 × 10&m. The association hits are more enriched in the SNP-based analyses 
than in the haplotype-based analysis. This can be explained by the fact that height is a trait 
driven by a lot of common genetic variants which may be in LD with genotyped SNPs on 
SNP chips and thus SNP-based analyses should capture the effect of most of the genetic 
variants in height.      
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Figure 6.2. The genome-wide evidence of haplotype block association for Major Depressive Disorder.  
Analysis done with i. mixed linear model (MLM) ii. BayesR iii. SNP-based regional GREML 
model and iv. Haplotype-based regional GREML model. The points on the BayesR plot are 
plots of the posterior inclusion probability of SNPs. The points on the remaining plots are 
plots of -log10 of the p-values of SNP tested for MLM analysis and regions tested for the 
regional GREML analyses. The red dashed lines are the Bonferroni-corrected genome-wide 
significance threshold and the green dashed lines are suggestive significance threshold 
calculated to be p-value < 5 × 10&m. The association hits are more enriched as one moves 
from the SNP-based analyses to the haplotype-based analysis. This can be down to the fact 
that the genetic variation in MDD may be driven by rare genetic variants which may be in 
LD with haplotypes and thus their effects are captured by haplotype-based models.  
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The GBLUP results for both traits are shown in Figure 6.3. The assumption of 
GBLUP is that the effect of each genetic variant is sampled from the same normal 
distribution. Thus, the SNP effect smooths across the genome. The effect sizes of 
genetic variants in height are two orders of magnitude bigger than MDD. Height is 
highly heritable and is controlled by a lot of common genetic variants as opposed to 
MDD that has a low heritability and controlled by rare variants and this can explain 
the results observed. 
i.  
ii.  
Figure 6.3. The genome-wide plot of SNP effects for height and Major Depressive Disorder.  i. 
height ii. MDD. The effect sizes of genetic variants in height are two orders of 
magnitude bigger than MDD. 
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6.3.2 Comparison with published GWAS  
For both traits, the SNPs in the regions that were significant at both genome-
wide and suggestive p-values were compared to SNPs reported in the GWAS 
catalogue to be significant for the two traits. The GWAS catalogue was accessed on 
the 16th of July 2018. The results are presented in Table 6.2. The two models, SNP-
based and haplotype-based models, taking all SNPs within significant blocks, 
identified 1,403 and 58 SNPs respectively for height, and 87 and 663 SNPs 
respectively for MDD. 
Table 6.2. Comparison of SNPs within significant regions identified by both models and 
published GWAS results for height and MDD.  The columns are the name of the trait, 
number of SNPs in regions identified by SNP-based (Sbm) and haplotype-based 
model (Hbm) with p-value < 5 × 10&m and SNPs in published GWAS (pGWAS) for 
the traits, and the number of SNPs overlapping between the three.   
 Number of SNPs  Number of overlapping SNPs 
Trait Sbm Hbm pGWAS Sbm & Hbm Sbm & pGWAS Hbm & pGWAS 
Height 1403 58 931 0 100 0 
MDD 87 663 521 0 0 1 
 
 
6.3.3 Association test for SNPs in the genome-wide significant region identified 
by Hbm for MDD  
A SNP-based association test was performed for the region identified by the 
haplotype-based model for MDD in GS: SFHS to be genome-wide significant, p-
value < 2.04 × 10&¹. The results are shown in Table 6.3. Five SNPs within this region 
are nominally significant at p-value < 0.05.  Four out of these five SNPs confer about 
2% increased risk of the disease each. These four SNPs lie within the MYRIP gene 
sequence (Figure 6.4). The MYRIP gene is expressed in the brain (Ganat et al., 2012). 
SNPs in the MYRIP gene have been reported to be associated with brain processing 
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speed in the Lothian Birth cohort (Luciano et al., 2011), sleep duration (Gottlieb et 






Figure 6.4. LD plot of most significant region for MDD identified by the haplotype-based model in 
the GS: SFHS cohort. The SNPs within this region lie in the MYRIP gene region. The SNPs in 
the MYRIP gene sequence (bounded by blue square) are in relatively high LD. The MYRIP 
gene has reported roles in processes that can be linked to MDD.   
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Table 6.3. SNP-based association test for regions identified by Hbm for MDD to be genome-
wide significant. The columns are the regions, SNP ID, chromosome, genome 
position of SNP, minor allele frequency, odds ratio, a log of the odds ratio, standard 
error of log odds ratio and association p-value.   
SNP Information Depression Association 
SNP ID Chr Pos MAF OR Log (OR) SE (logOR) p 
rs9842160 3 39844703 0.14 0.97 -0.030 0.013 0.02 
rs9858242 3 39847606 0.19 1.02 0.025 0.011 0.03 
rs1599902 3 39954674 0.41 1.02 0.019 0.009 0.04 
rs7618607 3 39947936 0.41 1.02 0.019 0.009 0.04 
rs9860916 3 39944942 0.41 1.02 0.019 0.009 0.04 
6.3.4 Replication of GS: SFHS MDD regions identified by Hbm in UK Biobank 
Replication of the genomic regions that were identified as associated with 
MDD within the GS: SFHS by the haplotype-based model with p-value < 5 × 10&m 
was sought in the UK Biobank Leeds cohort. The results are shown in Table 6.4. One 
region located on chromosome 15 was replicated with p-value < 0.00416.      
 Discussion  
In this study, I have used a regional GREML method to perform a genome-
wide analysis of height and MDD to identify genomic regions associated with height 
and MDD. This regional GREML method differs from a previous method (Cebamanos 
et al., 2014) in two ways. First is by the way regions are defined: genomic regions in 
my analysis are not defined by a fixed number of SNPs but are naturally defined using 
recombination hotspots from a reference human genome (Genome Reference 
Consortium Human Build 37 (International Human Genome Sequencing Consortium, 
2004)). Second is that this method fits a haplotype-based GRM in a haplotype-based 
regional GREML model (Hbm).  
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Table 6.4. The replication of the genomic regions identified by the haplotype-based model 
to be associated with the GS: SFHS MDD phenotype at p-value < 5 × 10&m in UK 
Biobank.  The columns are chromosome number, region size in mega base-pairs, the 
number of SNPs typed in the region for the GS: SFHS cohort, the association p-values 
for GS: SFHS cohort, the number of SNPs typed in the region for the UK Biobank 
cohort and the association p-values for the UK Biobank cohort. 
Haplotype block GS: SFHS UK Biobank 
Chr Block size (Mb) No. SNPs  P-value No. SNPs  P-value 
3 0.174935 44 1.50E-06 34 0.5 
8 0.168933 40 2.21E-06 39 0.5 
18 0.282808 49 2.66E-06 56 0.279 
15 0.006625 6 3.50E-06 5 0.00416 
5 0.006451 4 4.34E-06 6 0.466 
2 0.025499 6 8.26E-06 10 0.5 
4 0.222993 39 1.15E-05 49 0.484 
10 0.046023 13 1.20E-05 13 0.5 
2 0.118657 45 1.50E-05 33 0.126 
22 0.474166 100 1.62E-05 132 - 
2 0.220003 32 2.31E-05 20 0.461 
15 0.028543 11 2.36E-05 15 0.349 
10 0.049176 19 2.75E-05 15 0.5 
5 0.018872 9 3.37E-05 7 - 
2 0.026776 3 3.38E-05 6 0.5 
15 0.042833 8 3.58E-05 12 0.0801 
12 0.28385 46 3.61E-05 46 0.5 
2 0.044811 12 3.99E-05 14 0.347 
1 0.327998 104 4.08E-05 85 - 
6 0.301042 24 4.46E-05 39 0.434 
2 0.338596 49 4.87E-05 67 - 
 
This study again differs from the haplotype association of MDD described by 
Howard et al. (2017) in two ways. That study set fixed haplotype windows sizes and 
used a sliding window approach to move along the genome to define haplotypes. 
And after the haplotypes are defined, they used a typical multiple regression GWAS 
to test for haplotype association with the MDD phenotype whereas I used the 
haplotypes in a regional GREML analysis. I draw comparisons with a model that fits a 
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conventional SNP-based GRM: a SNP-based regional GREML model (Sbm). I also 
compared the results obtained with the two models to those obtained with a linear 
mixed effect model (MLM), GBLUP and BayesR.   
The SNP-based regional GREML analysis identified 31 genomic regions in GS: 
SFHS cohort associated with height with p-value < 5 × 10&m out of which 14 were 
genome-wide (GW) significant, p-value < 1.02 × 10&¹ . For the MDD phenotype 
from the GS: SFHS cohort, the Sbm identified two associated regions with p-value <
5 × 10&m  of which one was GW significant. These regions harbour 1403 SNPs for 
height and 87 SNPs for MDD. Height is a highly polygenic trait with common genetic 
variants accounting for the majority of the additive genetic variation (Yang et al., 
2015). The SNP-based regional GREML model, therefore, is better suited to capture 
SNP loci in height compared to MDD which is believed to driven by rare genetic 
variants. One hundred of the SNPs identified for height by the Sbm had been 
reported by other studies to be associated with height.  
The SNP-based regional GREML analysis was able to capture a region on 
chromosome 10 that had been picked up by BayesR and MLM as being significantly 
associated with MDD. The SNP driving the association was found to lie in the CACNB2 
gene. This gene has been reported to be associated with major depressive disorder 
(Cross-Disorder Group of the Psychiatric Genomics Consortium, 2013).  
Three genomic regions were identified for height by the haplotype-based 
regional GREML model with p-value < 5 × 10&m none of which were genome-wide 
significant whereas, for MDD, the haplotype-based regional GREML model identified 
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21 regions of which one was genome-wide significant. Within these regions 
identified, there are 58 SNPs for height and 663 SNPs for MDD. The haplotype-based 
model works well for MDD because MDD is believed to be driven by rare genetic 
variants and the model can capture rare genetic variants. The haplotype model can 
capture rare variants because of the LD between rare variants (both typed and 
untyped) and the flanking markers which aggregate to form the haplotypes within 
genomic regions. 
There were no overlaps between regions identified by the haplotype-based 
model and SNP-based models (Sbm, MLM, GBLUP and BayesR) for each of the two 
traits, which again support the hypothesis that the two classes of models 
complement each other in mapping associated loci.  
The most significant region identified by the haplotype-based model for MDD 
is in the region of the MYRIP gene. Five SNPs within this region are individually 
significantly associated with MDD at the nominal level. Four of these SNPs lie within 
gene sequence of MYRIP and they each confer 2% disease risk. These nominally 
associated SNPs would have been missed by a conventional GWAS analysis because 
they will not reach genome-wide (GW) significance; although if the sample size were 
to be increased by say 10 times, then it might be possible to detect these SNPs at 
genome-wide significance level in a GWAS. Analysing the SNPs within the region as 
haplotypes, therefore, gave a greater power to detect the effect of the region at GW 
significance level with my relatively smaller sample size. This is because haplotypes 
can capture the joint effects of closely linked causal variants. Also, the haplotype-
based analysis reduces the number of association tests performed; all the regions 
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that contained just one SNP were skipped in the analysis. This reduction in tests 
performed makes it possible to apply a less stringent Bonferroni-corrected threshold 
for genome-wide significance. The haplotype-based model is, therefore, a powerful 
approach to map low effect loci in the presence of low sample size. 
The MYRIP gene identified in the GW significant region for MDD in the GS: 
SFHS cohort is expressed in the brain (Ganat et al., 2012). A SNP in this gene was 
reported to be associated with brain processing speed in the Lothian birth cohort 
(Luciano et al., 2011). Brain processing speed is an important cognitive function that 
is compromised in psychiatric illness such as schizophrenia and depression, and in 
old age. Also, a SNP in the MYRIP gene region associated with sleep duration (Gottlieb 
et al., 2007). Sleep duration outside the normal range (both short sleep and long 
sleep) has been found to be significantly associated with increased risk of depression 
(Mohan et al., 2017; Roberts and Duong, 2014; Watson et al., 2014; Zhai et al., 2015). 
The MYRIP gene is also reported to have a role in insulin secretion (Waselle et al., 
2003) and low insulin levels have been linked to depression (Greenwood et al., 2015; 
Pearson et al., 2010; Webb et al., 2017).    
I tried to replicate the 21 regions identified by the Hbm for GS: SFHS MDD 
phenotype in the UK Biobank cohort, but none of the regions was found to be 
genome-wide significant. Only one region on chromosome 15 was replicated with a 
p-value < 0.00416. The failure to replicate the regions in the UK Biobank cohort can 
be attributed to several things. First is that different SNPs may have been typed in 
the regions for the two cohorts which may generate different haplotypes, which can 
make replication of results impossible. Another reason is that the phenotype 
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ascertainment between the two cohorts was different: MDD cases in the GS: SFHS 
cohort was determined by a structured clinical interview for the diagnosis of mood 
disorders after participants had answered yes to one or more of initial screening 
questions whereas MDD cases in the UK Biobank were ascertained by participants 
answering yes to broad questions about having seen a GP or a psychiatrist for 
depression and related phenotypes. This difference in phenotype ascertainment 
introduces heterogeneity across the cohorts. And thus, the assayed regions may have 
different effects on the phenotype in each cohort. Another possibility is that the 
results obtained in the GS: SFHS cohort may be false positives, which will mean I was 
chasing shadows in the UK Biobank. However, the region identified by Hbm to be GW 
significant for MDD in the GS: SFHS cohort contained a gene which has SNPs reported 
to be associated with processes that can be linked to depression. This prior evidence 
increases support for the notion that the GS: SFHS results are real effects, but this is 
not conclusive. Again, maybe there was limited power to replicate the GS: SFHS 
results in the UK Biobank Leeds cohort. 
In conclusion, I have shown for the two phenotypes analysed for the GS: SFHS 
cohort that the haplotype-based regional GREML model picks regions of the genome 
that explain genetic variance that is missed by the conventional SNP-based models. 
The haplotype approach analyses combinations of alleles instead of genotypes, and 
thus has greater power to detect regions for which the causative variant(s) is well 
tagged by a given haplotype or a few haplotypes. The haplotype method identified a 
novel risk region for MDD in the GS: SFHS cohort. This discovery was supported by a 
SNP-based associations test of the region that showed that four SNPs within the 
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region each had a risk allele that increases the risk of disease by 2% above the 
background risk. These SNPs lie in the MYRIP gene which has been shown to play a 
role in processes that affect depression. The results were not replicated in a UK 
Biobank subpopulation cohort possibly because of phenotype heterogeneity and 
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7 General Discussion 
The development of efficient ways to estimate the genetic contribution to the 
phenotypic variation is critical to the genetic study of complex traits. This is because 
biased or inaccurate estimates will undermine the efforts aimed at unravelling the 
genetic contribution to the phenotypic variation. Therefore, in this thesis, my aim 
was to focus on the models used in the genome-wide association (GWA) study of 
complex human traits; investigating the performance of existing models and 
developing new methods to estimate genetic variance and map genomic loci 
associated with complex traits. Consequently, I have shown that normalisation of 
phenotype data helps minimise violations of GWA model assumptions and improves 
genetic associations. I have also presented the case for the use of a Bayesian mixture 
model in the GWA analysis of complex traits and shown that this Bayesian model 
does better than GBLUP in capturing genomic loci with effect especially for traits that 
are driven by a few large genomic loci. I then went on to show that utilizing 
haplotypes in a regional GREML setting can uncover components of the genetic 
variance that are missed by conventional GWAS. 
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In this final chapter, I revisit the main findings of this PhD project and situate 
them in the wider research context: discussing the relevance of these findings and 
shedding light on some of the limitations of the study. I also make some suggestions 
for future work.   
To investigate the impact of violation of GWA analysis model assumptions, I 
used a linear mixed model to perform a genome-wide association analysis of 
concentrations of eight urine electrolytes measured in 2,934 participants from the 
Generation Scotland: Scottish Family Health Study. The association analysis was 
performed on the residuals obtained after regressing normal-transformed and 
untransformed trait values on covariates. The traits were transformed prior to 
correcting for the covariates and not after, as normalizing corrected residuals can 
reintroduce the linear relationship between traits and covariates (Pain et al., 2018) 
and increase type I errors. The results showed that normal transformation improved 
evidence of SNP associations in most traits. The reason for this can be that 
transformation minimizes the violation of model assumptions which then improves 
the results from the analyses by minimizing the chances of committing either Type I 
or II errors (Osborne, 2010). The magnitude of the effect sizes of SNPs in the 
transformed data were, however, smaller compared to the untransformed data. This 
was the case because by transforming data, the nature of the relationship between 
the phenotypes and the genetic variants changes which can change the effect sizes 
in either direction, up or down as was in this case. I found that the significantly 
associated SNPs for these traits lie within regions of the genome that have genes 
nearby some of which have reported roles in processes or phenotypes relating to 
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kidney disease and function. It would have been great to explore these genes to 
understand their roles in the context of kidney disease development, but this was 
beyond the remit of this research and also because the heritability estimates from 
these traits were small to modest. There have been very scant GWAS reports on 
these traits which makes it difficult to assess my findings, but that makes these 
findings uniquely important, in terms of expanding the GWAS catalogue. 
The simulation study in chapter three suggests that BayesR (Erbe et al., 2012) 
is a good analytical tool for studying the genetic architecture of complex traits. This 
was further confirmed in chapter four where I applied the BayesR model to the urine 
phenotypes from the GS: SFHS. The model was able to unearth the underlying genetic 
architecture of these traits. The model has been shown to work not only in 
continuous traits but also in binary traits (Moser et al., 2015). The method gives an 
estimate of the number of loci affecting a trait and the proportion of the additive 
genetic variance they explain which potentially becomes useful to the efforts of 
trying to dissect the genetic architecture of complex traits. Using a simulation study, 
I explored the BayesR model in detail and drew comparisons with the GBLUP model 
(VanRaden, 2008). The results showed that the two models, BayesR and GBLUP give 
good estimates of the heritability of traits. The BayesR model, however, was better 
than GBLUP in capturing simulated effect SNPs. The GBLUP model assumes a normal 
distribution with a common variance for sampling the allelic substitutions effect for 
all marker loci. So, for any given locus, the GBLUP model does not have any prior on 
how big the locus effect is. The model does not differentiate between the marker 
loci: the fact that some may have a large effect, and some may be explaining a small 
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effect. This is because the GBLUP model primarily assumes traits are controlled by 
polygenes, i.e. many genes with each gene having a small effect on the trait. What 
happens then if a trait is affected by major genes? Because there is evidence from 
linkage studies that some human complex traits may be mainly driven by major genes 
with large effects; examples are given in some obesity-related traits (Comuzzie et al., 
1997; Hager et al., 1998), type 2 diabetes (Duggirala et al., 1999; Grant et al., 2006; 
Reynisdottir et al., 2003) and BMI (Luke et al., 2003; Moslehi et al., 2003). Which is 
why one goes towards a Bayesian model that allows the modelling of genetic variants 
with large effect. So, instead of assuming that all loci are expected to explain the 
same variance, one assumes that traits should have for example 90% of the loci 
explaining a small variance and 10% explaining a large variance. Based on this 
assumption then one can start to generalise and suggest that the distribution of the 
variances associated with marker loci is maybe an inverse chi-square as in Bayes B 
(Meuwissen et al., 2001), so there is a small proportion of marker loci that explains a 
large effect and most of the loci explain only very small effects. What is being done 
here is really just exploring the distribution of the SNP effects. That is instead of 
having a normal distribution for sampling SNP effects (as in GBLUP), other 
distributions that allow a much greater probability that some markers will have a 
much larger effect than others are used. In so doing, you are changing the possibility 
of finding SNPs with large effects. The Bayesian mixture model used in this thesis, 
BayesR, is built on the same idea. The model allows one to model the effect of SNPs 
as coming from four normal distributions instead of one: i.e. model a group of loci 
from a distribution with no effect on the trait, then another group that individually 
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have a small effect from a distribution with a small variance, then another group from 
a distribution with moderate variance and then another group still with bigger 
variance and so on. The BayesR model will, therefore, be better at modelling a 
genetic architecture with loci of different effect sizes than GBLUP as was shown in 
the simulation study in chapter three. The BayesR model is also well suited for 
dissecting the genetic architecture of complex traits. This is because the model allows 
the estimation of the number of loci affecting trait variation, their contribution to the 
additive genetic variance, and give the distribution of allelic effects.  
The accuracy of prediction obtained in chapter three, however, would 
suggest that GBLUP performs better at predicting phenotypes than BayesR. This 
result differs from those reported by Moser et al. (2015) who reported comparatively 
higher BayesR accuracies than GBLUP. The reason for this can be ascribed to the close 
family relationship structures in my dataset. About a third of the individuals used in 
my analysis had close relatives in the dataset, thus the random assignment of 
individuals to the training and validation set makes it possible that some of the 
individuals in the testing set will be related to individuals in the training set. The 
accuracy of prediction depends on the SNPs that are in LD with causal loci and on 
SNPs that capture the relationship structure between the individuals in the training 
and validation dataset (Habier and Fernando, 2013; Habier et al., 2008). Therefore, 
the availability of lots of closely related individuals in the dataset is bound to improve 
prediction accuracy if the model can capture these relationships. Between the two 
models, GBLUP is more effective in capturing genetic relationships because it fits all 
markers into the prediction model whereas BayesR fits markers sampled to have an 
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effect on the trait. So, in the case of GBLUP, the SNPs that don’t contribute anything 
to the trait variance will still contribute towards estimating the relationships and thus 
will contribute something towards prediction. So, in datasets with lots of close 
relationships, GBLUP will mostly perform better than BayesR. Bermingham et al. 
(2015) similarly reported slightly higher accuracies for GBLUP than a Bayesian model 
(Bayes C) in participants of the Orkney Complex Disease Study (ORCADES) (McQuillan 
et al., 2008). If pairwise relationships were very distant, GBLUP will never do that well 
because the model smooths SNP effects across the genome. Whereas for the BayesR 
approach, the model picks out SNPs that really have effects and predicts based on 
those SNPs. So, for BayesR, relationships between individuals don’t really matter as 
long as the effect SNPs that explain a large enough proportion of the genetic variance 
are identified and used in the prediction. The BayesR model on average picked 
between 3,000 and 7,000 SNPs to have an effect on simulated traits. Although in 
reality it correctly mapped on average between 50 and 200 of the 5,520 SNPs that 
were simulated to have an effect on the traits. The 20 large effect loci were however 
effectively mapped in the traits with moderate and higher heritability. The prediction 
accuracies obtained with the BayesR model will be largely driven by these large effect 
loci. In livestock populations, every individual is related to every other (Groeneveld 
et al., 2010) or at least everyone has a relative in the data, and thus GBLUP works 
very well. But the GBLUP model may not work very well going to human populations 
where relationships are less because it requires related individuals at some level. 
Whereas a Bayesian model potentially may have an advantage there because it 
Investigating the genetic control of complex traits 
General Discussion   188 
 
identifies SNP effects and puts weights on big SNP effects and does prediction with 
them.  
The BayesR accuracies obtained in chapter three were between 41% and 46% 
of the theoretical maximum attainable for these simulated traits which is good for 
this size of training dataset (about 2,000 individuals). So, the argument again would 
be to get more data. This is because when you get a lot of data, the training set is 
then more powerful at differentiating between the models because you’ve got more 
information which can be incorporated into the prediction. Fitting a normal 
distribution, a Laplace distribution, an inverse chi-square distribution or four normal 
distributions etc. would not do very much. Because by the time you get enough data 
to estimate SNP effects quite reliably, you are not doing very much regression back 
on the marker effects, i.e. you have got enough data, you are getting quite confident 
in your estimation of SNP effect and there isn’t much regression back towards the 
mean. Therefore, the influence of the prior distribution gets smaller when you have 
big data. So, yes, some analytical methods will have better power than others in 
capturing variants associated with complex traits because as I have shown different 
models are needed to accommodate different trait architectures but increasing the 
sample size will continue to be the best strategy in the effort to dissect the genetic 
architecture of complex traits. That is why I increased the data size to include about 
20,000 individuals in the analysis in the next chapters of the thesis. 
Following the Bayesian analysis of complex traits, I moved on to perform a 
regional GREML analysis that analysed the genome in haplotype blocks bounded by 
recombination hotspots. This analysis method draws strongly on the work of Shirali 
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et al. (2018) who performed a similar analysis on other human traits. This study 
differs from the work of Shirali et al. (2018) by the way phenotypes are simulated, 
which expands on the work done previously. The method is grounded on the 
hypothesis that analysing haplotypes can capture portions of the genetic variance 
that may be missed by conventional SNP-based analysis. Thus, the haplotype-based 
method will be complementary to existing GWA analysis methods. I confirmed this 
hypothesis in a simulation study that analysed 20 replicates of two types of 
phenotypes in which SNPs are simulated to have an effect and three types of 
phenotypes in which haplotypes are simulated to have an effect.       
The haplotype-based method, however, struggled to accurately capture the 
marker effect in regions with very long haplotypes. I tried to resolve this by breaking 
up these long haplotypes, but this resulted in reduced test statistics. I, therefore, 
recommend the use of a lower recombination rate threshold instead of artificially 
breaking up the haplotypes in such regions with long haplotypes to alleviate this 
issue. One other possibility to consider for this haplotype method is that the 
documented recombination hotspots from the Reference Consortium Human Build 
37 (International Human Genome Sequencing Consortium, 2004) that are used may 
not reflect the actual recombination hotspots in the population analysed. Therefore, 
it is possible that the hotspot boundaries used are inaccurate which then can 
negatively impact on the method and make it less effective especially in the analysis 
of real phenotypes. This was, however, found not to be a major problem when the 
method was implemented in chapter six to analyse real phenotype data from GS: 
SFHS. The haplotype boundaries defined in the GS: SFHS cohort using the 
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recombination hotspots from the reference genome worked fine and a novel locus 
was mapped for MDD. This locus harbours a gene which has reported functions in 
processes that are linked to MDD. 
In chapter six of the thesis, I discussed the main arguments that concern the 
issue of genome-wide association (GWA) studies of MDD not being successful in 
identifying genetic variants that are associated with MDD at genome-wide 
significance level. I then presented the argument that GWA studies of MDD that 
utilizes haplotypes can offer some solution to the problem. Although a couple of 
studies (Howard et al., 2017; Zeng et al., 2017a) have highlighted the importance of 
using haplotypes in GWA study of MDD, there has not been a strong focus on 
employing haplotypes in MDD GWA research. As such, I used chapter six to provide 
further insights into the use of haplotypes as one of the ways forward in uncovering 
associated genetic variants for MDD. The haplotype-based regional GREML analysis 
of MDD phenotype from the GS: SFHS cohort identified a novel risk region for MDD. 
Four SNPs within this region were found to confer about 2% risk of the disease each 
in a SNP-based associations test. These SNPs were found to lie in the sequence of the 
MYRIP gene which has reported roles in processes that affect depression. However, 
I failed to replicate the results in the UK Biobank Leeds cohort. One reason for this 
can be differences in phenotype ascertainment which introduces heterogeneity 
across the two cohorts. Another reason can be that the two cohorts have different 
LD structures arising from different recombination hotspots which possibly means 
they have different haplotype structures. The second reason may not be strong 
enough considering the two cohorts share the same ancestral population. Perhaps 
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another possibility for the failure to replicate the finding is that it may be a false 
positive. But in any case, one way forward is to perform a haplotype-based regional 
GREML analysis of the full genome of the full UK Biobank cohort. After which a meta-
analysis of significant regions between the UK Biobank and GS: SFHS cohorts can be 
performed. Meta-analysis of MDD has been shown to work by Wray et al. (2018) who 
identified 44 independent loci significantly associated with MDD in a GWA meta-
analysis of MDD. This, therefore, warrants a further investigation of the method 
through a meta-analysis of regions between the two cohorts.    
 Conclusion and future considerations      
In conclusion, the genome-wide association (GWA) studies have provided a 
great deal of insight into questions that bear on the genetic control of complex traits. 
This thesis has explored the underlying assumptions of some of the analytical 
approaches used in the GWA analysis of complex traits and offered novel insights 
into how to incorporate other genetic variants like haplotypes in the GWA study of 
complex traits.  
There are additional things to consider beyond what is presented in this thesis 
to support the effort to disentangle the genetic underpinning of complex traits. One 
key thing to be considered for future research is an investigation of how much 
information is lost when phenotype data is transformed. Pain et al. (2018) have 
already led this effort using simulation and real data to explore what happens to the 
phenotype – covariates relationship when phenotype data is transformed. There is 
still some work to be done in terms of investigating how transformation impacts 
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effect sizes, and whether it can increase false positives and so on. One way to do this 
is, perhaps, to simulate phenotypes with SNP effect sizes sampled from a non-normal 
distribution and investigate how much information is lost through normalisation. In 
addition to this, one can investigate the effect of normalisation on simulated 
phenotypes in which the environmental effects are sampled from a non-normal 
distribution. There are several possibilities in terms of the type of distribution the 
effects are sampled from and also what type of effect to simulate; whether additive, 
dominant or recessive, espistatic or a combination of all four.     
For the BayesR model, fitting a mixture of four normal distributions for 
sampling the effects of SNPs on all traits can be deemed overly simplistic. Thus, 
further research that tries to work out the best way to fit an ideal number of 
distributions for different types of traits will improve upon the model.   
Additionally, the haplotype regional GREML method in its current state, 
although shown to be useful in this thesis and by others (Shirali et al., 2018), still 
needs further improvement to make its use more appealing. It is currently 
computationally intensive which can make it particularly painful to use. I attempted 
to apply the method to the full set of participants in the UK Biobank cohort but that 
was fraught with several computing challenges. The most challenging limiting factors 
were RAM and CPU requirements. The regional GREML model involves the use of 
GRMs that get larger with increasing sample size. The RAM requirement for 
calculating these matrices increases by a factor of !% where ! is the sample size. So, 
when the sample size doubles, the RAM requirement for calculating the GRMs 
quadruples and this immediately became a problem for me. Because moving from 
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my sample size of about 20,000 individuals in the GS: SFHS to the UK Biobank sample 
size of 500,000 individuals, increased !  by 25 times. This increased the RAM 
requirement by 625 times. Similarly, the computational power requirements for the 
GREML analysis of one region grow by !. So, again the number of processor cores 
required to analyse one region in the full UK Biobank cohort increased by more than 
15,625 times compared to the GS: SFHS data. And I had over 30,000 genomic regions 
to analyse, which brings additional problems of compute cost in pounds sterling and 
also compute time, which basically meant I couldn’t do it in the time scale of my PhD. 
This is because on average, the GS: SFHS analyses required about an hour and a half 
of computational time to analyse one genomic region on four CPU cores with 8Gib of 
RAM per core (32Gib RAM total). This essentially means that for 30,000 genomic 
regions, the total compute time required was about 45,000 CPU hours per model 
(two models) for each phenotype (two phenotypes). And scaling this up to analyse 
the whole of the UK Biobank data will require at least 15,625 CPU cores with more 
than 20,000Gib of RAM in total, which simply becomes intractable for a PhD. So, 
although I have argued that it is good to have a large sample size because you get a 
significant boost in power to detect effects, fine mapping efforts like the haplotype 
regional GREML analysis can easily become intractable in large samples. The method 
has been shown in this thesis to be good for mapping novel genetic loci. However, 
there is not yet a practical way of implementing this kind of analysis on such large 
cohorts as the UK Biobank. It is still possible all the same, just that it will require highly 
skilled computer programmers with proficient knowledge in high performance 
computing structure and parallelisation to make this possible. Therefore, 
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collaborative research efforts with people in computer science and engineering 
should be pushed in the future.     
Finally, another thing that should be worthy of consideration in future 
research efforts into this method is to investigate how other types of data such as 
exome sequence and whole genome sequence data can be incorporated in the 
analysis. With the plummeting costs of whole genome resequencing, research focus 
in GWA studies is already shifting towards sequence data analysis. Although whole-
genome sequence data analysis would allow the incorporation of all the genetic 
variants that drive the phenotypic variation, there may still be some variants whose 
individual effects may be too small to be picked up in a conventional GWA analysis. 
However, regionally analysing sequence information can help overcome this because 
multiple small effect variants in a region can add up to a substantial regional effect 
which can be captured by a regional SNP GRM or tagged by a haplotype. Haplotypes 
can tag sequence information well and thus this method which can utilize haplotype 
information offers a lot of promise in the coming days. 
 
 











“Without data, you're just another person with an opinion.”  
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